TOKEN	PREDICTED
The	O
reported	O
adherence	O
rates	O
to	O
folic	O
acid	O
intake	O
in	O
other	O
countries	O
vary	O
depending	O
on	O
concomitant	O
recommendations	O
for	O
cereal	O
fortification	O
and	O
on	O
the	O
period	O
analysed	O
–	O
pre	O
-	O
or	O
peri	O
-	O
conception	O
.	O

There	O
are	O
some	O
differences	O
in	O
the	O
management	O
of	O
the	O
two	O
most	O
important	O
histotypes	O
:	O
DTC	O
(	O
differentiated	O
thyroid	O
cancer	O
:	O
follicular	O
and	O
papillary	O
cancer	O
)	O
and	O
MTC	O
(	O
medullary	O
thyroid	O
cancer	O
)	O
just	O
as	O
for	O
non	O
-	O
pregnant	O
patients	O
[	O
Boxes	O
1	O
-	O
2	O
].	O

A	O
detailed	O
description	O
of	O
the	O
follow	O
-	O
up	O
study	O
and	O
exposure	O
assessment	O
has	O
been	O
described	O
elsewhere	O
[	O
21	O
].	O

Ayas	O
et	O
al	O
,	O
in	O
their	O
study	O
of	O
70	O
,	O
026	O
US	O
nurses	O
,	O
followed	O
for	O
10	O
years	O
,	O
reported	O
that	O
individuals	O
who	O
slept	O
≤	O
5	O
hours	O
per	O
night	O
had	O
a	O
significantly	O
higher	O
risk	O
of	O
symptomatic	O
incident	O
diabetes	O
(	O
OR	O
=	O
1	O
.	O
34	O
;	O
95	O
%	O
CI	O
1	O
.	O
04	O
-	O
1	O
.	O
72	O
)	O
[	O
4	O
].	O

In	O
addition	O
,	O
authors	O
emphasize	O
importance	O
of	O
survival	O
and	O
health	O
of	O
cows	O
and	O
calves	O
and	O
of	O
subsequent	O
reproductive	O
performance	O
of	O
cows	O
for	O
relative	O
contribution	O
of	O
fetal	O
programming	O
to	O
the	O
profitability	O
of	O
beef	O
production	O
systems	O
when	O
developmental	O
programming	O
is	O
applied	O
[	O
33	O
].	O

The	O
remaining	O
piglets	O
were	O
cross	O
-	O
fostered	O
to	O
non	O
-	O
experimental	O
sows	O
of	O
2ndto	O
4thparities	O
,	O
which	O
were	O
on	O
the	O
AP	O
diet	O
during	O
gestation	O
.	O

Both	O
MS	O
and	O
IMF	O
contents	O
increased	O
with	O
increasing	O
slaughter	O
age	O
(	O
2	O
,	O
4	O
,	O
6	O
,	O
12	O
,	O
and	O
24	O
months	O
)	O
in	O
bulls	O
of	O
German	O
Angus	O
,	O
Galloway	O
,	O
and	O
Holstein	O
-	O
Friesian	O
breeds	O
[	O
24	O
].	O

To	O
our	O
knowledge	O
,	O
ours	O
is	O
one	O
of	O
the	O
first	O
studies	O
to	O
find	O
associations	O
between	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
loss	O
.	O

Therefore	O
,	O
the	O
participants	O
’	O
honesty	O
was	O
one	O
of	O
this	O
research	O
limits	O
.	O

Although	O
no	O
causality	O
was	O
found	O
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

First	O
Lamarck	O
,	O
and	O
then	O
Waddington	O
,	O
suggested	O
that	O
alternative	O
mechanisms	O
,	O
now	O
termed	O
epigenetics	O
,	O
must	O
also	O
contribute	O
to	O
phenotypic	O
outcomes	O
(	O
Noble2006	O
).	O

All	O
rights	O
reserved	O
PubMed	O
Central	O
:	O

(%)	O
<	O
25	O
normal	O
weight13	O
381	O
(	O
73	O
)	O
10	O
030	O
(	O
70	O
)	O
506	O
(	O
62	O
)	O
25	O
-	O
29	O
.	O
9	O
overweight3	O
697	O
(	O
20	O
)	O
3005	O
(	O
21	O
)	O
198	O
(	O
24	O
)	O
≥	O
30	O
obese770	O
(	O
4	O
)	O
857	O
(	O
6	O
)	O
71	O
(	O
9	O
)	O
missing563	O
(	O
3	O
)	O
503	O
(	O
3	O
)	O
42	O
(	O
5	O
)	O
Education	O
,	O
No	O
.	O

Nutritional	O
education	O
is	O
considered	O
an	O
important	O
tool	O
for	O
promoting	O
a	O
healthy	O
lifestyle	O
,	O
but	O
has	O
not	O
been	O
studied	O
as	O
a	O
determinant	O
for	O
maternal	O
use	O
of	O
supplements	O
during	O
pregnancy	O
,	O
especially	O
in	O
Romania	O
,	O
where	O
evidence	O
about	O
pregnancy	O
and	O
nutrition	O
is	O
scarce	O
.	O

This	O
study	O
is	O
therefore	O
designed	O
to	O
investigate	O
pregnant	O
women	O
'	O
s	O
perception	O
of	O
quality	O
of	O
ANC	O
services	O
rendered	O
in	O
health	O
facilities	O
within	O
the	O
Buea	O
Health	O
District	O
area	O
.	O

The	O
male	O
pups	O
were	O
weaned	O
on	O
postnatal	O
day	O
21	O
and	O
housed	O
in	O
groups	O
of	O
3	O
–	O
6	O
.	O

Mothers	O
are	O
asked	O
how	O
soon	O
after	O
birth	O
the	O
infant	O
was	O
breastfed	O
,	O
if	O
the	O
infant	O
is	O
currently	O
being	O
breastfed	O
and	O
if	O
not	O
,	O
the	O
duration	O
of	O
breastfeeding	O
.	O

Priority	O
was	O
given	O
to	O
papers	O
that	O
presented	O
original	O
data	O
rather	O
than	O
reviews	O
or	O
meta	O
-	O
analyses	O
.	O

Vitamin	O
D	O
levels	O
in	O
an	O
Australian	O
and	O
New	O
Zealand	O
cohort	O
and	O
the	O
association	O
with	O
pregnancy	O
outcome	O
Abstract	O
Background	O
Pregnant	O
women	O
are	O
at	O
increased	O
susceptibility	O
to	O
vitamin	O
D	O
deficiency	O
.	O

Moreover	O
,	O
the	O
usual	O
recommendations	O
to	O
avoid	O
sun	O
exposure	O
reduces	O
dermal	O
synthesis	O
of	O
vitamin	O
D3Although	O
vitamin	O
D	O
is	O
undoubtedly	O
important	O
for	O
foetal	O
bone	O
development	O
,	O
we	O
know	O
that	O
it	O
plays	O
a	O
much	O
wider	O
role	O
in	O
health	O
and	O
disease	O
prevention	O
.	O

It	O
is	O
important	O
to	O
pay	O
attention	O
to	O
Vitamin	O
D	O
nutritional	O
status	O
in	O
GDM	O
pregnancy	O
nutrition	O
management	O
.	O

Among	O
all	O
the	O
predicted	O
miRNAs	O
,	O
4	O
miRNAs	O
targeting	O
GR	O
were	O
quantitated	O
by	O
real	O
-	O
time	O
PCR	O
and	O
miRNA	O
-	O
124a	O
,	O
which	O
has	O
been	O
identified	O
to	O
target	O
GR	O
3	O
′	O
UTR	O
[	O
2	O
],[	O
3	O
],	O
was	O
more	O
highly	O
expressed	O
in	O
betaine	O
-	O
exposed	O
neonatal	O
livers	O
.	O

[	O
5	O
]	O
The	O
above	O
observations	O
highlight	O
the	O
fact	O
that	O
vitamin	O
D	O
has	O
a	O
key	O
role	O
to	O
play	O
in	O
the	O
pathogenesis	O
of	O
wheezing	O
/	O
asthma	O
.	O

The	O
mean	O
age	O
of	O
women	O
was	O
similar	O
in	O
all	O
three	O
regions	O
.	O

We	O
also	O
searched	O
for	O
unpublished	O
studies	O
,	O
PhD	O
dissertations	O
,	O
internal	O
reports	O
,	O
and	O
conference	O
proceedings	O
/	O
abstracts	O
.	O

New	O
drugs	O
with	O
anti	O
-	O
angiogenetic	O
,	O
anti	O
-	O
tyrosine	O
kinase	O
and	O
anti	O
-	O
VEGF	O
effects	O
are	O
currently	O
under	O
observation	O
.	O

Table	O
1	O
shows	O
the	O
demographics	O
and	O
clinical	O
characteristics	O
of	O
the	O
133	O
children	O
participants	O
in	O
this	O
study	O
with	O
measurement	O
of	O
circulating	O
cathelicidin	O
.	O

Using	O
the	O
Institute	O
of	O
Medicine	O
’	O
s	O
definition	O
of	O
sufficiency	O
(	O
total	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
≥	O
20	O
ng	O
/	O
mL	O
(	O
50	O
nmol	O
/	O
L	O
)	O
[	O
25	O
],	O
the	O
cohort	O
also	O
was	O
divided	O
into	O
two	O
groups	O
based	O
on	O
child	O
’	O
s	O
current	O
vitamin	O
D	O
status	O
,	O
with	O
those	O
with	O
25	O
(	O
OH	O
)	O
D	O
concentrations	O
<	O
20	O
ng	O
/	O
mL	O
(	O
50	O
.	O
0	O
nmol	O
/	O
L	O
)	O
defined	O
as	O
deficient	O
.	O

The	O
strengths	O
of	O
this	O
study	O
include	O
the	O
large	O
sample	O
size	O
,	O
population	O
-	O
based	O
ascertainment	O
of	O
placenta	O
samples	O
,	O
quantitative	O
assessment	O
of	O
LINE	O
-	O
1	O
and	O
AluYb8	O
methylation	O
,	O
and	O
the	O
use	O
of	O
a	O
well	O
-	O
established	O
,	O
high	O
-	O
density	O
methylation	O
array	O
for	O
methylation	O
profiling	O
.	O

[	O
13	O
]	O
and	O
Kruavit	O
et	O
al	O
.	O

DNA	O
is	O
methylated	O
by	O
a	O
family	O
of	O
DNA	O
methyltransferases	O
(	O
DNMTs	O
)	O
(	O
Bestor	O
&	O
Ingram1983	O
;	O
Li	O
et	O
al	O
.	O
1992	O
,	O
1996	O
;	O
Okano	O
et	O
al	O
.	O
1998	O
,	O
1999	O
;	O
Aapola	O
et	O
al	O
.	O
2000	O
;	O
Gowher	O
et	O
al	O
.	O
2005	O
).	O

Each	O
child	O
’	O
s	O
cathelicidin	O
concentration	O
also	O
was	O
compared	O
to	O
the	O
frequency	O
of	O
infections	O
each	O
child	O
had	O
diagnosed	O
within	O
the	O
last	O
year	O
,	O
and	O
to	O
the	O
age	O
of	O
the	O
child	O
.	O

Compared	O
with	O
women	O
who	O
did	O
not	O
snore	O
during	O
pregnancy	O
,	O
the	O
adjusted	O
mean	O
1	O
-	O
hour	O
glucose	O
concentrations	O
were	O
noted	O
to	O
be	O
6	O
.	O
4	O
mg	O
/	O
dl	O
higher	O
among	O
those	O
women	O
who	O
snored	O
during	O
pregnancy	O
(	O
β	O
=	O
6	O
.	O
4	O
mg	O
/	O
dl	O
,	O
95	O
%	O
CI	O
0	O
.	O
32	O
-	O
12	O
.	O
5	O
,	O
p	O
=	O
0	O
.	O
04	O
).	O

In	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
,	O
we	O
identified	O
three	O
clusters	O
that	O
differed	O
slightly	O
from	O
vaginally	O
delivered	O
infants	O
,	O
which	O
were	O
characterized	O
by	O
a	O
high	O
abundance	O
of	O
Bifidobacterium	O
,	O
high	O
Clostridium	O
and	O
low	O
Streptococcus	O
and	O
Ruminococcus	O
genera	O
,	O
and	O
high	O
abundance	O
of	O
the	O
family	O
Enterobacteriaceae	O
.	O

Not	O
really	O
a	O
vitamin	O
,	O
D3is	O
a	O
pro	O
-	O
prehormone	O
made	O
in	O
the	O
skin	O
in	O
response	O
to	O
ultraviolet	O
-	O
B	O
light	O
exposure	O
.	O

Alarmingly	O
,	O
in	O
the	O
birth	O
cohort	O
study	O
from	O
the	O
Isle	O
of	O
Wight	O
,	O
about	O
43	O
%	O
of	O
children	O
had	O
been	O
exposed	O
to	O
environmental	O
tobacco	O
smoke	O
during	O
their	O
first	O
year	O
of	O
life	O
[	O
38	O
].	O

Folate	O
Status	O
Both	O
brain	O
(	O
Figure	O
6a	O
)	O
and	O
plasma	O
(	O
Figure	O
6b	O
)	O
folate	O
levels	O
were	O
unaffected	O
by	O
the	O
diets	O
of	O
the	O
dams	O
but	O
were	O
elevated	O
by	O
the	O
high	O
multivitamin	O
or	O
high	O
folate	O
pup	O
diet	O
.	O

The	O
ROLO	O
trial	O
evaluated	O
the	O
effect	O
of	O
a	O
low	O
glycaemic	O
index	O
diet	O
among	O
women	O
who	O
had	O
previously	O
given	O
birth	O
to	O
an	O
infant	O
with	O
weight	O
above	O
4	O
kg	O
[	O
16	O
].	O

[	O
20	O
]	O
and	O
Oken	O
et	O
al	O
.	O

The	O
delivery	O
mode	O
was	O
drawn	O
from	O
maternal	O
delivery	O
records	O
,	O
and	O
maternal	O
pre	O
-	O
pregnancy	O
height	O
,	O
weight	O
,	O
and	O
parity	O
were	O
determined	O
via	O
a	O
self	O
-	O
administered	O
questionnaire	O
upon	O
study	O
entry	O
and	O
used	O
to	O
compute	O
pre	O
-	O
pregnancy	O
BMI	O
.	O

On	O
the	O
other	O
hand	O
,	O
these	O
outcomes	O
also	O
were	O
twice	O
as	O
common	O
among	O
children	O
whose	O
mothers	O
worked	O
at	O
an	O
electronics	O
assembly	O
plant	O
as	O
in	O
other	O
children	O
.	O
37	O
Animal	O
studies	O
suggest	O
potential	O
reproductive	O
implications	O
of	O
exposure	O
.	O

In	O
other	O
words	O
,	O
the	O
respective	O
growth	O
of	O
the	O
BAT	O
and	O
WAT	O
depots	O
depends	O
on	O
the	O
maternal	O
diet	O
during	O
gestation	O
and	O
it	O
may	O
be	O
responsible	O
for	O
the	O
development	O
of	O
obesity	O
,	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
in	O
the	O
offspring	O
,	O
later	O
in	O
life	O
(	O
Symonds	O
et	O
al	O
.,	O
2012	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Maternal	O
mean	O
1	O
-	O
hour	O
plasma	O
glucose	O
concentrations	O
after	O
a	O
50	O
-	O
g	O
oral	O
glucose	O
challenge	O
.	O

Results	O
18	O
411	O
women	O
were	O
classified	O
as	O
having	O
a	O
low	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
,	O
14	O
395	O
as	O
middle	O
and	O
817	O
as	O
having	O
a	O
high	O
level	O
.	O

For	O
fatty	O
fish	O
(	O
herring	O
/	O
mackerel	O
,	O
salmon	O
-	O
type	O
fish	O
),	O
the	O
strongest	O
inverse	O
association	O
was	O
found	O
for	O
an	O
intermediate	O
intake	O
(	O
RR	O
:	O
0	O
.	O
81	O
,	O
95	O
%	O
CI	O
,	O
0	O
.	O
66	O
-	O
0	O
.	O
98	O
),	O
whereas	O
a	O
high	O
intake	O
of	O
fatty	O
fish	O
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
RR	O
:	O
1	O
.	O
90	O
,	O
95	O
%	O
CI	O
,	O
1	O
.	O
34	O
-	O
2	O
.	O
70	O
).	O

2007	O
).	O

Because	O
of	O
notable	O
differences	O
in	O
vitamin	O
D	O
concentrations	O
between	O
African	O
Americans	O
and	O
Whites	O
,	O
analyses	O
were	O
stratified	O
by	O
race	O
.	O

As	O
shown	O
in	O
Table	O
1	O
,	O
the	O
age	O
was	O
33	O
.	O
4	O
±	O
4	O
.	O
1	O
years	O
old	O
(	O
ranges	O
from	O
24	O
to	O
46	O
years	O
old	O
),	O
the	O
gestational	O
weeks	O
were	O
29	O
.	O
0	O
±	O
3	O
.	O
3	O
weeks	O
(	O
ranges	O
from	O
14	O
to	O
39	O
weeks	O
),	O
pre	O
-	O
pregnancy	O
BMI	O
was	O
23	O
.	O
0	O
±	O
3	O
.	O
7	O
(	O
ranges	O
from	O
15	O
.	O
6	O
to	O
37	O
.	O
2	O
)	O
kg	O
/	O
m2	O
.	O

Interactions	O
between	O
time	O
and	O
sex	O
[	O
F	O
(	O
3	O
,	O
71	O
)=	O
34	O
.	O
005	O
,	O
P	O
<	O
0	O
.	O
01	O
],	O
and	O
diet	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
4	O
.	O
58	O
,	O
P	O
<	O
0	O
.	O
05	O
]	O
were	O
found	O
.	O

Then	O
,	O
they	O
were	O
provided	O
with	O
two	O
small	O
cans	O
containing	O
both	O
types	O
of	O
food	O
that	O
were	O
previously	O
weighed	O
.	O

All	O
the	O
investigators	O
will	O
have	O
the	O
right	O
to	O
analyse	O
and	O
publish	O
data	O
.	O

Concerning	O
to	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
during	O
the	O
post	O
-	O
weaning	O
period	O
(	O
Figure2D	O
),	O
we	O
found	O
a	O
main	O
effect	O
of	O
time	O
[	O
F	O
(	O
15	O
,	O
59	O
)=	O
1712	O
.	O
38	O
,	O
P	O
<	O
0	O
.	O
001	O
]	O
and	O
sex	O
[	O
F	O
(	O
1	O
,	O
73	O
)=	O
30	O
.	O
20	O
,	O
P	O
<	O
0	O
.	O
001	O
].	O

In	O
addition	O
,	O
nutritional	O
restriction	O
during	O
early	O
and	O
mid	O
gestation	O
reduced	O
ovarian	O
characteristics	O
(	O
wet	O
ovary	O
weight	O
,	O
luteal	O
tissue	O
weight	O
)	O
of	O
heifers	O
,	O
indicating	O
negative	O
effects	O
of	O
fetal	O
programming	O
on	O
productive	O
efficiency	O
of	O
replacement	O
heifers	O
.	O

Besides	O
,	O
P	O
-	O
values	O
<	O
0	O
.	O
05	O
were	O
considered	O
as	O
statistically	O
significant	O
.	O

Mothers	O
were	O
paid	O
$	O
25	O
for	O
attending	O
the	O
30	O
-	O
week	O
gestation	O
and	O
6	O
-	O
month	O
postpartum	O
assessments	O
.	O

The	O
ratio	O
of	O
muscle	O
to	O
fat	O
cells	O
varies	O
depending	O
on	O
the	O
amount	O
of	O
IMF	O
deposited	O
.	O

In	O
infants	O
with	O
risk	O
of	O
allergy	O
,	O
introduction	O
of	O
solid	O
foods	O
in	O
general	O
should	O
be	O
postponed	O
until	O
6	O
months	O
of	O
age	O
,	O
milk	O
products	O
until	O
12	O
months	O
,	O
hen	O
'	O
s	O
egg	O
until	O
24	O
months	O
,	O
and	O
peanut	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
until	O
at	O
least	O
36	O
months	O
.	O

Although	O
relatively	O
rare	O
,	O
clinicians	O
must	O
maintain	O
a	O
high	O
index	O
of	O
suspicion	O
for	O
aortic	O
dissection	O
in	O
any	O
pregnant	O
female	O
who	O
presents	O
with	O
acute	O
onset	O
chest	O
pain	O
.	O

Partial	O
adherence	O
to	O
the	O
model	O
of	O
care	O
may	O
have	O
attenuated	O
changes	O
in	O
medication	O
requirements	O
and	O
dietary	O
patterns	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
in	O
liver	O
and	O
perirenal	O
adipose	O
tissue	O
of	O
adult	O
offspring	O
Gene	O
expression	O
of	O
relevant	O
metabolic	O
enzymes	O
regulating	O
de	O
novo	O
lipogenesis	O
(	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
)	O
and	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
,	O
Cpt1b	O
,	O
Acox1	O
),	O
and	O
key	O
regulators	O
of	O
lipid	O
and	O
cholesterol	O
metabolism	O
(	O
Chrebp	O
,	O
Srebp1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
)	O
and	O
mitochondrial	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
was	O
also	O
evaluated	O
in	O
the	O
liver	O
and	O
the	O
PAT	O
(	O
Figure5	O
).	O

These	O
studies	O
do	O
not	O
necessarily	O
rule	O
out	O
an	O
epigenetic	O
mechanism	O
of	O
toxicity	O
per	O
se	O
,	O
but	O
they	O
do	O
exclude	O
a	O
link	O
between	O
the	O
specific	O
epigenetic	O
,	O
exposure	O
and	O
/	O
or	O
adverse	O
endpoints	O
/	O
markers	O
investigated	O
.	O

Based	O
on	O
the	O
sum	O
population	O
prevalence	O
of	O
schizophrenia	O
and	O
other	O
psychoses	O
in	O
middle	O
-	O
aged	O
women	O
[	O
54	O
],	O
we	O
might	O
expect	O
that	O
2	O
-	O
3	O
%	O
of	O
the	O
study	O
participants	O
would	O
cross	O
the	O
boundaries	O
to	O
clinically	O
valid	O
syndromes	O
.	O

(	O
2012	O
)	O
*	O
Lifestyle	O
factors	O
Smoking	O
:	O
Cigarette	O
smokeAdulthood	O
LifetimeAdulthoodCOPD	O
Breast	O
and	O
lung	O
cancer	O
↓	O
lung	O
cancer	O
overall	O
survivalDNA	O
methylation	O
Epigenetic	O
machinery	O
miRNAsLin	O
et	O
al	O
.	O

This	O
highlights	O
the	O
importance	O
of	O
prenatal	O
care	O
,	O
both	O
in	O
terms	O
of	O
frequency	O
and	O
content	O
,	O
in	O
improving	O
adherence	O
to	O
programs	O
to	O
prevent	O
anaemia	O
.	O

These	O
differences	O
cannot	O
be	O
compared	O
directly	O
due	B
to	I
discrepancies	O
in	O
national	O
guidelines	O
and	O
the	O
financial	O
barriers	O
in	O
some	O
regions	O
[	O
27	O
].	O

Pregnancy	O
is	O
a	O
special	O
situation	O
in	O
oncology	O
:	O
we	O
need	O
to	O
control	O
two	O
patients	O
at	O
the	O
same	O
time	O
,	O
and	O
both	O
are	O
vulnerable	O
.	O

One	O
recent	O
study	O
suggests	O
that	O
both	O
the	O
microbial	O
and	O
fatty	O
acid	O
composition	O
of	O
breast	O
milk	O
may	O
differ	O
by	O
delivery	O
mode	O
[	O
18	O
],	O
so	O
the	O
differential	O
effect	O
of	O
maternal	O
dairy	O
intake	O
by	O
delivery	O
mode	O
on	O
the	O
infant	O
gut	O
microbiome	O
may	O
be	O
attributable	O
to	O
the	O
differences	O
in	O
breast	O
milk	O
microbiota	O
or	O
lipids	O
in	O
relation	O
to	O
maternal	O
diet	O
by	O
delivery	O
mode	O
.	O

found	O
that	O
a	O
prolonged	O
labor	O
(	O
greater	O
than	O
18	O
–	O
24	O
hours	O
)	O
resulted	O
in	O
an	O
increased	O
risk	O
for	O
autism	O
[	O
18	O
].	O

Prokaryote	O
genomes	O
contain	O
only	O
10	O
%	O
ncDNA	O
,	O
more	O
complex	O
fungi	O
and	O
animals	O
>	O
50	O
%,	O
rising	O
to	O
>	O
98	O
%	O
in	O
complex	O
mammals	O
(	O
including	O
mice	O
and	O
humans	O
)	O
(	O
Carey2011	O
).	O

When	O
evidence	O
for	O
associations	O
persisted	O
,	O
we	O
considered	O
other	O
factors	O
which	O
can	O
be	O
considered	O
either	O
as	O
potential	O
confounders	B
or	O
potential	O
mediators	O
of	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
outcomes	O
,	O
i	O
.	O
e	O
.	O

Food	O
items	O
similar	O
in	O
nutrient	O
profile	O
were	O
combined	O
into	O
33	O
predefined	O
food	O
groups	O
(	O
Table	O
1	O
).	O

Interestingly	O
,	O
the	O
CB2	O
receptor	O
activation	O
was	O
associated	O
with	O
anti	O
-	O
obesity	O
effects	O
(	O
Verty	O
et	O
al	O
.,	O
2015	O
)	O
and	O
a	O
decreased	O
risk	O
for	O
cardiovascular	O
diseases	O
.	O

As	O
these	O
nuclear	O
receptors	O
has	O
been	O
also	O
linked	O
to	O
the	O
activation	O
of	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
and	O
insulin	O
sensitivity	O
(	O
Auwerx	O
,	O
1999	O
;	O
Minnich	O
et	O
al	O
.,	O
2001	O
),	O
their	O
decreased	O
levels	O
in	O
RC	O
females	O
might	O
be	O
associated	O
to	O
alterations	O
in	O
lipid	O
and	O
glucose	O
metabolism	O
(	O
Liu	O
et	O
al	O
.,	O
2015	O
).	O

The	O
MiG	O
Study	O
randomized	O
751	O
women	O
with	O
GDM	O
to	O
treatment	O
with	O
insulin	O
or	O
metformin	O
.	O
72The	O
women	O
in	O
the	O
metformin	O
arm	O
were	O
treated	O
with	O
supplemental	O
insulin	O
if	O
the	O
maximal	O
dose	O
of	O
metformin	O
,	O
2500	O
mg	O
daily	O
,	O
failed	O
to	O
meet	O
the	O
glucose	O
targets	O
.	O

Despite	O
few	O
cases	O
of	O
IUFD	O
in	O
the	O
GraviD	O
cohort	O
,	O
our	O
results	O
suggest	O
that	O
vitamin	O
D	O
deficiency	O
in	O
early	O
pregnancy	O
may	O
be	O
linked	O
to	O
IUFD	O
.	O

Similarly	O
,	O
indoor	O
-	O
outdoor	O
pets	O
are	O
efficient	O
carriers	O
of	O
agents	O
into	O
the	O
home	O
,	O
and	O
also	O
pose	O
an	O
exposure	O
source	O
for	O
pesticides	O
from	O
anti	O
flea	O
/	O
tick	O
collars	O
,	O
sprays	O
,	O
and	O
shampoos	O
.	O

Maternal	O
intelligence	O
,	O
alcohol	O
consumption	O
,	O
smoking	O
and	O
breastfeeding	O
practices	O
were	O
included	O
as	O
covariates	O
in	O
all	O
studies	O
.	O

For	O
example	O
,	O
the	O
maternal	O
aMED	O
score	O
was	O
consistently	O
positively	O
and	O
negatively	O
associated	O
with	O
the	O
Enterobacteriaceae	O
family	O
,	O
and	O
additionally	O
negatively	O
associated	O
with	O
the	O
species	O
Escherichia	O
coli	O
,	O
in	O
both	O
delivery	O
mode	O
strata	O
.	O

In	O
two	O
separate	O
studies	O
,	O
early	O
-	O
weaned	O
steers	O
(	O
weaned	O
at	O
177	O
d	O
[	O
study	O
1	O
]	O
and	O
158	O
d	O
[	O
study	O
2	O
]	O
of	O
age	O
and	O
placed	O
on	O
a	O
finishing	O
diet	O
)	O
increased	O
MS	O
and	O
body	O
weight	O
gain	O
,	O
improved	O
feed	O
efficiency	O
,	O
and	O
improved	O
QG	O
of	O
the	O
beef	O
compared	O
with	O
normally	O
weaned	O
steers	O
or	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
[	O
51	O
].	O

In	O
general	O
,	O
miRNAs	O
repress	O
gene	O
expression	O
by	O
binding	O
to	O
mRNAs	O
in	O
a	O
sequence	O
-	O
specific	O
manner	O
and	O
either	O
inducing	O
their	O
degradation	O
or	O
inhibiting	O
their	O
translation	O
(	O
Ivey	O
&	O
Srivastava2015	O
),	O
whereas	O
piRNAs	O
and	O
esiRNAs	O
bind	O
to	O
complementary	O
transposable	O
elements	O
(	O
TEs	O
)	O
and	O
induce	O
their	O
degradation	O
(	O
Watanabe	O
et	O
al	O
.	O
2006	O
,	O
2008	O
).	O

Associated	O
symptoms	O
include	O
nausea	O
,	O
vomiting	O
,	O
diaphoresis	O
,	O
and	O
light	O
-	O
headedness	O
.	O

The	O
presence	O
of	O
somatostatin	O
receptors	O
provides	O
the	O
basis	O
for	O
treatment	O
with	O
longacting	O
analogues	O
of	O
somatostatin	O
or	O
with	O
Y	O
-	O
octreotide	O
(	O
DOTATOC	O
)	O
in	O
some	O
patients	O
.	O

BAT	O
activation	O
by	O
cold	O
exposure	O
,	O
β3	O
-	O
agonist	O
or	O
thyroid	O
hormone	O
treatment	O
was	O
shown	O
to	O
improve	O
glucose	O
tolerance	O
and	O
insulin	O
sensitivity	O
(	O
Cawthorne	O
et	O
al	O
.,	O
1984	O
;	O
Forest	O
et	O
al	O
.,	O
1987	O
;	O
Peirce	O
and	O
Vidal	O
-	O
Puig	O
,	O
2013	O
).	O

The	O
HDL	O
was	O
10	O
-	O
fold	O
reduced	O
in	O
the	O
plasma	O
of	O
RC	O
females	O
,	O
which	O
indicates	O
a	O
significant	O
reduction	O
of	O
the	O
outlet	O
rate	O
of	O
fat	O
molecules	O
(	O
cholesterol	O
,	O
phospholipids	O
and	O
triglycerides	O
)	O
from	O
cells	O
.	O

They	O
are	O
also	O
complicated	O
by	O
the	O
fact	O
that	O
the	O
biological	O
material	O
under	O
study	O
,	O
often	O
blood	O
cells	O
,	O
is	O
not	O
from	O
the	O
target	O
organ	O
/	O
tissue	O
.	O

The	O
FFQ	O
was	O
used	O
to	O
estimate	O
total	O
energy	O
intake	O
and	O
daily	O
nutrient	O
intake	O
,	O
by	O
multiplying	O
the	O
daily	O
frequency	O
of	O
consumption	O
of	O
a	O
food	O
by	O
the	O
nutrient	O
content	O
[	O
14	O
]	O
of	O
a	O
standard	O
portion	O
[	O
15	O
]	O
of	O
that	O
food	O
,	O
and	O
summing	O
this	O
for	O
all	O
the	O
foods	O
consumed	O
.	O

High	O
fat	O
feeding	O
of	O
pregnant	O
or	O
lactating	O
mothers	O
was	O
shown	O
to	O
induce	O
glucose	O
intolerance	O
and	O
the	O
development	O
of	O
obesity	O
in	O
the	O
progeny	O
during	O
adult	O
life	O
(	O
Bayol	O
et	O
al	O
.,	O
2008	O
;	O
Samuelsson	O
et	O
al	O
.,	O
2008	O
).	O

However	O
,	O
weaning	O
treatment	O
did	O
not	O
affect	O
feed	O
efficiency	O
,	O
post	O
weaning	O
growth	O
,	O
MS	O
,	O
and	O
other	O
carcass	O
traits	O
.	O

The	O
two	O
study	O
groups	O
were	O
similar	O
regarding	O
to	O
age	O
,	O
job	O
,	O
education	O
,	O
parity	O
and	O
sun	O
exposure	O
.	O

Salmeterol	O
is	O
the	O
preferred	O
agent	O
when	O
long	O
-	O
acting	O
β2	O
agonists	O
are	O
indicated	O
in	O
pregnant	O
women	O
as	O
add	O
-	O
on	O
treatment	O
of	O
persistent	O
asthma	O
.	O

Current	O
international	O
dietary	O
guidelines	O
advise	O
people	O
to	O
reduce	O
their	O
consumption	O
of	O
sugar	O
,	O
and	O
more	O
particularly	O
free	O
sugars	O
,	O
which	O
comprise	O
sugars	O
(	O
monosaccharides	O
and	O
disaccharides	O
)	O
added	O
to	O
foods	O
or	O
drinks	O
by	O
the	O
manufacturer	O
,	O
cook	O
or	O
consumer	O
,	O
and	O
sugars	O
naturally	O
present	O
in	O
honey	O
,	O
syrups	O
and	O
unsweetened	O
fruit	O
juices	O
[	O
4	O
].	O

Telephone	O
interviews	O
conducted	O
every	O
4	O
months	O
ascertained	O
the	O
infant	O
’	O
s	O
feeding	O
method	O
,	O
including	O
the	O
timing	O
of	O
breastfeeding	O
cessation	O
and	O
the	O
start	O
date	O
of	O
each	O
new	O
formula	O
,	O
as	O
applicable	O
,	O
as	O
well	O
as	O
medication	O
use	O
such	O
as	O
antibiotics	O
.	O

Spearman	O
Rank	O
correlation	O
test	O
showed	O
a	O
negative	O
significant	O
relationship	O
between	O
second	O
trimester	O
visfatin	O
level	O
and	O
birth	O
height	O
(	O
p	O
=	O
0	O
.	O
015	O
,	O
r	O
=-	O
0	O
.	O
523	O
)	O
in	O
group	O
B	O
(	O
Table	O
2	O
).	O

It	O
is	O
noted	O
that	O
the	O
detection	O
rate	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
study	O
is	O
19	O
.	O
4	O
%,	O
higher	O
than	O
the	O
usual	O
5	O
%	O
in	O
the	O
general	O
population	O
[	O
3	O
].	O

The	O
total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
was	O
grouped	O
into	O
six	O
categories	O
(	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
).	O

Access	O
to	O
IFA	O
supplements	O
is	O
through	O
antenatal	O
care	O
,	O
however	O
,	O
in	O
rural	O
Bangladesh	O
,	O
the	O
median	O
gestation	O
that	O
women	O
commence	O
antenatal	O
care	O
is	O
5	O
.	O
2	O
months	O
,	O
and	O
44	O
%	O
of	O
women	O
report	O
no	O
use	O
of	O
antenatal	O
care	O
[	O
5	O
].	O

It	O
would	O
not	O
be	O
possible	O
however	O
to	O
relate	O
such	O
levels	O
to	O
prenatal	O
exposure	O
.	O

The	O
researchers	O
found	O
that	O
prematurity	O
,	O
low	O
Apgar	O
scores	O
,	O
growth	O
restriction	O
,	O
or	O
macrosomia	O
,	O
and	O
if	O
the	O
mother	O
was	O
from	O
sub	O
-	O
Saharan	O
Africa	O
or	O
East	O
Asia	O
had	O
a	O
positive	O
correlation	O
with	O
autism	O
spectrum	O
disorders	O
[	O
9	O
].	O

Mining	O
in	O
the	O
area	O
had	O
mostly	O
ceased	O
by	O
the	O
mid	O
-	O
1960s	O
.	O

Pre	O
-	O
publication	O
history	O
The	O
pre	O
-	O
publication	O
history	O
for	O
this	O
paper	O
can	O
be	O
accessed	O
here	O
:	O
http	O
://	O
www	O
.	O
biomedcentral	O
.	O
com	O
/	O
1471	O
-	O
2458	O
/	O
13	O
/	O
1105	O
/	O
prepub	O
Supplementary	O
Material	O
Caption	O
(	O
SUPPLEMENTARY	O
-	O
MATERIAL	O
)	O
Additional	O
file	O
1	O
Nutritional	O
knowledge	O
questionnaire	O
.	O

However	O
,	O
previous	O
studies	O
suggested	O
that	O
specific	O
CB1	O
receptor	O
deletion	O
in	O
the	O
hypothalamus	O
was	O
able	O
to	O
decrease	O
body	O
weight	O
and	O
increase	O
energy	O
expenditure	O
,	O
but	O
was	O
not	O
accompanied	O
with	O
changes	O
in	O
food	O
intake	O
(	O
Cardinal	O
et	O
al	O
.,	O
2012	O
).	O

Labor	O
Time	O
A	O
review	O
of	O
literature	O
found	O
limited	O
number	O
of	O
researches	O
on	O
the	O
topic	O
of	O
labor	O
time	O
and	O
autism	O
.	O

However	O
,	O
for	O
left	O
-	O
handed	O
and	O
ambidextrous	O
participants	O
born	O
from	O
late	O
fall	O
through	O
early	O
spring	O
,	O
glioma	O
risk	O
also	O
has	O
been	O
shown	O
to	O
be	O
higher	O
than	O
for	O
those	O
born	O
at	O
other	O
times	O
of	O
the	O
year	O
[	O
16	O
].	O

There	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
any	O
of	O
the	O
baseline	O
characteristics	O
between	O
the	O
groups	O
(	O
table	O
1	O
),	O
including	O
reported	O
sun	O
exposure	O
.	O

The	O
average	O
daily	O
Vitamin	O
D	O
intake	O
dose	O
in	O
the	O
rest	O
eighty	O
-	O
four	O
participants	O
was	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

There	O
will	O
be	O
one	O
FI	O
for	O
each	O
cluster	O
.	O

In	O
contrast	O
,	O
“	O
brite	O
”	O
adipocytes	O
have	O
been	O
shown	O
to	O
originate	O
from	O
Myf	O
-	O
negative	O
(	O
Myf	O
5	O
−)	O
progenitor	O
cells	O
,	O
much	O
like	O
white	O
adipocytes	O
(	O
Petrovic	O
et	O
al	O
.,	O
2010	O
;	O
Long	O
et	O
al	O
.,	O
2014	O
).	O

Nevertheless	O
,	O
such	O
work	O
provides	O
valuable	O
data	O
.	O

of	O
regulated	O
genesGenes	O
involved	O
in	O
pathway94	O
dpcWnt	O
signalingup1	O
.	O
20	O
*	O
E	O
-	O
29ACVR1	O
,	O
CSNK1G3	O
,	O
FZD4	O
,	O
FZD6	O
,	O
MAP3K7	O
,	O
MMP7	O
,	O
TCF4	O
,	O
TCF7L2	O
,	O
WNT5AMitotic	O
roles	O
of	O
Polo	O
-	O
like	O
kinasedown5	O
.	O
15	O
*	O
E	O
-	O
811CCNB1	O
,	O
CCNB2	O
,	O
CDC23	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
FZR1	O
,	O
SP90AA1	O
,	O
KIF11	O
,	O
PLK1	O
,	O
PPP2R1B	O
,	O
PTTG1G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
76	O
*	O
E	O
-	O
58CCND2	O
,	O
CCND3	O
,	O
CCNE1	O
,	O
CDK4	O
,	O
E2F1	O
,	O
E2F4	O
,	O
RB1	O
,	O
TFDP1G2	O
/	O
M	O
DNA	O
damage	O
checkpoint	O
regulationdown1	O
.	O
53	O
*	O
E	O
-	O
35CCNB1	O
,	O
CCNB2	O
,	O
CDC25B	O
,	O
CDK1	O
,	O
PLK11	O
dpn	O
-----	O
28	O
dpnComplement	O
systemup2	O
.	O
07	O
*	O
E	O
-	O
55C4B	O
,	O
C5	O
,	O
C6	O
,	O
C9	O
,	O
CD55G1	O
/	O
S	O
checkpoint	O
regulationdown2	O
.	O
49	O
*	O
E	O
-	O
23CDKN1B	O
,	O
HDAC11	O
,	O
TGFB3188	O
dpnVEGF	O
signalingup2	O
.	O
80	O
*	O
E	O
-	O
412ACTA2	O
,	O
AKT3	O
,	O
BCL2	O
,	O
EIF2B1	O
,	O
KDR	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PRKCB	O
,	O
RRAS2	O
,	O
VCL	O
,	O
VEGFCmTOR	O
signalingup6	O
.	O
29	O
*	O
E	O
-	O
313AKT3	O
,	O
EIF3B	O
,	O
EIF4B	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
PIK3R3	O
,	O
PPP2CB	O
,	O
PRKAB2	O
,	O
PRKCB	O
,	O
RHOJ	O
,	O
RRAS2	O
,	O
TSC1	O
,	O
VEGFCSynthesis	O
and	O
degradation	O
of	O
ketone	O
bodiesup1	O
.	O
18	O
*	O
E	O
-	O
34ACAA1	O
,	O
BDH1	O
,	O
HADHA	O
,	O
HADHBBile	O
acid	O
synthesisup3	O
.	O
33	O
*	O
E	O
-	O
37ACAA1	O
,	O
ADH5	O
,	O
ADHFE1	O
,	O
ALDH7A1	O
,	O
HADHA	O
,	O
HADHB	O
,	O
LIPAFatty	O
acid	O
elongation	O
in	O
mitochondriaup4	O
.	O
81	O
*	O
E	O
-	O
34ACAA1	O
,	O
AUH	O
,	O
HADHA	O
,	O
HADHBGlucocorticoid	O
receptor	O
signalingup3	O
.	O
99	O
*	O
E	O
-	O
217AKT3	O
,	O
BCL2	O
,	O
CCL2	O
,	O
GTF2A2	O
,	O
GTF2B	O
,	O
GTF2E2	O
,	O
HSP90AB1	O
,	O
HSPA1B	O
,	O
IL1RN	O
,	O
MAPK1	O
,	O
MRAS	O
,	O
NCOR1	O
,	O
PBX1	O
,	O
PIK3R3	O
,	O
RRAS2	O
,	O
TAF4	O
,	O
VCAM1Val	O
,	O
Leu	O
,	O
Ile	O
degradationup8	O
.	O
32	O
*	O
E	O
-	O
38ACAA1	O
,	O
ACAD10	O
,	O
ALDH7A1	O
,	O
AUH	O
,	O
BCKDHB	O
,	O
HADHA	O
,	O
HADHB	O
,	O
HIBADHBiosynthesis	O
of	O
steroidsdown7	O
.	O
65	O
*	O
E	O
-	O
35CYP24A1	O
,	O
CYP7B1	O
,	O
DHCR7	O
,	O
FDFT1	O
,	O
MVD	O
The	O
comparison	O
between	O
the	O
dietary	O
gestational	O
protein	O
diets	O
(	O
LP	O
vs	O
.	O
AP	O
)	O
is	O
shown	O
in	O
dependence	O
of	O
the	O
regulatory	O
direction	O
(	O
up	O
or	O
down	O
).	O

Any	O
explanation	O
for	O
these	O
dimorphisms	O
should	O
be	O
supported	O
by	O
the	O
elevated	O
gene	O
expression	O
of	O
Cnr2	O
in	O
the	O
liver	O
and	O
PAT	O
of	O
the	O
RC	O
female	O
offspring	O
compared	O
to	O
those	O
of	O
the	O
RC	O
males	O
.	O

Discussion	O
In	O
our	O
study	O
,	O
less	O
than	O
half	O
the	O
participants	O
used	O
folic	O
acid	O
or	O
iron	O
during	O
their	O
pregnancy	O
,	O
while	O
approximately	O
two	O
thirds	O
took	O
multivitamin	O
supplements	O
.	O

This	O
review	O
indicates	O
that	O
the	O
benefits	O
of	O
diets	O
providing	O
moderate	O
amounts	O
of	O
fish	O
during	O
pregnancy	O
outweigh	O
potential	O
detrimental	O
effects	O
in	O
regards	O
to	O
offspring	O
neurodevelopment	O
.	O

Our	O
population	O
had	O
more	O
male	O
infants	O
than	O
female	O
infants	O
(	O
57	O
.	O
2	O
%	O
males	O
),	O
and	O
an	O
average	O
birth	O
weight	O
and	O
gestational	O
age	O
of	O
3427	O
g	O
and	O
39	O
.	O
3	O
weeks	O
,	O
respectively	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Flow	O
diagram	O
for	O
inclusion	O
of	O
journal	O
articles	O
[	O
17	O
].	O

Venous	O
blood	O
is	O
processed	O
within	O
1	O
h	O
after	O
blood	O
draw	O
;	O
plasma	O
/	O
serum	O
separated	O
and	O
red	O
blood	O
cells	O
washed	O
twice	O
with	O
normal	O
saline	O
.	O

Moreover	O
,	O
their	O
offspring	O
displayed	O
normoweight	O
at	O
birth	O
and	O
during	O
lactation	O
in	O
a	O
sex	O
and	O
diet	O
-	O
independent	O
manner	O
.	O

Newborn	O
and	O
infant	O
children	O
have	O
greater	O
contact	O
with	O
these	O
contaminants	O
since	O
they	O
lie	O
,	O
crawl	O
and	O
play	O
near	O
the	O
ground	O
and	O
frequently	O
place	O
their	O
hands	O
,	O
objects	O
or	O
food	O
in	O
their	O
mouths	O
[	O
29	O
,	O
33	O
,	O
34	O
].	O

This	O
review	O
will	O
deal	O
only	O
with	O
dietary	O
and	O
environmental	O
control	O
measures	O
(	O
see	O
later	O
)	O
for	O
the	O
prevention	O
(	O
primary	O
and	O
secondary	O
)	O
of	O
atopic	O
diseases	O
.	O

However	O
,	O
subungual	O
exostosis	O
has	O
a	O
fibrous	O
cap	O
and	O
lacks	O
capillary	O
proliferation	O
.	O

Interestingly	O
,	O
recent	O
studies	O
have	O
documented	O
epigenetic	O
modifications	O
or	O
affectation	O
of	O
adrenocortical	O
growth	O
in	O
offspring	O
after	O
maternal	O
dietary	O
restriction	O
around	O
the	O
time	O
of	O
conception	O
(	O
Nicholas	O
et	O
al	O
.,	O
2013	O
;	O
Zhang	O
et	O
al	O
.,	O
2013	O
),	O
pointing	O
out	O
the	O
importance	O
of	O
the	O
periconceptional	O
window	O
in	O
the	O
metabolic	O
programming	O
.	O

If	O
the	O
measurements	O
cannot	O
be	O
taken	O
by	O
the	O
study	O
nurses	O
,	O
hospital	O
records	O
are	O
used	O
to	O
obtain	O
anthropometrical	O
data	O
(	O
using	O
the	O
same	O
calibrated	O
infant	O
scale	O
).	O

Exposure	O
to	O
such	O
an	O
intra	O
-	O
uterine	O
environment	O
potentially	O
creates	O
a	O
vicious	O
cycle	O
in	O
which	O
the	O
propensity	O
to	O
obesity	O
is	O
perpetuated	O
,	O
with	O
major	O
adverse	O
public	O
health	O
implications	O
[	O
11	O
,	O
12	O
],	O
and	O
implications	O
for	O
the	O
health	O
of	O
successive	O
generations	O
[	O
13	O
].	O

Our	O
inclusion	O
criteria	O
were	O
infants	O
aged	O
1	O
–	O
11	O
months	O
and	O
living	O
in	O
our	O
study	O
region	O
.	O

We	O
did	O
not	O
see	O
a	O
U	O
-	O
shaped	O
association	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
SGA	O
,	O
as	O
previously	O
indicated	O
[	O
9	O
].	O

Although	O
risk	O
estimates	O
varied	O
by	O
study	O
center	O
,	O
combined	O
results	O
suggest	O
that	O
maternal	O
supplementation	O
for	O
two	O
trimesters	O
may	O
decrease	O
risk	O
of	O
brain	O
tumor	O
(	O
odds	O
ratio	O
[	O
OR	O
]	O
0	O
.	O
7	O
,	O
95	O
%	O
confidence	O
interval	O
[	O
CI	O
]	O
0	O
.	O
5	O
-	O
0	O
.	O
9	O
),	O
with	O
a	O
trend	O
of	O
less	O
risk	O
with	O
longer	O
duration	O
of	O
use	O
(	O
p	O
trend	O
=	O
0	O
.	O
0007	O
).	O

It	O
has	O
been	O
suggested	O
that	O
vitamin	O
D	O
might	O
be	O
used	O
in	O
the	O
treatment	O
of	O
opportunistic	O
and	O
antibiotic	O
-	O
resistant	O
infections	O
.	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

Furthermore	O
,	O
in	O
the	O
year	O
2013	O
,	O
around	O
8	O
.	O
48	O
crore	O
children	O
and	O
1	O
.	O
9	O
crore	O
mothers	O
have	O
utilized	O
the	O
benefit	O
of	O
supplemental	O
nutrition	O
services	O
(	O
2	O
).	O

For	O
searches	O
performed	O
using	O
MASCOT	O
,	O
E	O
-	O
value	O
and	O
Score	O
,	O
as	O
well	O
as	O
matching	O
peptides	O
and	O
sequence	O
coverage	O
,	O
were	O
used	O
to	O
determine	O
matches	O
.	O

Dietary	O
intake	O
of	O
omega	O
-	O
3	O
,	O
omega	O
-	O
6	O
fatty	O
acids	O
,	O
vitamin	O
D	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
by	O
the	O
level	O
of	O
fatty	O
acids	O
intake	O
is	O
shown	O
in	O
Table3	O
.	O

Case	O
report	O
A	O
12	O
-	O
week	O
-	O
pregnant	O
35	O
-	O
year	O
-	O
old	O
woman	O
presented	O
with	O
an	O
approximately	O
4	O
-	O
week	O
history	O
of	O
a	O
growing	O
,	O
tender	O
papule	O
under	O
her	O
right	O
great	O
toenail	O
.	O

Statistical	O
analysis	O
Statistical	O
analysis	O
was	O
performed	O
using	O
SPSS11	O
.	O
5	O
software	O
.	O

(	O
PDF	O
3429	O
kb	O
)	O
PubMed	O
Central	O
:	O

Of	O
the	O
routine	O
antianaphylaxis	O
medications	O
,	O
epinephrine	O
and	O
diphenhydramine	O
have	O
been	O
implicated	O
in	O
causing	O
fetal	O
malformations	O
.	O

Immunotherapy	O
may	O
be	O
continued	O
as	O
maintenance	O
treatment	O
but	O
should	O
not	O
be	O
initiated	O
during	O
pregnancy	O
.	O

Animal	O
studies	O
,	O
studies	O
not	O
reported	O
in	O
English	O
,	O
and	O
studies	O
of	O
populations	O
exposed	O
to	O
contaminants	O
were	O
excluded	O
.	O

Overall	O
,	O
the	O
current	O
study	O
extends	O
existing	O
work	O
by	O
suggesting	O
that	O
exposure	O
to	O
foods	O
or	O
drinks	O
high	O
in	O
sugar	O
content	O
early	O
in	O
gestation	O
may	O
predispose	O
offspring	O
to	O
higher	O
weight	O
status	O
early	O
in	O
infancy	O
,	O
independent	O
of	O
maternal	O
GWG	O
.	O

Evidence	O
in	O
some	O
studies	O
pointed	O
out	O
that	O
hyperphagia	O
could	O
be	O
a	O
transitory	O
effect	O
that	O
disappears	O
when	O
the	O
underweighted	O
animals	O
after	O
maternal	O
undernutrition	O
were	O
able	O
to	O
reach	O
the	O
weight	O
as	O
controls	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

The	O
non	O
-	O
linearity	O
in	O
the	O
association	O
might	O
seemingly	O
argue	O
against	O
a	O
possible	O
causal	O
relationship	O
.	O

Side	O
Effects	O
of	O
Iron	O
Supplements	O
Gastrointestinal	O
distress	O
is	O
commonly	O
observed	O
in	O
women	O
consuming	O
high	O
levels	O
of	O
supplemental	O
iron	O
on	O
an	O
empty	O
stomach	O
[	O
7	O
].	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
identified	O
between	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
and	O
those	O
in	O
the	O
Standard	O
Care	O
group	O
with	O
regards	O
to	O
the	O
overall	O
Ages	O
and	O
Stages	O
total	O
score	O
(	O
Lifestyle	O
Advice	O
262	O
.	O
47	O
(±	O
34	O
.	O
92	O
)	O
vs	O
.	O
Standard	O
Care	O
258	O
.	O
72	O
(±	O
36	O
.	O
54	O
);	O
aMD	O
3	O
.	O
53	O
;	O
95	O
%	O
CI	O
−	O
0	O
.	O
33	O
to	O
7	O
.	O
40	O
;	O
p	O
=	O
0	O
.	O
07	O
),	O
or	O
in	O
the	O
proportion	O
of	O
infants	O
identified	O
with	O
>	O
1	O
domain	O
below	O
the	O
cut	O
-	O
off	O
(	O
Lifestyle	O
Advice	O
49	O
(	O
4	O
.	O
58	O
%)	O
vs	O
.	O
Standard	O
Care	O
69	O
(	O
6	O
.	O
51	O
%);	O
aRR	O
0	O
.	O
69	O
;	O
95	O
%	O
CI	O
0	O
.	O
43	O
to	O
1	O
.	O
11	O
;	O
p	O
=	O
0	O
.	O
13	O
)	O
(	O
Table	O
3	O
).	O

The	O
result	O
was	O
that	O
196	O
participants	O
will	O
be	O
required	O
.	O

It	O
was	O
interesting	O
to	O
investigate	O
trend	O
of	O
vitamin	O
D	O
effectiveness	O
in	O
the	O
two	O
primiparous	O
and	O
multiparous	O
subgroups	O
.	O

In	O
contrast	O
,	O
CC	O
females	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Cpt1b	O
and	O
Cox4i1	O
(	O
Figures5C	O
,	O
D	O
).	O

In	O
the	O
fetal	O
stage	O
,	O
the	O
main	O
process	O
is	O
increasing	O
the	O
number	O
of	O
adipocytes	O
(	O
hyperplasia	O
)	O
derived	O
from	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
[	O
21	O
].	O

Dose	O
,	O
route	O
,	O
metabolism	O
,	O
timing	O
and	O
mixtures	O
of	O
exposure	O
Whether	O
,	O
or	O
not	O
,	O
an	O
environmental	O
exposure	O
elicits	O
a	O
response	O
depends	O
on	O
a	O
range	O
of	O
interacting	O
variables	O
,	O
including	O
dose	O
,	O
route	O
of	O
administration	O
,	O
metabolism	O
and	O
additional	O
/	O
pre	O
-	O
existing	O
exposures	O
(	O
mixtures	O
).	O

Maternal	O
diet	O
was	O
assessed	O
by	O
self	O
-	O
report	O
between	O
24	O
and	O
28	O
weeks	O
of	O
gestation	O
,	O
and	O
it	O
is	O
possible	O
that	O
dietary	O
patterns	O
change	O
near	O
the	O
end	O
of	O
pregnancy	O
or	O
during	O
lactation	O
.	O

The	O
questionnaire	O
asked	O
about	O
76	O
food	O
items	O
,	O
plus	O
use	O
of	O
vitamins	O
,	O
certain	O
reduced	O
-	O
fat	O
foods	O
,	O
and	O
cooking	O
fat	O
.	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	O
due	O
to	O
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

While	O
,	O
the	O
mean	O
depression	O
scores	O
were	O
significantly	O
lower	O
in	O
the	O
vitamin	O
D	O
group	O
than	O
the	O
control	O
one	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
p	O
>	O
0	O
.	O
001	O
)	O
(	O
Table	O
3	O
).	O

We	O
also	O
examined	O
GWG	O
as	O
an	O
independent	O
predictor	O
and	O
potential	O
mediator	O
of	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
weight	O
outcomes	O
(	O
Table	O
4	O
).	O

However	O
,	O
the	O
neonatal	O
mortality	O
analyses	O
were	O
post	O
-	O
hoc	O
analyses	O
,	O
and	O
the	O
sample	O
size	O
was	O
small	O
resulting	O
in	O
poor	O
precision	O
in	O
the	O
effect	O
estimates	O
,	O
and	O
reduced	O
power	O
to	O
explore	O
all	O
the	O
factors	O
modifying	O
the	O
effects	O
on	O
neonatal	O
mortality	O
.	O

Because	O
of	O
use	O
of	O
cohort	O
and	O
control	O
groups	O
,	O
it	O
not	O
only	O
allowed	O
a	O
representative	O
sample	O
of	O
Utah	O
children	O
,	O
but	O
also	O
as	O
a	O
surveillance	O
study	O
could	O
not	O
directly	O
assess	O
cases	O
and	O
controls	O
[	O
48	O
].	O

One	O
paediatric	O
trial	O
showed	O
16	O
%	O
higher	O
rates	O
of	O
tuberculosis	O
symptom	O
resolution	O
,	O
29an	O
adult	O
trial	O
showed	O
23	O
%	O
greater	O
sputum	O
conversion	O
rate	O
at	O
6	O
months	O
,	O
30another	O
trial	O
showed	O
20	O
%	O
greater	O
restriction	O
of	O
BCG	O
-	O
lux	O
growth	O
in	O
blood	O
,	O
31another	O
trial	O
found	O
accelerated	O
sputum	O
conversion	O
only	O
in	O
a	O
certain	O
genotype	O
of	O
the	O
sample	O
,	O
20whereas	O
yet	O
another	O
found	O
no	O
significant	O
difference	O
in	O
sputum	O
conversion32in	O
the	O
intervention	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Our	O
results	O
suggest	O
that	O
habitual	O
short	O
/	O
long	O
sleep	O
duration	O
and	O
snoring	O
precede	O
the	O
clinical	O
diagnosis	O
of	O
GDM	O
.	O

Although	O
,	O
the	O
point	O
estimates	O
indicated	O
a	O
marginal	O
increased	O
risk	O
for	O
developing	O
any	O
pregnancy	O
complication	O
with	O
severe	O
(<	O
25	O
nmol	O
/	O
L	O
)	O
vitamin	O
D	O
deficiency	O
compared	O
to	O
those	O
who	O
had	O
levels	O
between	O
50	O
and	O
75	O
nmol	O
/	O
L	O
(	O
aRR	O
:	O
1	O
.	O
10	O
;	O
95	O
%	O
CI	O
:	O
0	O
.	O
89	O
,	O
1	O
.	O
36	O
).	O

One	O
third	O
of	O
respondents	O
were	O
single	O
(	O
n	O
=	O
113	O
).	O

Similarly	O
,	O
histone	O
acetylases	O
require	O
the	O
co	O
-	O
substrate	O
acetyl	O
-	O
CoA	O
,	O
and	O
altered	O
glycolytic	O
production	O
of	O
acetyl	O
-	O
CoA	O
can	O
lead	O
to	O
changes	O
in	O
histone	O
acetylation	O
(	O
Wellen	O
et	O
al	O
.	O
2009	O
;	O
Moussaieff	O
et	O
al	O
.	O
2015	O
).	O

Consistent	O
with	O
these	O
observations	O
,	O
genes	O
associated	O
with	O
lipid	O
metabolism	O
were	O
found	O
to	O
be	O
altered	O
at	O
pre	O
-	O
and	O
postnatal	O
stages	O
in	O
rodents	O
,	O
where	O
the	O
LP	O
model	O
was	O
studied	O
intensively	O
[	O
44	O
-	O
49	O
].	O

During	O
the	O
final	O
stage	O
,	O
from	O
18	O
months	O
to	O
slaughter	O
(	O
28	O
to	O
30	O
months	O
of	O
age	O
),	O
the	O
concentrate	O
is	O
84	O
.	O
2	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
,	O
and	O
the	O
rest	O
is	O
roughage	O
(	O
rice	O
straw	O
).	O

Those	O
who	O
did	O
not	O
complete	O
the	O
interview	O
were	O
recorded	O
as	O
having	O
refused	O
to	O
participate	O
and	O
were	O
taken	O
into	O
account	O
when	O
calculating	O
the	O
refusal	O
rate	O
,	O
but	O
excluded	O
from	O
the	O
final	O
analysis	O
.	O

These	O
findings	O
indicate	O
that	O
leptin	O
action	O
and	O
,	O
therefore	O
,	O
the	O
normal	O
function	O
of	O
leptin	O
receptors	O
reduces	O
the	O
endocannabinoid	O
tone	O
and	O
CB1	O
receptor	O
activity	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
).	O

Two	O
key	O
global	O
epigenetic	O
re	O
-	O
programing	O
and	O
programing	O
events	O
occur	O
,	O
one	O
after	O
fertilization	O
in	O
the	O
early	O
embryo	O
in	O
all	O
cells	O
,	O
and	O
the	O
second	O
in	O
germ	O
cells	O
only	O
during	O
primordial	O
germ	O
cell	O
(	O
PGC	O
)	O
development	O
(	O
Figure	O
1	O
).	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
5	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
enzymes	O
and	O
regulators	O
of	O
the	O
lipogenesis	O
(	O
Chrebp	O
,	O
Acaca	O
,	O
Fasn	O
,	O
Scd1	O
),	O
fatty	O
-	O
acid	O
β	O
-	O
oxidation	O
(	O
Cpt1a	O
/	O
b	O
,	O
Acox1	O
),	O
cholesterol	O
metabolism	O
(	O
Srebf1	O
/	O
2	O
,	O
Insig1	O
/	O
2	O
,	O
Hmgcr	O
),	O
and	O
thermogenesis	O
/	O
mitochondria	O
respiration	O
(	O
Ucp1	O
,	O
Cox4i1	O
)	O
in	O
the	O
liver	O
(	O
A	O
,	O
B	O
)	O
and	O
/	O
or	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
)	O
(	O
C	O
,	O
D	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

2	O
).	O

However	O
,	O
no	O
differences	O
in	O
body	O
weight	O
between	O
CC	O
and	O
RC	O
females	O
were	O
found	O
.	O

Pethick	O
et	O
al	O
[	O
69	O
]	O
reported	O
that	O
a	O
high	O
level	O
of	O
diet	O
processing	O
can	O
increase	O
the	O
accessibility	O
of	O
dietary	O
starch	O
granules	O
for	O
both	O
rumen	O
and	O
small	O
intestine	O
amylases	O
,	O
resulting	O
in	O
maximum	O
glucose	O
availability	O
to	O
the	O
fattening	O
animal	O
[	O
113	O
].	O

Macrosomia	O
was	O
defined	O
as	O
weight	O
>	O
4000	O
grams	O
[	O
21	O
].	O

Iron	O
deficiency	O
is	O
not	O
only	O
the	O
most	O
prevalent	O
but	O
also	O
the	O
most	O
neglected	O
nutrient	O
deficiency	O
in	O
the	O
world	O
,	O
particularly	O
among	O
pregnant	O
women	O
and	O
children	O
in	O
developing	O
countries	O
[	O
7	O
].	O

In	O
other	O
words	O
,	O
ICDS	O
reflects	O
the	O
country	O
’	O
s	O
obligation	O
to	O
enhance	O
the	O
pre	O
-	O
school	O
education	O
rates	O
and	O
an	O
effective	O
strategy	O
to	O
break	O
the	O
vicious	O
cycle	O
of	O
malnutrition	O
,	O
infection	O
and	O
mortality	O
(	O
3	O
).	O

Eighty	O
-	O
four	O
cases	O
(	O
85	O
.	O
7	O
%)	O
took	O
Vitamin	O
D	O
supplements	O
with	O
duration	O
of	O
2w	O
-	O
31w	O
,	O
and	O
with	O
average	O
daily	O
intake	O
dose	O
of	O
517	O
.	O
5	O
±	O
113	O
.	O
1	O
IU	O
.	O

In	O
order	O
to	O
make	O
the	O
MAR	O
assumption	O
more	O
plausible	O
,	O
a	O
range	O
of	O
auxiliary	O
variables	O
,	O
including	O
stratification	O
(	O
centre	O
,	O
parity	O
,	O
BMI	O
category	O
)	O
and	O
adjustment	O
variables	O
(	O
socioeconomic	O
status	O
,	O
smoking	O
,	O
maternal	O
age	O
at	O
consent	O
,	O
infant	O
gender	O
),	O
along	O
with	O
infant	O
birth	O
measures	O
(	O
weight	O
,	O
length	O
,	O
circumferences	O
and	O
skinfold	O
thickness	O
measures	O
),	O
were	O
included	O
in	O
the	O
imputation	O
model	O
.	O

An	O
unquantified	O
food	O
frequency	O
questionnaire	O
for	O
the	O
infant	O
is	O
administered	O
at	O
phases	O
6	O
and	O
8	O
for	O
qualitative	O
assessment	O
(	O
types	O
and	O
frequency	O
)	O
of	O
milk	O
and	O
complementary	O
feeding	O
at	O
6	O
and	O
12	O
months	O
postnatally	O
.	O

The	O
PCM	O
-	O
I	O
consists	O
of	O
items	O
derived	O
from	O
:	O
1	O
)	O
the	O
Kilifi	O
Developmental	O
Inventory	O
(	O
KDI	O
)	O
[	O
63	O
],	O
previously	O
used	O
by	O
the	O
investigators	O
to	O
determine	O
psychomotor	O
development	O
in	O
an	O
infant	O
population	O
in	O
South	O
Africa	O
[	O
64	O
],	O
2	O
)	O
the	O
Developmental	O
Milestone	O
Checklist	O
(	O
DMC	O
-	O
II	O
)	O
[	O
65	O
,	O
66	O
],	O
and	O
3	O
)	O
the	O
Profile	O
of	O
Social	O
-	O
Emotional	O
Development	O
(	O
PSED	O
),	O
which	O
is	O
based	O
in	O
part	O
on	O
the	O
Brief	O
Infant	O
/	O
Toddler	O
Social	O
Emotional	O
Assessment	O
[	O
67	O
].	O

This	O
could	O
be	O
interpreted	O
as	O
support	O
of	O
our	O
finding	O
that	O
late	O
rather	O
than	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
is	O
the	O
stronger	O
predictor	O
of	O
fetal	O
growth	O
restriction	O
.	O

Circulating	O
concentrations	O
of	O
25OHD	O
below	O
25	O
or	O
30	O
nmol	O
/	O
L	O
have	O
been	O
associated	O
with	O
50	O
–	O
300	O
%	O
increased	O
odds	O
of	O
SGA	O
,	O
compared	O
to	O
higher	O
concentrations	O
[	O
5	O
–	O
7	O
].	O

BAT	O
,	O
the	O
principal	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
i	O
.	O
e	O
.,	O
heat	O
production	O
that	O
does	O
not	O
involve	O
skeletal	O
muscle	O
contraction	O
),	O
is	O
present	O
in	O
most	O
mammals	O
and	O
its	O
maturation	O
in	O
the	O
perinatal	O
period	O
varies	O
between	O
species	O
,	O
according	O
to	O
their	O
developmental	O
status	O
at	O
birth	O
(	O
Tews	O
and	O
Wabitsch	O
,	O
2011	O
).	O

We	O
computed	O
the	O
relative	O
abundance	O
for	O
each	O
OTU	O
by	O
dividing	O
the	O
read	O
count	O
in	O
each	O
cell	O
by	O
the	O
total	O
number	O
of	O
reads	O
in	O
the	O
sample	O
and	O
filtered	O
out	O
OTUs	O
with	O
zero	O
or	O
near	O
-	O
zero	O
variance	O
using	O
the	O
caret	O
package	O
in	O
R	O
.	O
This	O
results	O
in	O
624	O
OTUs	O
.	O

However	O
,	O
its	O
use	O
should	O
be	O
limited	O
to	O
a	O
selected	O
group	O
of	O
patients	O
who	O
are	O
unable	O
to	O
tolerate	O
oral	O
iron	O
and	O
in	O
whom	O
oral	O
iron	O
therapy	O
fails	O
due	O
to	O
noncompliance	O
.	O

The	O
PAT	O
of	O
adult	O
male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
specifically	O
exhibited	O
a	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
the	O
β	O
-	O
oxidation	O
enzymes	O
Cpt1b	O
and	O
Acox1	O
,	O
the	O
mitochondrial	O
respiratory	O
chain	O
subunit	O
Cox4i1	O
and	O
the	O
lipid	O
storage	O
-	O
stimulating	O
transcription	O
factor	O
Ppar	O
γ	O
.	O

Surely	O
,	O
it	O
is	O
better	O
for	O
both	O
society	O
and	O
public	O
health	O
to	O
fully	O
assess	O
the	O
potential	O
epigenetic	O
effects	O
of	O
environmental	O
exposures	O
and	O
introduce	O
regulations	O
and	O
TGs	O
based	O
on	O
relevant	O
data	O
and	O
proven	O
mechanisms	O
of	O
toxicity	O
.	O

Furthermore	O
,	O
genes	O
involved	O
in	O
'	O
actin	O
cytoskeleton	O
signaling	O
',	O
'	O
RhoA	O
signaling	O
',	O
'	O
Rac	O
signaling	O
'	O
and	O
'	O
complement	O
system	O
'	O
were	O
found	O
to	O
be	O
down	O
-	O
regulated	O
.	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

We	O
conducted	O
the	O
key	O
informant	O
interviews	O
to	O
understand	O
the	O
community	O
norms	O
around	O
IFA	O
supplementation	O
,	O
and	O
challenges	O
and	O
successes	O
of	O
the	O
existing	O
programme	O
.	O

Epigenetic	O
changes	O
that	O
act	O
as	O
markers	O
of	O
exposure	O
and	O
/	O
or	O
predictors	O
of	O
future	O
toxicity	O
,	O
but	O
do	O
not	O
in	O
themselves	O
directly	O
induce	O
an	O
adverse	O
effect	O
,	O
may	O
also	O
be	O
useful	O
in	O
risk	O
assessment	O
and	O
intervention	O
.	O

Regarding	O
the	O
timing	O
of	O
restriction	O
,	O
protein	O
deficiency	O
during	O
early	O
pregnancy	O
induces	O
a	O
less	O
preference	O
to	O
a	O
high	O
-	O
fat	O
diet	O
in	O
the	O
female	O
offspring	O
(	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
),	O
whereas	O
a	O
high	O
preference	O
was	O
obtained	O
when	O
restriction	O
was	O
applied	O
through	O
other	O
gestational	O
periods	O
(	O
Bellinger	O
et	O
al	O
.,	O
2004	O
;	O
Bellinger	O
and	O
Langley	O
-	O
Evans	O
,	O
2005	O
).	O

Our	O
study	O
can	O
be	O
the	O
basis	O
for	O
further	O
and	O
more	O
precise	O
studies	O
.	O

Several	O
risk	O
factors	O
during	O
the	O
pregnancy	O
and	O
labor	O
periods	O
have	O
been	O
associated	O
with	O
autism	O
;	O
yet	O
further	O
studies	O
with	O
large	O
populations	O
are	O
needed	O
to	O
establish	O
definitive	O
associations	O
.	O

Introduction	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
patients	O
and	O
is	O
more	O
frequently	O
diagnosed	O
in	O
women	O
.	O

As	O
gestational	O
diabetes	O
is	O
associated	O
with	O
adverse	O
pregnancy	O
outcomes	O
,	O
and	O
has	O
long	O
-	O
term	O
implications	O
for	O
both	O
mother	O
and	O
child	O
,	O
it	O
is	O
important	O
that	O
it	O
is	O
recognized	O
and	O
appropriately	O
managed	O
.	O

The	O
strength	O
in	O
this	O
study	O
includes	O
long	O
followup	O
and	O
low	O
risk	O
of	O
selection	O
bias	B
,	O
but	O
numerous	O
subgroup	O
analyses	O
may	O
lead	O
to	O
risk	O
of	O
chance	O
influencing	O
significant	O
associations	O
.	O

The	O
investigators	O
found	O
signs	O
of	O
kidney	O
damage	O
that	O
increased	O
with	O
higher	O
daily	O
intake	O
of	O
uranium	O
in	O
the	O
drinking	O
water	O
.	O
27	O
Uranium	O
appears	O
to	O
exert	O
its	O
chemical	O
effects	O
on	O
the	O
kidney	O
’	O
s	O
proximal	O
tubules	O
.	O
28Arsenic	O
and	O
cadmium	O
—	O
which	O
,	O
along	O
with	O
other	O
potentially	O
hazardous	O
metals	O
,	O
are	O
sometimes	O
found	O
in	O
uranium	O
tailings29	O
—	O
create	O
similar	O
signatures	O
of	O
metal	O
damage	O
in	O
the	O
kidneys	O
.	O
30	O
Lewis	O
’	O
s	O
early	O
data	O
from	O
the	O
DiNEH	O
Project	O
suggest	O
that	O
self	O
-	O
reported	O
kidney	O
disease	O
,	O
hypertension	O
,	O
and	O
autoimmune	O
diseases	O
were	O
more	O
prevalent	O
among	O
people	O
who	O
lived	O
closer	O
to	O
mine	O
waste	O
sites	O
.	O
31Her	O
colleague	O
at	O
the	O
University	O
of	O
New	O
Mexico	O
,	O
immunologist	O
Ester	O
Erdei	O
,	O
believes	O
the	O
increase	O
in	O
hypertension	O
and	O
autoimmune	O
diseases	O
might	O
be	O
connected	O
to	O
consumption	O
of	O
contaminated	O
water	O
.	O

The	O
remaining	O
four	O
studies	O
did	O
not	O
correct	O
for	O
either	O
paternal	O
IQ	O
or	O
home	O
environment	O
.	O

With	O
respect	O
to	O
schizophrenia	O
,	O
several	O
of	O
proteins	O
identified	O
in	O
this	O
study	O
have	O
also	O
been	O
reported	O
to	O
be	O
disrupted	O
in	O
post	O
-	O
mortem	O
brain	O
tissue	O
from	O
patients	O
with	O
schizophrenia	O
.	O

Transcriptional	O
excursions	O
regarding	O
stress	O
and	O
immune	O
response	O
The	O
biological	O
effect	O
of	O
glucocorticoids	O
is	O
modulated	O
by	O
glucocorticoid	O
receptors	O
.	O

All	O
the	O
different	O
cell	O
types	O
that	O
comprise	O
the	O
new	O
individual	O
develop	O
from	O
this	O
zygote	O
and	O
so	O
contain	O
the	O
same	O
unique	O
genome	O
.	O

Here	O
the	O
focus	O
is	O
on	O
the	O
hepatic	O
transcriptomic	O
response	O
.	O

The	O
health	O
centres	O
are	O
run	O
by	O
senior	O
nurses	O
or	O
midwives	O
(	O
Head	O
of	O
centres	O
)	O
with	O
the	O
exception	O
of	O
Muea	O
health	O
centre	O
which	O
is	O
headed	O
by	O
a	O
medical	O
doctor	O
.	O

Curiously	O
,	O
it	O
has	O
recently	O
been	O
shown	O
that	O
dynamin	O
1	O
-	O
like	O
protein	O
is	O
also	O
important	O
for	O
mitochondrial	O
fission	O
and	O
general	O
morphology	O
[	O
33	O
].	O

Several	O
biologic	O
mechanisms	O
underlying	O
the	O
nutritional	O
programming	O
,	O
which	O
become	O
altered	O
after	O
the	O
exposure	O
to	O
a	O
maternal	O
restricted	O
diet	O
during	O
pregnancy	O
,	O
have	O
been	O
identified	O
.	O

Sampling	O
The	O
target	O
population	O
of	O
the	O
survey	O
comprised	O
all	O
pregnant	O
women	O
in	O
Belgium	O
during	O
the	O
first	O
and	O
the	O
third	O
trimester	O
of	O
pregnancy	O
in	O
the	O
period	O
from	O
September	O
2010	O
to	O
June	O
2011	O
.	O

A	O
computational	O
analysis	O
of	O
these	O
data	O
revealed	O
that	O
many	O
of	O
the	O
proteins	O
dysregulated	O
in	O
the	O
DVD	O
model	O
have	O
also	O
been	O
shown	O
to	O
be	O
altered	O
in	O
schizophrenia	O
post	O
-	O
mortem	O
brain	O
studies	O
[	O
18	O
].	O

In	O
each	O
region	O
the	O
obstetric	O
clinics	O
were	O
ordered	O
by	O
province	O
and	O
size	O
based	O
on	O
the	O
number	O
of	O
deliveries	O
during	O
the	O
past	O
year	O
and	O
60	O
clusters	O
of	O
4	O
clinics	O
were	O
selected	O
per	O
region	O
using	O
systematic	O
sampling	O
in	O
order	O
to	O
have	O
enough	O
replacement	O
clinics	O
in	O
case	O
some	O
refused	O
to	O
participate	O
.	O

Age	O
and	O
overall	O
dietary	O
intake	O
as	O
well	O
as	O
the	O
intake	O
of	O
fish	O
and	O
fatty	O
acids	O
did	O
not	O
differ	O
significantly	O
between	O
those	O
who	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
and	O
those	O
who	O
did	O
not	O
(	O
drop	O
-	O
outs	O
).	O

1	O
).	O

Ancient	O
Chinese	O
Cancer	O
Secret	O
?	O

Model	O
system	O
Stage	O
of	O
development	O
Environmental	O
exposureSpeciesRoute	O
of	O
administrationExposureEffectAdverse	O
phenotype	O
(	O
s	O
)	O
Epigenetic	O
change	O
(	O
s	O
)	O
ReferenceChemicals	O
Bisphenol	O
A	O
(	O
BPA	O
)	O
Mouse	O
RatOral	O
(	O
diet	O
)	O
(	O
50	O
µg	O
-	O
50	O
mg	O
/	O
kg	O
)	O
Oral	O
(	O
gavage	O
)	O
(	O
40	O
–	O
200	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Injection	O
(	O
not	O
specified	O
)	O
(	O
20	O
or	O
40	O
µg	O
/	O
kg	O
/	O
d	O
)	O
Combinations	O
of	O
:	O
Pre	O
-	O
conception	O
(	O
maternal	O
)	O
In	O
utero	O
Lactation	O
Neonatal	O
Childhood	O
Adulthood	O
In	O
utero	O
Neonatal	O
Childhood	O
Adulthood	O
F0	O
-	O
F2generationsReproductive	O
,	O
neurological	O
,	O
behavioral	O
,	O
metabolic	O
and	O
cardiac	O
abnormalitiesDNA	O
methylation	O
Epigenetic	O
machineryChao	O
et	O
al	O
.	O

Thus	O
,	O
the	O
incorporation	O
of	O
epigenetics	O
within	O
chemical	O
regulation	O
could	O
ultimately	O
reduce	O
animal	O
usage	O
and	O
the	O
time	O
and	O
cost	O
of	O
chemical	O
research	O
and	O
development	O
,	O
while	O
simultaneously	O
improving	O
the	O
protection	O
of	O
public	O
health	O
worldwide	O
.	O

Glucose	O
is	O
derived	O
from	O
either	O
glucose	O
synthesis	O
via	O
gluconeogenesis	O
from	O
propionate	O
/	O
lactate	O
or	O
glucose	O
absorbed	O
from	O
the	O
small	O
intestinal	O
digestion	O
of	O
the	O
rumen	O
bypass	O
[	O
86	O
].	O

Specifically	O
,	O
it	O
is	O
the	O
prescriptions	O
taken	O
during	O
pregnancy	O
,	O
the	O
length	O
of	O
labor	O
,	O
viral	O
infection	O
,	O
abnormal	O
presentation	O
at	O
delivery	O
,	O
and	O
finally	O
low	O
birth	O
weight	O
that	O
were	O
associated	O
with	O
autism	O
.	O

Our	O
exclusion	O
criteria	O
were	O
families	O
expecting	O
to	O
move	O
to	O
another	O
town	O
within	O
18	O
months	O
,	O
diagnosis	O
of	O
rickets	O
or	O
treatment	O
with	O
vitamin	O
D	O
in	O
the	O
previous	O
3	O
months	O
,	O
and	O
clinical	O
diagnosis	O
of	O
Kwashiorkor	O
or	O
Marasmus	O
.	O

Quantitatively	O
,	O
it	O
was	O
estimated	O
that	O
50	O
g	O
of	O
BAT	O
can	O
burn	O
as	O
much	O
as	O
20	O
%	O
of	O
daily	O
energy	O
intake	O
(	O
Rothwell	O
and	O
Stock	O
,	O
1983	O
).	O

The	O
research	O
team	O
took	O
written	O
approval	O
for	O
the	O
study	O
from	O
Directorate	O
General	O
of	O
Health	O
Service	O
(	O
DGHS	O
)	O
under	O
Ministry	O
of	O
Health	O
&	O
Family	O
Welfare	O
before	O
allocating	O
the	O
clusters	O
to	O
a	O
treatment	O
group	O
or	O
the	O
trial	O
interventions	O
begin	O
.	O

Written	O
informed	O
consent	O
is	O
again	O
obtained	O
before	O
infant	O
assessments	O
at	O
6	O
weeks	O
postnatally	O
.	O

Under	O
this	O
condition	O
,	O
FGF21	O
expression	O
was	O
indeed	O
decreased	O
in	O
the	O
liver	O
,	O
but	O
enhanced	O
in	O
BAT	O
,	O
as	O
well	O
as	O
in	O
WAT	O
,	O
where	O
it	O
acted	O
to	O
markedly	O
increase	O
UCP1	O
expression	O
and	O
the	O
“	O
browning	O
”	O
of	O
subcutaneous	O
tissue	O
(	O
Fisher	O
et	O
al	O
.,	O
2012	O
).	O

However	O
,	O
the	O
adult	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
showed	O
a	O
decreased	O
gene	O
expression	O
of	O
Cnr1	O
and	O
the	O
eCBs	O
-	O
degrading	O
enzymes	O
Faah	O
and	O
Mgll	O
in	O
liver	O
as	O
well	O
as	O
the	O
NAEs	O
-	O
synthesizing	O
enzyme	O
Napepld	O
in	O
PAT	O
.	O

However	O
,	O
the	O
present	O
study	O
is	O
the	O
first	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
in	O
Belgium	O
.	O

The	O
following	O
narrative	O
review	O
aims	O
to	O
better	O
understand	O
the	O
existing	O
evidence	O
for	O
perinatal	O
and	O
labor	O
-	O
related	O
associations	O
with	O
autism	O
.	O

From	O
the	O
infants	O
,	O
a	O
2	O
–	O
5	O
ml	O
urine	O
sample	O
is	O
collected	O
at	O
phases	O
6	O
,	O
7	O
and	O
8	O
using	O
adhesive	O
paediatric	O
urine	O
collection	O
bags	O
.	O

Statistical	O
significance	O
was	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
(	O
two	O
-	O
sided	O
)	O
with	O
no	O
adjustment	O
for	O
multiple	O
comparisons	O
,	O
and	O
all	O
analyses	O
followed	O
a	O
pre	O
-	O
specified	O
plan	O
.	O

These	O
studies	O
can	O
be	O
ranked	O
into	O
categories	O
that	O
demonstrate	O
(	O
1	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
global	O
epigenetic	O
change	O
(	O
s	O
);	O
(	O
2	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
(	O
including	O
further	O
subcategories	O
,	O
such	O
as	O
dose	O
-	O
and	O
/	O
or	O
time	O
-	O
dependent	O
changes	O
,	O
single	O
changes	O
within	O
relevant	O
biological	O
pathways	O
,	O
multiple	O
changes	O
within	O
the	O
same	O
biological	O
pathway	O
,	O
correlation	O
of	O
changes	O
with	O
gene	O
expression	O
at	O
mRNA	O
and	O
/	O
or	O
protein	O
level	O
,	O
use	O
of	O
additional	O
mechanistically	O
relevant	O
controls	O
,	O
robust	O
statistical	O
analysis	O
);	O
(	O
3	O
)	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
that	O
were	O
reversed	O
by	O
an	O
inhibitor	O
/	O
treatment	O
,	O
absent	O
in	O
a	O
knock	O
out	O
/	O
down	O
model	O
,	O
and	O
/	O
or	O
mechanistically	O
linked	O
in	O
a	O
relevant	O
in	O
vitro	O
system	O
;	O
or	O
(	O
4	O
)	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
rodent	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

The	O
women	O
were	O
selected	O
via	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
sampling	O
design	O
.	O

Adipogenesis	O
normally	O
begins	O
around	O
mid	O
-	O
gestation	O
in	O
ruminant	O
animals	O
[	O
20	O
].	O

Vitamin	O
D	O
is	O
also	O
a	O
potential	O
immunosuppressant	O
,	O
which	O
down	O
-	O
regulates	O
the	O
expression	O
of	O
pro	O
-	O
inflammation	O
markers	O
,	O
such	O
as	O
TNF	O
-	O
α	O
and	O
IL	O
-	O
2	O
,	O
among	O
pregnant	O
women	O
with	O
GDM	O
[	O
8	O
].	O

The	O
newborn	O
in	O
this	O
case	O
also	O
had	O
hypernatremia	O
thereby	O
raising	O
possibilities	O
of	O
vasopressinase	O
crossing	O
the	O
placenta	O
.	O

For	O
other	O
abbreviations	O
,	O
see	O
text	O
.	O

An	O
important	O
limitation	O
of	O
this	O
study	O
is	O
that	O
we	O
measured	O
dietary	O
intake	O
only	O
once	O
,	O
involving	O
misclassification	B
among	O
those	O
who	O
changed	O
their	O
dietary	O
pattern	O
during	O
follow	O
-	O
up	O
.	O

Oral	O
antihistamines	O
should	O
be	O
avoided	O
during	O
the	O
first	O
trimester	O
,	O
unless	O
definitely	O
clinically	O
indicated	O
,	O
and	O
then	O
should	O
be	O
used	O
at	O
the	O
lowest	O
effective	O
dose	O
,	O
starting	O
with	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
.	O

Discussion	O
Gestational	O
diabetes	O
insipidus	O
is	O
a	O
rare	O
complication	B
of	O
pregnancy	O
that	O
occurs	O
in	O
4	O
out	O
of	O
100	O
,	O
000	O
pregnancies	O
as	O
discussed	O
by	O
Durr	O
[	O
1	O
].	O

To	O
examine	O
gene	O
-	O
related	O
CpG	O
methylation	O
on	O
a	O
subset	O
of	O
the	O
samples	O
(	O
n	O
=	O
184	O
),	O
methylation	O
was	O
measured	O
at	O
27	O
,	O
578	O
CpG	O
loci	O
using	O
the	O
Infinium	O
HumanMethylation27	O
BeadArray	O
(	O
Illumina	O
,	O
San	O
Diego	O
,	O
CA	O
).	O

Tested	O
at	O
42	O
months	O
,	O
7	O
and	O
8	O
years	O
.	O
Two	O
FFQs	O
during	O
pregnancy	O
(	O
at	O
15	O
weeks	O
and	O
32	O
weeks	O
)	O
were	O
used	O
to	O
estimate	O
fish	O
intake	O
in	O
early	O
and	O
late	O
pregnancy	O
.	O
Cognitive	O
&	O
behavioural	O
outcomes	O
in	O
offspring	O
at	O
9	O
years	O
using	O
the	O
Wechsler	O
Abbreviated	O
Scale	O
of	O
Intelligence	O
.	O

There	O
are	O
other	O
more	O
time	O
and	O
financially	O
economical	O
ways	O
in	O
which	O
lifetime	O
,	O
multigenerational	O
and	O
/	O
or	O
transgenerational	O
toxicity	O
could	O
be	O
assessed	O
,	O
for	O
example	O
using	O
zebrafish	O
models	O
,	O
both	O
respecting	O
the	O
3Rs	O
and	O
satisfying	O
sufficient	O
statistical	O
power	O
.	O

A	O
wide	O
range	O
of	O
services	O
encompassing	O
supplementary	O
nutrition	O
;	O
immunization	O
services	O
;	O
health	O
check	O
-	O
ups	O
for	O
children	O
less	O
than	O
six	O
years	O
of	O
age	O
;	O
antenatal	O
care	O
of	O
expectant	O
mothers	O
and	O
postnatal	O
care	O
of	O
nursing	O
mothers	O
;	O
referral	O
services	O
to	O
the	O
beneficiaries	O
who	O
are	O
in	O
the	O
need	O
of	O
prompt	O
medical	O
attention	O
;	O
non	O
-	O
formal	O
pre	O
-	O
school	O
education	O
for	O
children	O
in	O
the	O
3	O
-	O
6	O
years	O
age	O
group	O
;	O
and	O
nutrition	O
&	O
health	O
education	O
especially	O
for	O
the	O
women	O
in	O
the	O
15	O
-	O
45	O
years	O
age	O
group	O
are	O
provided	O
to	O
the	O
beneficiaries	O
(	O
4	O
,	O
5	O
).	O

It	O
has	O
been	O
proposed	O
that	O
the	O
ratio	O
of	O
omega	O
-	O
3	O
:	O
omega	O
-	O
6	O
fatty	O
acids	O
might	O
be	O
more	O
important	O
in	O
inhibiting	O
the	O
development	O
of	O
several	O
diseases	O
,	O
including	O
cancer	O
,	O
inflammatory	O
and	O
heart	O
diseases	O
[	O
45	O
,	O
46	O
].	O

Priority	O
questions	O
:	O
What	O
dose	O
(	O
s	O
)	O
via	O
what	O
route	O
(	O
s	O
)	O
of	O
administration	O
are	O
human	O
populations	O
actually	O
exposed	O
to	O
,	O
and	O
what	O
metabolite	O
(	O
s	O
)	O
are	O
formed	O
?	O

Furthermore	O
,	O
two	O
Vietnamese	O
studies	O
showed	O
similar	O
improvements	O
in	O
iron	O
stores	O
following	O
ingestion	O
of	O
ironfortified	O
fish	O
sauce	O
for	O
six	O
to	O
12	O
months	O
[	O
42	O
,	O
43	O
].	O

We	O
will	O
exclude	O
five	O
Upazilas	O
from	O
Kishoreganj	O
,	O
six	O
Upazilas	O
from	O
Netrokona	O
and	O
two	O
Upazilas	O
from	O
Sherpur	O
because	O
of	O
insufficient	O
BRAC	O
Program	O
Officer	O
(	O
PO	O
)	O
coverage	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
4	O
Effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
the	O
gene	O
expression	O
of	O
components	O
of	O
the	O
endocannabinoid	O
system	O
(	O
Cnr1	O
,	O
Cnr2	O
,	O
Napepld	O
,	O
Faah	O
,	O
Dagl	O
α	O
,	O
Dagl	O
β	O
,	O
Mgll	O
)	O
in	O
the	O
hypothalamus	O
(	O
A	O
)	O
,	O
liver	O
(	O
B	O
)	O
,	O
and	O
perirenal	O
adipose	O
tissue	O
(	O
PAT	O
,	O
C	O
)	O
of	O
male	O
and	O
female	O
offspring	O
at	O
adulthood	O
.	O

The	O
activity	O
of	O
ATP	O
citrate	O
lyase	O
is	O
known	O
to	O
be	O
low	O
in	O
ruminants	O
[	O
87	O
];	O
thus	O
,	O
glucose	O
is	O
used	O
as	O
a	O
lipogenic	O
substrate	O
less	O
in	O
ruminants	O
than	O
in	O
monogastric	O
animals	O
[	O
87	O
].	O

The	O
inverse	O
probability	O
weighting	O
analysis	O
also	O
produced	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

Eligibility	O
criteria	O
included	O
nonsmoking	O
,	O
adults	O
(	O
age	O
>	O
18	O
years	O
),	O
fluency	O
in	O
English	O
,	O
access	O
to	O
telephone	O
,	O
gestational	O
age	O
between	O
10	O
and	O
16	O
weeks	O
,	O
singleton	O
pregnancy	O
,	O
no	O
current	O
or	O
history	O
of	O
eating	O
disorders	O
,	O
and	O
without	O
major	O
psychiatric	O
illness	O
(	O
i	O
.	O
e	O
.,	O
schizophrenia	O
,	O
bipolar	O
disorder	O
,	O
and	O
panic	O
/	O
anxiety	O
disorder	O
)	O
or	O
major	O
medical	O
problems	O
,	O
including	O
diabetes	O
,	O
stroke	O
,	O
and	O
cancer	O
.	O

Prenatal	O
vitamin	O
D	O
inadequacy	O
has	O
been	O
hypothesized	O
as	O
a	O
risk	O
factor	O
for	O
pediatric	O
atopy	O
and	O
asthma	O
.	O

Statistical	O
analysis	O
Data	O
analysis	O
will	O
be	O
by	O
intention	O
to	O
treat	O
.	O

The	O
dams	O
were	O
limited	O
in	O
their	O
feed	O
to	O
maintain	O
similar	O
energy	O
intake	O
among	O
the	O
groups	O
.	O

Alternatively	O
,	O
an	O
equally	O
effective	O
,	O
safe	O
,	O
and	O
affordable	O
iron	O
compound	O
with	O
little	O
or	O
no	O
side	O
effect	O
can	O
be	O
developed	O
for	O
use	O
especially	O
in	O
public	O
health	O
antenatal	O
supplementation	O
programmes	O
.	O

To	O
avoid	O
litter	O
effects	O
,	O
samples	O
from	O
6	O
to	O
15	O
liters	O
per	O
perinatal	O
group	O
were	O
used	O
in	O
all	O
determinations	O
.	O

A	O
number	O
of	O
reporter	O
mouse	O
models	O
,	O
including	O
the	O
Agouti	O
Avy	O
,	O
CabpIAP	O
and	O
AuxinFu	O
,	O
have	O
also	O
been	O
used	O
to	O
investigate	O
environmentally	O
induced	O
epigenetic	O
changes	O
in	O
in	O
vivo	O
exploratory	O
research	O
(	O
Dolinoy	O
et	O
al	O
.	O
2007	O
;	O
Waterland	O
et	O
al	O
.	O
2006	O
;	O
Rosenfeld2010	O
).	O

We	O
therefore	O
sought	O
to	O
review	O
the	O
existing	O
literature	O
(	O
up	O
to	O
7	O
March	O
2016	O
)	O
to	O
evaluate	O
the	O
current	O
evidence	O
for	O
such	O
toxicity	O
.	O

To	O
verify	O
physical	O
presence	O
of	O
the	O
data	O
collectors	O
at	O
the	O
households	O
we	O
will	O
record	O
a	O
Geographic	O
Information	O
System	O
(	O
GIS	O
)	O
data	O
point	O
.	O

However	O
,	O
the	O
depression	O
scores	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
not	O
different	O
significantly	O
(	O
p	O
=	O
0	O
.	O
217	O
).	O

‡	O
Studies	O
demonstrating	O
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
animal	O
model	O
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

We	O
plan	O
to	O
explore	O
these	O
issues	O
in	O
future	O
experiments	O
.	O

No	O
genes	O
were	O
found	O
consistently	O
differentially	O
expressed	O
between	O
the	O
groups	O
along	O
all	O
examined	O
stages	O
.	O

The	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
exhibited	O
higher	O
plasma	O
levels	O
of	O
LDL	O
and	O
glucose	O
as	O
well	O
as	O
a	O
reduction	O
in	O
chocolate	O
and	O
caloric	O
intake	O
at	O
post	O
-	O
weaning	O
periods	O
in	O
the	O
feeding	O
tests	O
.	O

While	O
a	O
previous	O
ecological	O
study	O
reported	O
a	O
positive	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
the	O
limitations	O
of	O
ecological	O
studies	O
for	O
inferring	O
causality	O
are	O
well	O
known	O
(	O
not	O
least	O
because	B
of	O
the	O
high	O
likelihood	O
of	O
confounding	B
)	O
[	O
36	O
].	O

In	O
view	O
of	O
the	O
foregoing	O
,	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
was	O
conducted	O
;	O
furthermore	O
,	O
constraints	B
were	O
highlighted	O
and	O
suggestions	O
for	O
improvement	O
were	O
provided	O
.	O

Even	O
fewer	O
(	O
18	O
of	O
the	O
47	O
to	O
-	O
date	O
)	O
further	O
established	O
causality	O
,	O
all	O
of	O
which	O
were	O
studies	O
in	O
rodent	O
models	O
.	O

No	O
studies	O
reported	O
adjusting	O
results	O
from	O
the	O
FFQ	O
for	O
energy	O
intake	O
,	O
a	O
recommendation	O
made	O
by	O
Freedman	O
et	O
al	O
.	O

High	O
educational	O
level	O
(	O
high	O
school	O
and	O
university	O
)	O
(	O
X2	O
=	O
8	O
.	O
714	O
;	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
first	O
time	O
pregnancy	O
(	O
X2	O
=	O
4	O
.	O
217	O
;	O
p	O
=	O
0	O
.	O
04	O
)	O
were	O
significantly	O
associated	O
with	O
poor	O
satisfaction	O
.	O

Furthermore	O
,	O
the	O
high	O
frequency	O
of	O
gastrointestinal	O
side	O
effects	O
experienced	O
by	O
people	O
with	O
type	O
2	O
diabetes	O
suggests	O
that	O
any	O
future	O
role	O
of	O
acarbose	O
,	O
even	O
if	O
subsequent	O
studies	O
confirm	O
safety	O
,	O
will	O
be	O
limited	O
.	O

For	O
example	O
,	O
researchers	O
have	O
reported	O
a	O
common	O
occurrence	O
of	O
unbooked	O
pregnancies	O
[	O
49	O
,	O
50	O
]	O
and	O
a	O
wide	O
range	O
(	O
60	O
%	O
to	O
90	O
%)	O
of	O
antenatal	O
care	O
utilization	O
rates	O
(	O
i	O
.	O
e	O
.,	O
antenatal	O
care	O
clinic	O
attendance	O
of	O
at	O
least	O
once	O
during	O
most	O
recent	O
pregnancy	O
)	O
[	O
51	O
–	O
53	O
].	O

Nulliparous	O
and	O
multiparous	O
pregnant	O
women	O
were	O
entered	O
into	O
this	O
study	O
.	O

Besides	O
sunlight	O
exposure	O
,	O
Vitamin	O
D	O
supplementation	O
is	O
also	O
an	O
important	O
factor	O
that	O
affects	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
among	O
women	O
with	O
GDM	O
.	O

Our	O
objectives	O
were	O
to	O
study	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
,	O
as	O
well	O
as	O
change	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
with	O
neonatal	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

We	O
had	O
no	O
information	O
about	O
socioeconomic	O
status	O
,	O
but	O
the	O
adjustment	O
for	O
education	O
,	O
which	O
is	O
strongly	O
associated	O
with	O
socioeconomic	O
status	O
,	O
did	O
not	O
change	O
the	O
estimates	O
.	O

Several	O
small	O
studies	O
comparing	O
metformin	O
to	O
insulin	O
for	O
the	O
treatment	O
of	O
GDM	O
have	O
also	O
been	O
performed	O
(	O
Table	O
5	O
).	O

[	O
47	O
],	O
we	O
identified	O
clusters	O
of	O
the	O
infant	O
gut	O
microbiome	O
at	O
6	O
weeks	O
of	O
age	O
using	O
the	O
partitioning	O
around	O
medoids	O
(	O
PAM	O
)	O
method	O
of	O
clustering	O
on	O
generalized	O
UniFrac	O
distances	O
.	O

Sample	O
collection	O
At	O
21	O
–	O
23	O
postnatal	O
weeks	O
,	O
adult	O
offspring	O
were	O
sacrificed	O
by	O
decapitation	O
after	O
the	O
administration	O
of	O
Equitesin	O
®	O
(	O
3	O
mg	O
/	O
kg	O
).	O

In	O
second	O
trimester	O
,	O
development	O
of	O
muscles	O
,	O
organs	O
occurs	O
,	O
so	O
the	O
diet	O
rich	O
in	O
proteins	O
is	O
advised	O
.	O

Labor	O
induction	O
and	O
augmentation	O
appear	O
to	O
be	O
an	O
area	O
of	O
association	O
.	O

A	O
positive	O
score	O
on	O
any	O
of	O
these	O
three	O
symptoms	O
indicates	O
an	O
allergic	O
phenotype	O
.	O

For	O
simplicity	O
of	O
language	O
we	O
abbreviated	O
'	O
relative	O
risk	O
ratio	O
'	O
to	O
'	O
relative	O
risk	O
'	O
(	O
RR	O
).	O

For	O
our	O
per	O
-	O
protocol	O
analysis	O
we	O
included	O
children	O
who	O
in	O
both	O
groups	O
received	O
all	O
doses	O
with	O
an	O
interval	O
between	O
the	O
doses	O
of	O
60	O
and	O
120	O
days	O
and	O
had	O
not	O
violated	O
the	O
randomisation	O
codes	O
.	O

Normal	O
weight	O
and	O
overweight	O
/	O
obese	O
categories	O
were	O
based	O
on	O
the	O
1990	O
IOM	O
cut	O
points	O
[	O
17	O
]:	O
normal	O
weight	O
BMI	O
=	O
19	O
.	O
8	O
to	O
26	O
.	O
0	O
or	O
overweight	O
/	O
obese	O
BMI	O
26	O
.	O
1	O
–	O
40	O
.	O
0	O
[	O
17	O
].	O

Mass	O
fortification	O
programme	O
of	O
common	O
local	O
staple	O
foods	O
with	O
iron	O
and	O
folic	O
acid	O
is	O
a	O
long	O
-	O
term	O
goal	O
,	O
which	O
national	O
governments	O
in	O
developing	O
countries	O
should	O
consider	O
as	O
a	O
strategy	O
aimed	O
at	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
general	O
population	O
.	O

All	O
authors	O
have	O
read	O
and	O
approved	O
the	O
submitted	O
manuscript	O
.	O

The	O
treatment	O
also	O
enhanced	O
UCP1	O
protein	O
levels	O
in	O
BAT	O
,	O
via	O
stimulation	O
of	O
the	O
sympathetic	O
nervous	O
system	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Measurement	O
of	O
the	O
vasopressinase	O
serum	O
concentrations	O
is	O
not	B
available	O
commercially	O
,	O
and	O
the	O
diagnosis	O
is	O
usually	O
established	O
based	O
on	O
the	O
clinical	O
presentation	O
and	O
the	O
appropriate	O
laboratory	O
studies	O
.	O

Sample	O
size	O
The	O
available	O
sample	O
size	O
for	O
follow	O
-	O
up	O
assessment	O
at	O
6	O
-	O
months	O
of	O
age	O
was	O
predetermined	O
by	O
the	O
LIMIT	O
trial	O
,	O
which	O
was	O
powered	O
on	O
the	O
primary	O
outcome	O
of	O
large	O
for	O
gestational	O
age	O
,	O
with	O
2212	O
women	O
randomised	O
[	O
22	O
].	O

We	O
computed	O
birth	O
weight	O
for	O
gestational	O
age	O
z	O
-	O
scores	O
using	O
US	O
Natality	O
reference	O
data	O
from	O
Oken	O
et	O
al	O
.	O

When	O
dividing	O
the	O
cohort	O
by	O
vitamin	O
D	O
sufficiency	O
status	O
for	O
additional	O
analyses	O
,	O
vitamin	O
D	O
deficiency	O
was	O
defined	O
as	O
<	O
20	O
ng	O
/	O
mL	O
(<	O
50	O
nmol	O
/	O
L	O
)).	O

Obviously	O
,	O
the	O
increased	O
mRNA	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
regulators	O
within	O
developmental	O
period	O
I	O
in	O
LP	O
offspring	O
accounts	O
for	O
compensatory	O
regulations	O
regarding	O
the	O
lowered	O
fetal	O
weight	O
due	O
to	O
the	O
gestational	O
diet	O
.	O

The	O
cDNA	O
was	O
synthesized	O
using	O
the	O
High	O
Capacity	O
cDNA	O
Archive	O
Kit	O
in	O
the	O
ABI	O
(	O
Applied	O
Biosystems	O
Inc	O
,	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
)	O
Gene	O
Amp	O
PCR	O
System	O
2700	O
.	O

For	O
laryngeal	O
spasm	O
,	O
intubation	O
and	O
,	O
in	O
rare	O
cases	O
,	O
tracheotomy	O
may	O
be	O
necessary	O
.	O

Although	O
a	O
weak	O
correlation	O
was	O
found	O
between	O
poor	O
intrauterine	O
environments	O
and	O
ASD	O
with	O
intellectual	O
disabilities	O
,	O
there	O
was	O
no	O
relationship	O
found	O
between	O
ASD	O
without	O
intellectual	O
disabilities	O
and	O
perinatal	O
factors	O
[	O
12	O
].	O

Recent	O
research	O
has	O
suggested	O
that	O
effects	O
of	O
methyl	O
-	O
mercury	O
on	O
infant	O
brain	O
development	O
may	O
be	O
mediated	O
by	O
LC	O
n	O
-	O
3PUFA	O
[	O
36	O
].	O

Then	O
,	O
myogenic	O
progenitor	O
cells	O
further	O
develop	O
into	O
muscle	O
fibres	O
and	O
satellite	O
cells	O
,	O
while	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
develop	O
into	O
the	O
stromal	O
–	O
vascular	O
fraction	O
of	O
skeletal	O
muscle	O
,	O
where	O
adipocytes	O
,	O
fibroblasts	O
,	O
and	O
resident	O
adipogenic	O
–	O
fibrogenic	O
progenitor	O
cells	O
reside	O
[	O
16	O
].	O

Out	O
of	O
which	O
,	O
79	O
women	O
(	O
42	O
.	O
9	O
%)	O
scored	O
<	O
9	O
,	O
90	O
women	O
(	O
57	O
.	O
1	O
%)	O
scored	O
9	O
–	O
13	O
and	O
15	O
women	O
(	O
8	O
.	O
2	O
%)	O
scored	O
>	O
13	O
.	O

For	O
many	O
years	O
,	O
fast	O
-	O
acting	O
(	O
regular	O
)	O
insulin	O
,	O
and	O
intermediate	O
-	O
acting	O
(	O
isophane	O
)	O
insulin	O
have	O
been	O
the	O
preferred	O
insulins	O
for	O
the	O
treatment	O
of	O
GDM	O
.	O

Rodents	O
are	O
commonly	O
used	O
to	O
investigate	O
the	O
mechanisms	O
underlying	O
long	O
-	O
term	O
programming	O
of	O
energy	O
balance	O
in	O
the	O
offspring	O
.	O

Other	O
variables	O
abstracted	O
from	O
infant	O
medical	O
records	O
included	O
infant	O
sex	O
and	O
gestational	O
age	O
at	O
birth	O
(	O
calculated	O
from	O
last	O
menstrual	O
period	O
or	O
from	O
second	O
trimester	O
ultrasound	O
if	O
the	O
two	O
estimated	O
differed	O
by	O
>	O
10	O
days	O
).	O

In	O
addition	O
to	O
genetic	O
factors	O
[	O
9	O
],	O
placenta	O
structural	O
[	O
10	O
]	O
and	O
environmental	O
factors	O
affect	O
fetal	O
growth	O
in	O
utero	O
[	O
9	O
],	O
and	O
maternal	O
nutritional	O
status	O
could	O
impact	O
on	O
fetal	O
growth	O
and	O
development	O
[	O
11	O
].	O

Postponing	O
surgery	O
to	O
at	O
least	O
6	O
-	O
7	O
months	O
after	O
diagnosis	O
of	O
DTC	O
in	O
the	O
first	O
trimester	O
does	O
not	O
adversely	O
affect	O
prognosis	O
;	O
on	O
the	O
other	O
hand	O
,	O
thyroidectomy	O
can	O
be	O
safely	O
performed	O
in	O
the	O
second	O
trimester	O
of	O
pregnancy	O
or	O
after	O
delivery15	O
.	O

1	O
.	O

In	O
AP	O
fetuses	O
,	O
cell	O
cycle	O
parameters	O
were	O
found	O
to	O
be	O
decreased	O
in	O
expression	O
within	O
developmental	O
period	O
I	O
,	O
which	O
indicates	O
a	O
terminated	O
fetal	O
growth	O
.	O

The	O
sequences	O
of	O
all	O
the	O
porcine	O
miRNAs	O
were	O
acquired	O
from	O
miRBase	O
(	O
http	O
://	O
www	O
.	O
mirbase	O
.	O
org	O
/).	O

Higher	O
IMF	O
deposition	O
with	O
higher	O
concentrate	O
feeding	O
may	O
occur	O
if	O
IMF	O
preferentially	O
uses	O
glucose	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
,	O
while	O
subcutaneous	O
fat	O
uses	O
acetate	O
,	O
as	O
described	O
by	O
Smith	O
and	O
Crouse	O
[	O
88	O
].	O

©	O
2009	O
Dove	O
Medical	O
Press	O
Limited	O
.	O

E1	O
–	O
education	O
:	O
>	O
12	O
years	O
;	O
E2	O
–	O
9	O
–	O
12	O
years	O
;	O
reference	O
category	O
-	O
≤	O
8	O
years	O
.	O

In	O
subjects	O
with	O
type	O
2	O
diabetes	O
,	O
the	O
ADOPT	O
Study	O
has	O
demonstrated	O
that	O
metformin	O
is	O
superior	O
to	O
glyburide	O
in	O
this	O
regard	O
.	O
76As	O
there	O
is	O
transplacental	O
passage	O
of	O
metformin	O
,	O
77	O
,	O
78its	O
effect	O
on	O
fetal	O
insulin	O
resistance	O
might	O
even	O
provide	O
further	O
benefit	O
in	O
light	O
of	O
data	O
of	O
insulin	O
resistance	O
and	O
insulin	O
secretory	O
defects	O
in	O
offspring	O
of	O
diabetic	O
pregnancies	O
.	O
19However	O
,	O
any	O
pharmacological	O
agent	O
which	O
crosses	O
the	O
placenta	O
must	O
be	O
viewed	O
with	O
caution	O
as	O
there	O
always	O
remains	O
the	O
possibility	O
of	O
unexpected	O
long	O
-	O
term	O
effects	O
.	O

Within	O
the	O
entire	O
cohort	O
,	O
age	O
of	O
the	O
child	O
and	O
cathelicidin	O
concentration	O
demonstrated	O
a	O
positive	O
correlation	O
(	O
ρ	O
=	O
0	O
.	O
236	O
,	O
p	O
=	O
0	O
.	O
005	O
).	O

There	O
was	O
a	O
significant	O
positive	O
correlation	O
between	O
age	O
and	O
cathelicidin	O
concentration	O
(	O
ρ	O
=	O
0	O
.	O
236	O
,	O
p	O
=	O
0	O
.	O
005	O
);	O
ρ	O
value	O
represents	O
Spearman	O
correlation	O
.	O

Further	O
questions	O
arise	O
with	O
respect	O
to	O
the	O
previous	O
treatment	O
trial	O
in	O
the	O
same	O
region	O
of	O
Kabul	O
,	O
which	O
showed	O
that	O
a	O
single	O
high	O
-	O
dose	O
supplementation	O
with	O
100	O
000	O
IU	O
vitamin	O
D3given	O
orally	O
to	O
young	O
children	O
,	O
along	O
with	O
antibiotic	O
treatment	O
at	O
the	O
time	O
of	O
diagnosis	O
,	O
reduced	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
subsequent	O
3	O
months	O
.	O
3The	O
inconsistent	O
results	O
could	O
be	O
related	O
to	O
the	O
evidence	O
that	O
stimulation	O
of	O
Toll	O
-	O
like	O
receptors	O
on	O
macrophages	O
and	O
monocytes	O
by	O
bacterial	O
antigens	O
is	O
important	O
in	O
up	O
-	O
regulation	O
of	O
CYP27B1	O
and	O
the	O
vitamin	O
D	O
receptor	O
,	O
5which	O
are	O
crucial	O
in	O
production	O
of	O
cathelicidins	O
in	O
vitamin	O
-	O
D	O
-	O
depleted	O
individuals	O
.	O

Recent	O
data	O
has	O
extended	O
this	O
list	O
to	O
include	O
specific	O
regions	O
not	O
associated	O
with	O
TEs	O
that	O
are	O
preferentially	O
located	O
within	O
CGIs	O
,	O
enhancers	O
,	O
promoters	O
and	O
gene	O
bodies	O
(	O
Seisenberger	O
et	O
al	O
.	O
2012	O
;	O
Hackett	O
et	O
al	O
.	O
2013	O
;	O
Tang	O
et	O
al	O
.	O
2015	O
).	O

A	O
possible	O
increase	O
in	O
the	O
rate	O
of	O
miscarriages	O
has	O
been	O
reported	O
to	O
occur	O
in	O
the	O
early	O
period	O
after	O
therapy	O
,	O
but	O
it	O
remains	O
uncertain	O
whether	O
abortion	O
can	O
be	O
caused	O
either	O
by	O
I	O
-	O
131	O
itself	O
,	O
by	O
the	O
thyroid	O
autoimmunity	O
often	O
associated	O
with	O
disease	O
or	O
by	O
the	O
hypothyroid	O
-	O
hyperprolactinaemic	O
status	O
accompanying	O
I	O
-	O
131	O
therapy	O
.	O

In	O
the	O
analyses	O
stratified	O
to	O
infants	O
born	O
vaginally	O
and	O
adjusted	O
for	O
other	O
potential	O
confounders	O
,	O
maternal	O
fruit	O
intake	O
was	O
associated	O
with	O
infant	O
gut	O
microbial	O
community	O
structure	O
(	O
PERMANOVA	O
,	O
p	O
<	O
0	O
.	O
05	O
).	O

In	O
this	O
respect	O
,	O
government	O
recommendations	O
must	O
be	O
carefully	O
worded	O
,	O
as	O
1	O
study	O
found	O
that	O
avoidance	O
of	O
peanuts	O
was	O
overdone	O
among	O
pregnant	O
women	O
:	O
although	O
such	O
avoidance	O
was	O
recommended	O
only	O
for	O
women	O
with	O
atopy	O
risk	O
,	O
65	O
%	O
of	O
all	O
pregnant	O
women	O
had	O
avoided	O
peanuts	O
during	O
pregnancy	O
(	O
42	O
%	O
of	O
all	O
women	O
who	O
responded	O
had	O
heard	O
about	O
the	O
advice	O
,	O
eg	O
,	O
from	O
their	O
midwives	O
,	O
and	O
50	O
%	O
subsequently	O
changed	O
their	O
diet	O
)	O
[	O
101	O
].	O

An	O
association	O
between	O
thyroid	O
cancer	O
and	O
parity	O
or	O
full	O
-	O
term	O
pregnancy	O
has	O
been	O
assessed	O
in	O
many	O
studies	O
without	O
significant	O
or	O
conclusive	O
results6	O
.	O

In	O
an	O
adjusted	O
analysis	O
,	O
maternal	O
dairy	O
intake	O
was	O
associated	O
with	O
infant	O
stool	O
microbiome	O
composition	O
(	O
generalized	O
UniFrac	O
distance	O
PERMANOVA	O
,	O
p	O
=	O
0	O
.	O
034	O
;	O
Fig	O
.	O

For	O
diagnosis	O
,	O
a	O
diary	O
of	O
allergy	O
symptoms	O
and	O
avoidance	O
of	O
specific	O
allergens	O
accompanied	O
by	O
monitoring	O
of	O
changes	O
of	O
allergic	O
symptoms	O
may	O
be	O
helpful	O
.	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

The	O
upper	O
and	O
lower	O
edges	O
of	O
the	O
box	O
represent	O
the	O
75thpercentile	O
and	O
the	O
25thpercentile	O
of	O
cathelicidin	O
concentration	O
,	O
respectively	O
,	O
measured	O
by	O
ELISA	O
and	O
reported	O
in	O
ng	O
/	O
mL	O
.	O

Other	O
Allergens	O
Avoidance	O
of	O
allergens	O
(	O
pets	O
,	O
house	O
dust	O
,	O
contact	O
allergens	O
,	O
drugs	O
)	O
is	O
not	O
recommended	O
except	O
when	O
sensitization	O
has	O
already	O
been	O
diagnosed	O
.	O

Results	O
Cohort	O
While	O
194	O
children	O
had	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
(	O
55	O
%	O
of	O
the	O
original	O
cohort	O
participating	O
in	O
the	O
vitamin	O
D	O
pregnancy	O
study	O
),	O
133	O
(	O
38	O
%)	O
had	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
study	O
visit	O
and	O
thus	O
,	O
were	O
able	O
to	O
have	O
cathelicidin	O
measured	O
.	O

First	O
,	O
an	O
unmatched	O
RV	O
post	O
-	O
weaning	O
diet	O
fed	O
the	O
offspring	O
born	O
to	O
HV	O
dams	O
resulted	O
in	O
increased	O
food	O
intake	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
,	O
as	O
observed	O
previously	O
.	O
4Second	O
,	O
the	O
HV	O
and	O
HFol	O
post	O
-	O
weaning	O
diets	O
prevented	O
these	O
effects	O
.	O

CQ	O
and	O
MAW	O
drafted	O
the	O
manuscript	O
.	O

Harmon	O
and	O
McLeod	O
[	O
111	O
]	O
reported	O
that	O
starch	O
digestion	O
is	O
more	O
efficient	O
in	O
the	O
small	O
intestine	O
than	O
during	O
fermentation	O
in	O
the	O
rumen	O
:	O
the	O
total	O
energetic	O
efficiency	O
of	O
rumen	O
-	O
fermented	O
starch	O
was	O
about	O
73	O
%	O
that	O
of	O
small	O
intestine	O
-	O
digested	O
starch	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

However	O
,	O
keeping	O
the	O
prevalence	O
figures	O
for	O
psychotic	O
disorders	O
in	O
mind	O
,	O
rather	O
few	O
participants	O
in	O
our	O
population	O
sample	O
are	O
likely	O
to	O
have	O
a	O
disorder	O
,	O
which	O
may	O
diminish	O
the	O
problem	B
of	O
reversed	O
causality	O
related	O
to	O
psychotic	O
diagnosis	O
or	O
medication	O
.	O

The	O
Vitamin	O
D	O
dietary	O
supplements	O
they	O
took	O
included	O
Vitamin	O
D3	O
calcium	O
,	O
multi	O
-	O
Vitamin	O
supplement	O
,	O
most	O
are	O
in	O
the	O
form	O
of	O
Vitamin	O
D3	O
,	O
only	O
4	O
participants	O
took	O
supplements	O
in	O
the	O
form	O
of	O
D2	O
(	O
Forceval	O
,	O
Vitamin	O
D2	O
200	O
IU	O
/	O
pill	O
,	O
once	O
daily	O
).	O

Birth	O
weight	O
percentile	O
was	O
calculated	O
using	O
the	O
Fenton	O
growth	O
chart	O
from	O
gestational	O
age	O
and	O
birth	O
weight	O
in	O
grams	O
(	O
Fenton	O
2003	O
),	O
allowing	O
us	O
to	O
account	O
for	O
gestational	O
age	O
in	O
our	O
birth	O
weight	O
metric	O
and	O
to	O
create	O
a	O
normalized	O
distribution	O
for	O
birth	O
weight	O
through	O
birth	O
weight	O
percentile	O
.	O

Age	O
had	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
18	O
and	O
39	O
,	O
respectively	O
.	O

Post	O
-	O
intervention	O
,	O
significantly	O
more	O
women	O
(	O
50	O
.	O
6	O
%)	O
received	O
best	O
-	O
practice	O
care	O
(	O
2	O
+	O
reviews	O
)	O
(	O
p	O
=	O
0	O
.	O
02	O
).	O

Infant	O
immune	O
response	O
The	O
infant	O
’	O
s	O
IgG	O
response	O
to	O
measles	O
immunisation	O
is	O
assessed	O
at	O
phase	O
7	O
,	O
which	O
is	O
6	O
weeks	O
after	O
measles	O
immunisation	O
was	O
administered	O
at	O
the	O
study	O
site	O
.	O

To	O
clarify	O
the	O
TFBSs	O
overrepresented	O
among	O
loci	O
whose	O
methylation	O
was	O
associated	O
with	O
either	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
gene	O
set	O
enrichment	O
analysis	O
(	O
GSEA	O
)	O
(	O
Subramanian	O
et	O
al	O
.	O

Data	O
analysis	O
Overall	O
,	O
data	O
processing	O
and	O
statistical	O
analysis	O
are	O
performed	O
using	O
the	O
SAS	O
statistical	O
package	O
(	O
SAS	O
,	O
Cary	O
,	O
NC	O
,	O
USA	O
).	O

The	O
mean	O
visfatin	O
and	O
adiponectin	O
levels	O
were	O
significantly	O
higher	O
in	O
the	O
macrosomia	O
group	O
compared	O
with	O
the	O
AGA	O
group	O
.	O

Conversely	O
,	O
results	O
from	O
a	O
US	O
cohort	O
study	O
demonstrated	O
a	O
significant	O
improvement	O
in	O
IQ	O
with	O
consumption	O
of	O
more	O
than	O
two	O
maternal	O
servings	O
of	O
fish	O
intake	O
per	O
week	O
as	O
assessed	O
via	O
‘	O
milestone	O
’	O
achievement	O
in	O
children	O
aged	O
six	O
months	O
and	O
eighteen	O
months	O
[	O
23	O
].	O

In	O
third	O
trimester	O
retention	O
of	O
water	O
,	O
constipation	O
is	O
seen	O
&	O
finally	O
preparation	O
of	O
genital	O
tract	O
for	O
delivery	O
is	O
needed	O
.	O

Vitamins	O
Several	O
vitamins	O
,	O
including	O
vitamins	O
A	O
,	O
D	O
,	O
and	O
C	O
,	O
are	O
implicated	O
in	O
regulating	O
IMF	O
deposition	O
.	O

Glucose	O
can	O
also	O
be	O
used	O
as	O
a	O
substrate	O
for	O
FA	O
de	O
novo	O
synthesis	O
in	O
ruminants	O
.	O

3	O
.	O

In	O
addition	O
the	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
10	O
ng	O
/	O
ml	O
(	O
severe	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
severe	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
same	O
predictors	O
in	O
the	O
model	O
.	O

Pregnancyassociated	O
immune	O
tolerance	O
,	O
designed	O
for	O
foetal	O
survival	O
,	O
might	O
enhance	O
disease	O
progression	O
.	O

…	O
But	O
for	O
mining	O
,	O
one	O
can	O
just	O
walk	O
to	O
it	O
in	O
the	O
canyon	O
.	O

Also	O
,	O
the	O
present	O
study	O
has	O
been	O
recorded	O
in	O
the	O
Iranian	O
Registry	O
of	O
Clinical	O
Trials	O
’	O
website	O
with	O
the	O
code	O
number	O
IRCT2015020310327N11	O
.	O

We	O
will	O
check	O
the	O
model	O
assumptions	O
and	O
make	O
appropriate	O
adjustments	O
to	O
the	O
analysis	O
where	O
necessary	O
.	O

Household	O
pets	O
were	O
assessed	O
during	O
pregnancy	O
and	O
serum	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
)	O
in	O
cord	O
blood	O
was	O
used	O
as	O
the	O
measure	O
of	O
vitamin	O
D	O
and	O
a	O
marker	O
of	O
maternal	O
level	O
.	O

The	O
median	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
[	O
25	O
-(	O
OH	O
)	O
D	O
]	O
concentration	O
was	O
significantly	O
lower	O
in	O
the	O
first	O
trimester	O
(	O
20	O
.	O
4	O
ng	O
/	O
ml	O
)	O
than	O
in	O
third	O
trimester	O
(	O
22	O
.	O
7	O
ng	O
/	O
ml	O
).	O

Other	O
research	O
has	O
found	O
that	O
a	O
reduction	O
in	O
physical	O
activity	O
by	O
bed	O
rest	O
was	O
associated	O
with	O
an	O
increase	O
in	O
infant	O
birth	O
weight	O
[	O
44	O
].	O

Investigations	O
revealed	O
normal	O
hemoglobin	O
,	O
total	O
and	O
differential	O
counts	O
and	O
normal	O
c	O
-	O
reactive	O
protein	O
.	O

The	O
child	O
was	O
treated	O
with	O
600	O
,	O
000	O
IU	O
of	O
oral	O
vitamin	O
D	O
and	O
discharged	O
on	O
maintenance	O
doses	O
of	O
calcium	O
gluconate	O
and	O
800	O
IU	O
of	O
oral	O
vitamin	O
D	O
daily	O
for	O
3	O
months	O
.	O

Therefore	O
glyburide	O
has	O
the	O
potential	O
to	O
result	O
in	O
earlier	O
development	O
of	O
maternal	O
diabetes	O
,	O
and	O
long	O
-	O
term	O
follow	O
-	O
up	O
of	O
the	O
mothers	O
are	O
needed	O
to	O
alleviate	O
this	O
concern	B
.	O

Pregnancy	O
data	O
are	O
collected	O
at	O
the	O
antenatal	O
care	O
(	O
ANC	O
)	O
clinic	O
of	O
RMMCH	O
in	O
addition	O
to	O
routine	O
care	O
.	O

ncRNAs	O
can	O
then	O
inhibit	O
the	O
production	O
of	O
protein	O
from	O
mRNAs	O
either	O
via	O
mRNA	O
degradation	O
and	O
/	O
or	O
reduced	O
translation	O
,	O
and	O
/	O
or	O
protect	O
genome	O
stability	O
via	O
the	O
degradation	O
of	O
transposable	O
elements	O
(	O
retrotransposons	O
).	O

Secondary	O
prevention	O
addresses	O
individuals	O
with	O
early	O
indicators	O
of	O
atopic	O
disease	O
.	O

Associations	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
We	O
separately	O
assessed	O
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
infant	O
gut	O
microbiome	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
(	O
n	O
=	O
48	O
).	O

Thus	O
,	O
the	O
rate	O
of	O
refusal	O
was	O
relatively	O
low	O
,	O
of	O
only	O
2	O
.	O
5	O
%	O
of	O
all	O
the	O
women	O
invited	O
to	O
participate	O
in	O
the	O
study	O
.	O

It	O
has	O
been	O
suggested	O
that	O
foods	O
containing	O
allergy	O
-	O
provoking	O
proteins	O
such	O
as	O
milk	O
,	O
egg	O
,	O
peanuts	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
should	O
not	O
be	O
introduced	O
into	O
the	O
diet	O
of	O
the	O
child	O
before	O
the	O
age	O
of	O
6	O
months	O
to	O
3	O
years	O
[	O
117	O
].	O

However	O
,	O
literature	O
has	O
presented	O
different	O
views	O
on	O
iron	O
requirements	O
during	O
pregnancy	O
ranging	O
from	O
450	O
to	O
1	O
,	O
150	O
mg	O
with	O
a	O
median	O
of	O
790	O
mg	O
[	O
14	O
,	O
19	O
–	O
21	O
].	O

The	O
risk	O
of	O
belonging	O
to	O
the	O
high	O
or	O
middle	O
psychotic	O
-	O
like	O
symptom	O
group	O
compared	O
to	O
the	O
low	O
level	O
group	O
was	O
significantly	O
lower	O
among	O
women	O
with	O
a	O
high	O
intake	O
of	O
white	O
fish	O
(	O
cod	O
/	O
saithe	O
/	O
pike	O
)	O
or	O
total	O
fish	O
and	O
seafood	O
products	O
.	O

PubMed	O
Central	O
:	O

The	O
authors	O
suggested	O
that	O
metabolic	O
imprinting	O
by	O
early	O
weaning	O
and	O
a	O
high	O
concentrate	O
feeding	O
before	O
grazing	O
is	O
a	O
feasible	O
method	O
to	O
improve	O
MS	O
and	O
carcass	O
weight	O
.	O

Potential	O
confounders	O
for	O
the	O
associations	O
studied	O
were	O
identified	O
using	O
directed	O
acyclic	O
graphs	O
(	O
www	O
.	O
dagitty	O
.	O
net	O
)	O
[	O
17	O
].	O

Upstream	O
signaling	O
events	O
of	O
'	O
mTOR	O
signaling	O
'	O
include	O
alterations	O
in	O
amino	O
acid	O
availability	O
,	O
abundance	O
of	O
hormones	O
,	O
AMP	O
and	O
growth	O
factors	O
[	O
32	O
].	O

Another	O
significant	O
factor	O
for	O
sample	O
loss	B
was	O
that	O
a	O
number	O
of	O
the	O
women	O
did	O
not	O
return	O
to	O
the	O
specified	O
hospital	O
for	O
childbirth	O
.	O

We	O
performed	O
crude	O
and	O
adjusted	O
analyses	O
for	O
each	O
dietary	O
food	O
group	O
variable	O
individually	O
,	O
normalized	O
by	O
maternal	O
calorie	O
consumption	O
,	O
and	O
maternal	O
aMED	O
score	O
and	O
MUFA	O
:	O
SFA	O
ratio	O
in	O
vaginally	O
delivered	O
infants	O
.	O

In	O
contrast	O
to	O
BMP7	O
and	O
BMP8B	O
,	O
BMP4	O
was	O
shown	O
to	O
promote	O
the	O
differentiation	O
of	O
mesenchymal	O
stem	O
cells	O
into	O
white	O
adipocytes	O
,	O
inducing	O
fat	O
storage	O
and	O
decreasing	O
energy	O
expenditure	O
in	O
rodents	O
(	O
Modica	O
and	O
Wolfrum	O
,	O
2013	O
;	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

Specifications	O
table	O
TableSubject	O
areaBiologyMore	O
specific	O
subject	O
areaAnimal	O
nutrition	O
and	O
metabolismType	O
of	O
dataFigure	O
of	O
miRNAs	O
predicted	O
to	O
target	O
GR	O
,	O
Table	O
of	O
miRNAs	O
expressionHow	O
data	O
was	O
acquiredQuantitative	O
PCR	O
analysis	O
was	O
performed	O
using	O
SYBR	O
Premix	O
Ex	O
Taq	O
™	O
PCR	O
Master	O
Mix	O
in	O
Mastercycler	O
®	O
ep	O
realplex	O
PCR	O
detection	O
system	O
.	O
Data	O
formatFiltered	O
and	O
analyzedExperimental	O
factorsMaternal	O
gestational	O
betaine	O
supplementationExperimental	O
featuresRNA	O
isolation	O
and	O
polyadenylation	O
;	O
real	O
-	O
time	O
PCR	O
.	O
Data	O
source	O
locationDafeng	O
,	O
Jiangsu	O
,	O
ChinaData	O
accessibilityData	O
are	O
provided	O
in	O
the	O
paper	O
Value	O
of	O
the	O
data	O
miRNAs	O
participation	O
in	O
post	O
-	O
transcription	O
of	O
genes	O
could	O
be	O
included	O
in	O
other	O
studies	O
of	O
fetal	O
programming	O
.	O

In	O
juvenile	O
piglets	O
(	O
stage	O
28	O
dpn	O
)	O
483	O
probe	O
-	O
sets	O
differed	O
between	O
LP	O
and	O
AP	O
offspring	O
.	O

Guidelines	O
could	O
be	O
developed	O
for	O
improved	O
molecular	O
(	O
in	O
vivo	O
,	O
in	O
vitro	O
and	O
epidemiological	O
)	O
and	O
bioinformatic	O
study	O
designs	O
that	O
incorporate	O
suitable	O
new	O
technologies	O
(	O
such	O
as	O
omics	O
platforms	O
)	O
and	O
appropriate	O
inhibitors	O
/	O
treatments	O
/	O
cessations	O
(	O
for	O
exposure	O
/	O
change	O
/	O
effect	O
validation	O
)	O
to	O
definitively	O
identify	O
detailed	O
epigenetic	O
mechanisms	O
that	O
link	O
,	O
or	O
act	O
as	O
markers	O
of	O
,	O
environmental	O
exposures	O
and	O
adverse	O
health	O
outcomes	O
.	O

Diets	O
were	O
formulated	O
to	O
be	O
isocaloric	O
(	O
13	O
.	O
6	O
MJ	O
ME	O
/	O
kg	O
on	O
average	O
)	O
[	O
15	O
].	O

An	O
overview	O
of	O
the	O
relevant	O
TGs	O
that	O
could	O
be	O
explored	O
for	O
adaptation	O
(	O
updated	O
from	O
Greally	O
&	O
Jacobs2013	O
),	O
is	O
provided	O
inTable	O
3	O
.	O

The	O
lower	O
SEI	O
of	O
the	O
Adelaide	O
women	O
could	O
therefore	O
make	O
them	O
more	O
susceptible	O
to	O
lower	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
because	O
of	O
factors	O
relating	O
to	O
disadvantage	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
6	O
month	O
infant	O
neurodevelopmental	O
outcomes	O
by	O
treatment	O
group	O
,	O
assessed	O
by	O
the	O
Ages	O
and	O
Stages	O
QuestionnaireOutcomeLifestyle	O
advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
treatment	O
effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueCommunication	O
domain51	O
.	O
30	O
(	O
9	O
.	O
03	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
63	O
)	O
0	O
.	O
35	O
(−	O
0	O
.	O
68	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
5010	O
.	O
36	O
(−	O
0	O
.	O
67	O
,	O
1	O
.	O
38	O
)	O
0	O
.	O
493Gross	O
motor	O
domain53	O
.	O
35	O
(	O
10	O
.	O
05	O
)	O
52	O
.	O
74	O
(	O
10	O
.	O
84	O
)	O
0	O
.	O
61	O
(−	O
0	O
.	O
54	O
,	O
1	O
.	O
75	O
)	O
0	O
.	O
2970	O
.	O
55	O
(−	O
0	O
.	O
59	O
,	O
1	O
.	O
69	O
)	O
0	O
.	O
344Fine	O
motor	O
domain52	O
.	O
25	O
(	O
10	O
.	O
52	O
)	O
51	O
.	O
20	O
(	O
10	O
.	O
74	O
)	O
1	O
.	O
05	O
(−	O
0	O
.	O
11	O
,	O
2	O
.	O
21	O
)	O
0	O
.	O
0751	O
.	O
00	O
(−	O
0	O
.	O
13	O
,	O
2	O
.	O
14	O
)	O
0	O
.	O
082Problem	O
solving	O
domain53	O
.	O
60	O
(	O
9	O
.	O
55	O
)	O
52	O
.	O
86	O
(	O
9	O
.	O
15	O
)	O
0	O
.	O
74	O
(−	O
0	O
.	O
29	O
,	O
1	O
.	O
76	O
)	O
0	O
.	O
1580	O
.	O
72	O
(−	O
0	O
.	O
31	O
,	O
1	O
.	O
74	O
)	O
0	O
.	O
170Social	O
domain51	O
.	O
71	O
(	O
9	O
.	O
52	O
)	O
50	O
.	O
95	O
(	O
9	O
.	O
74	O
)	O
0	O
.	O
77	O
(−	O
0	O
.	O
34	O
,	O
1	O
.	O
87	O
)	O
0	O
.	O
1730	O
.	O
69	O
(−	O
0	O
.	O
41	O
,	O
1	O
.	O
79	O
)	O
0	O
.	O
218Total	O
score262	O
.	O
47	O
(	O
34	O
.	O
92	O
)	O
258	O
.	O
72	O
(	O
36	O
.	O
54	O
)	O
3	O
.	O
75	O
(−	O
0	O
.	O
13	O
,	O
7	O
.	O
63	O
)	O
0	O
.	O
0583	O
.	O
53	O
(−	O
0	O
.	O
33	O
,	O
7	O
.	O
40	O
)	O
0	O
.	O
073More	O
than	O
1	O
score	O
below	O
cut	O
-	O
off	O
*	O
49	O
(	O
4	O
.	O
58	O
)	O
69	O
(	O
6	O
.	O
51	O
)	O
0	O
.	O
70	O
(	O
0	O
.	O
44	O
,	O
1	O
.	O
12	O
)	O
0	O
.	O
1370	O
.	O
69	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
126	O
Values	O
are	O
mean	O
and	O
standard	O
deviation	O
(	O
or	O
number	O
and	O
percentage	O
),	O
and	O
treatment	O
effects	O
are	O
differences	O
in	O
means	O
(	O
or	O
relative	O
risks	O
)	O
and	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

The	O
potential	O
for	O
such	O
adaptations	O
is	O
already	O
acknowledged	O
at	O
the	O
OECD	O
,	O
but	O
more	O
applied	O
development	O
of	O
key	O
markers	O
and	O
subsequent	O
validation	O
work	O
is	O
needed	O
to	O
formally	O
incorporate	O
epigenetic	O
endpoints	O
into	O
TGs	O
.	O

Smoking	O
status	O
was	O
categorised	O
as	O
the	O
maximum	O
exposure	O
during	O
pregnancy	O
(	O
never	O
,	O
passive	O
smoking	O
only	O
,	O
1	O
–	O
9	O
,	O
10	O
–	O
19	O
and	O
≥	O
20	O
cigarettes	O
per	O
day	O
).	O

(	O
2014	O
)‡	O
Yang	O
et	O
al	O
.	O

Birth	O
Weight	O
Many	O
studies	O
have	O
evaluated	O
the	O
association	O
between	O
birth	O
weight	O
and	O
the	O
development	O
of	O
autism	O
.	O

Unexpectedly	O
,	O
the	O
intake	O
of	O
fatty	O
fish	O
(	O
salmon	O
,	O
herring	O
and	O
mackerel	O
)	O
or	O
shellfish	O
more	O
than	O
twice	O
a	O
week	O
increased	O
the	O
risk	O
of	O
being	O
in	O
the	O
group	O
with	O
the	O
highest	O
level	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

Guidelines	O
for	O
evaluation	O
and	O
treatment	O
of	O
thyroid	O
cancer	O
must	O
consider	O
the	O
gestational	O
age	O
but	O
also	O
the	O
patients	O
'	O
desires	O
.	O

It	O
will	O
also	O
serve	O
as	O
a	O
reminder	O
for	O
regular	O
consumption	O
and	O
safely	O
store	O
the	O
medicines	O
away	O
from	O
child	O
access	O
.	O

Peptide	O
mass	O
maps	O
of	O
tryptic	O
peptides	O
were	O
generated	O
by	O
matrix	O
assisted	O
laser	O
desorption	O
/	O
ionisation	O
time	O
-	O
of	O
-	O
flight	O
mass	O
spectrometry	O
(	O
MALDI	O
-	O
TOF	O
MS	O
)	O
using	O
an	O
Applied	O
Biosystems	O
Q	O
-	O
STAR	O
Pulsar	O
with	O
MALDI	O
source	O
(	O
APAF	O
,	O
University	O
of	O
Sydney	O
).	O

found	O
that	O
5000	O
IU	O
vitamin	O
D	O
per	O
day	O
for	O
6	O
weeks	O
had	O
no	O
effect	O
on	O
men	O
and	O
women	O
’	O
s	O
cognitive	O
and	O
emotional	O
function	O
[	O
69	O
].	O

Our	O
model	O
indicates	O
that	O
gestational	O
LP	O
diets	O
affected	O
the	O
hepatic	O
expression	O
profiles	O
in	O
an	O
acute	O
,	O
short	O
-	O
term	O
as	O
well	O
as	O
in	O
a	O
delayed	O
,	O
long	O
-	O
term	O
manner	O
in	O
LP	O
offspring	O
.	O

Exposure	O
to	O
Tobacco	O
Smoke	O
One	O
of	O
the	O
most	O
frequently	O
discussed	O
risk	O
factors	O
for	O
induction	O
of	O
sensitization	O
in	O
all	O
populations	O
and	O
age	O
groups	O
is	O
tobacco	O
smoke	O
(	O
active	O
smoking	O
or	O
the	O
passive	O
environmental	O
exposure	O
).	O

While	O
much	O
of	O
the	O
work	O
to	O
date	O
has	O
focused	O
on	O
rodent	O
models	O
,	O
there	O
is	O
also	O
some	O
evidence	O
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
in	O
other	O
mammalian	O
species	O
,	O
including	O
sheep	O
and	O
monkeys	O
(	O
Wu	O
et	O
al	O
.	O
2008	O
;	O
Begum	O
et	O
al	O
.	O
2013	O
;	O
Lie	O
et	O
al	O
.	O
2014a	O
,	O
2014b	O
).	O

2007	O
;	O
Choi	O
et	O
al	O
.	O

On	O
a	O
subsequent	O
encounter	O
with	O
the	O
allergen	O
,	O
bridging	O
of	O
2	O
or	O
more	O
IgE	O
antibodies	O
leads	O
to	O
degranulation	O
of	O
the	O
mast	O
cell	O
with	O
release	O
of	O
preformed	O
mediators	O
such	O
as	O
histamine	O
,	O
serotonin	O
,	O
tryptase	O
,	O
chymase	O
,	O
kininogenase	O
,	O
and	O
heparin	O
.	O

These	O
findings	O
are	O
largely	O
driven	O
by	O
data	O
from	O
the	O
United	O
States	O
,	O
where	O
most	O
mothers	O
took	O
vitamins	O
.	O

The	O
characteristics	O
of	O
the	O
pregnant	O
women	O
included	O
in	O
the	O
study	O
are	O
shown	O
inTable	O
2	O
.	O

Objective	O
To	O
evaluate	O
and	O
relate	O
pre	O
-	O
pregnancy	O
body	O
mass	O
index	O
(	O
PPBMI	O
),	O
weight	O
gain	O
and	O
energy	O
intake	O
at	O
diagnosis	O
of	O
GDM	O
.	O

[	O
48	O
],	O
which	O
has	O
been	O
validated	O
against	O
weighed	O
dietary	O
records	O
and	O
modified	O
in	O
the	O
light	O
of	O
a	O
more	O
recent	O
weighed	O
dietary	O
survey	O
[	O
13	O
].	O

Persistence	O
and	O
clinical	O
relevant	O
impairment	O
may	O
be	O
related	O
to	O
a	O
family	O
history	O
of	O
schizophrenia	O
and	O
environmental	O
risk	O
factors	O
that	O
might	O
interact	O
with	O
the	O
genetic	O
risk	O
.	O

Generally	O
,	O
the	O
relationship	O
between	O
visfatin	O
and	O
the	O
infants	O
’	O
s	O
growth	O
indicators	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

The	O
first	O
choice	O
in	O
the	O
prophylaxis	O
of	O
iron	O
deficiency	O
anaemia	O
for	O
almost	O
all	O
women	O
is	O
oral	O
iron	O
replacement	O
because	O
of	O
its	O
effectiveness	O
,	O
safety	O
,	O
and	O
low	O
cost	O
[	O
25	O
].	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
adiposity	O
in	O
adult	O
offspring	O
We	O
detected	O
a	O
prenatal	O
diet	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perirenal	O
and	O
abdominal	O
fat	O
relative	O
to	O
body	O
weight	O
(	O
Table2	O
).	O

One	O
case	O
of	O
anaphylaxis	O
and	O
3	O
cases	O
of	O
serious	O
allergic	O
reaction	O
involved	O
women	O
taking	O
prenatal	O
supplements	O
,	O
two	O
of	O
which	O
reported	O
spontaneous	O
abortion	O
.	O

This	O
was	O
a	O
single	O
-	O
blind	O
study	O
.	O

She	O
clarified	O
the	O
study	O
’	O
s	O
goals	O
and	O
if	O
the	O
mothers	O
were	O
willing	O
to	O
participation	O
a	O
written	O
informed	O
consent	O
was	O
obtained	O
from	O
them	O
.	O

These	O
modifications	O
alter	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
(	O
such	O
as	O
transcription	O
factors	O
and	O
RNA	O
polymerases	O
)	O
so	O
that	O
it	O
is	O
the	O
overall	O
combined	O
effect	O
of	O
the	O
histone	O
code	O
that	O
determines	O
an	O
active	O
or	O
repressive	O
chromatin	O
structure	O
and	O
thus	O
regulates	O
gene	O
expression	O
.	O

Moreover	O
,	O
there	O
were	O
additional	O
studies	O
that	O
have	O
investigated	O
environmentally	O
induced	O
epigenetic	O
changes	O
without	O
simultaneously	O
assessing	O
any	O
phenotypic	O
/	O
toxicological	O
endpoints	O
and	O
/	O
or	O
focused	O
on	O
acute	O
exposures	O
(	O
less	O
than	O
24	O
h	O
).	O

Of	O
total	O
participants	O
92	O
(	O
60	O
.	O
1	O
%)	O
mothers	O
were	O
nulliparous	O
and	O
61	O
(	O
39	O
.	O
9	O
%)	O
were	O
multiparous	O
women	O
.	O

Paradoxically	O
,	O
central	O
IL	O
-	O
6	O
delivery	O
was	O
shown	O
to	O
suppress	O
weight	O
gain	O
and	O
visceral	O
obesity	O
,	O
without	O
affecting	O
food	O
intake	O
(	O
Li	O
et	O
al	O
.,	O
2002	O
).	O

The	O
mRNA	O
expression	O
level	O
of	O
genes	O
associated	O
with	O
cell	O
cycle	O
,	O
mitosis	O
,	O
and	O
metabolism	O
of	O
purines	O
and	O
pyrimidines	O
was	O
increased	O
in	O
LP	O
offspring	O
.	O

Differences	O
in	O
physical	O
activity	O
levels	O
were	O
clinically	O
,	O
but	O
not	O
significantly	O
different	O
(	O
15	O
.	O
5	O
mins	O
vs	O
9l	O
.	O
8mins	O
/	O
week	O
).	O

Total	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
and	O
chocolate	O
preference	O
(	O
calculated	O
as	O
the	O
percentage	O
of	O
chocolate	O
eaten	O
on	O
overall	O
intake	O
)	O
were	O
evaluated	O
at	O
adolescence	O
(	O
postnatal	O
weeks	O
8	O
–	O
9	O
)	O
and	O
reevaluated	O
at	O
adulthood	O
(	O
postnatal	O
weeks	O
12	O
–	O
13	O
)	O
in	O
all	O
experimental	O
groups	O
.	O

PubMed	O
Central	O
:	O

PubMed	O
Central	O
:	O

Only	O
,	O
4	O
women	O
(	O
2	O
.	O
2	O
%)	O
were	O
sufficient	O
(	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
of	O
≥	O
30	O
ng	O
/	O
mL	O
).	O

In	O
normal	O
weight	O
mothers	O
,	O
higher	O
intake	O
of	O
soft	O
drinks	O
was	O
the	O
strongest	O
predictor	O
of	O
higher	O
offspring	O
weight	O
status	O
at	O
birth	O
but	O
was	O
not	O
a	O
significant	O
predictor	O
of	O
weight	O
at	O
6	O
months	O
.	O

Finally	O
,	O
thyroid	O
cancer	O
patients	O
often	O
undergo	O
total	O
thyroidectomy	O
and	O
thus	O
need	O
adequate	O
supplementation	O
of	O
both	O
calcium	O
and	O
thyroxine	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

Metformin	O
alters	O
gene	O
expression	O
in	O
mice	O
livers	O
and	O
has	O
been	O
demonstrated	O
to	O
have	O
an	O
antiproliferative	O
effect	O
through	O
reductions	O
in	O
cyclin	O
D1	O
and	O
activation	O
of	O
AMP	O
kinase	O
.	O
79The	O
programming	O
and	O
developmental	O
effects	O
of	O
these	O
on	O
a	O
fetus	O
are	O
unknown	O
.	O

The	O
dynamics	O
of	O
this	O
first	O
re	O
-	O
programing	O
and	O
programing	O
event	O
are	O
particularly	O
well	O
highlighted	O
by	O
the	O
functional	O
switching	O
of	O
sncRNAs	O
from	O
a	O
focus	O
on	O
guarding	O
the	O
genome	O
to	O
guiding	O
development	O
.	O

Serum	O
25	O
-	O
hydroxyvitamin	O
D	O
as	O
the	O
main	O
precursor	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
has	O
a	O
circulating	O
half	O
-	O
life	O
of	O
2	O
–	O
3	O
weeks	O
.	O

The	O
decreased	O
flake	O
thickness	O
of	O
steam	O
-	O
flaked	O
sorghum	O
increased	O
starch	O
digestion	O
and	O
liver	O
gluconeogenesis	O
[	O
114	O
].	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
2	O
Regulated	O
pathways	O
in	O
liver	O
tissue	O
between	O
ontogenetic	O
stages	O
and	O
diets	O
.	O

Major	O
Maternal	O
Dietary	O
Patterns	O
during	O
Early	O
Pregnancy	O
and	O
Their	O
Association	O
with	O
Neonatal	O
Anthropometric	O
Measurement	O
Abstract	O
Background	O
Anthropometric	O
measurements	O
of	O
newborn	O
infant	O
are	O
widely	O
assessed	O
as	O
determinants	O
of	O
maternal	O
nutrition	O
.	O

The	O
uncertainty	O
concerning	B
the	O
optimal	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
is	O
even	O
higher	O
.	O

Q	O
:	O
quintile	O
.#:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

Fear	O
of	O
labor	O
pain	O
is	O
another	O
concern	O
of	O
the	O
modern	O
-	O
day	O
mothers	O
[	O
78	O
].	O

Reactions	O
were	O
performed	O
in	O
a	O
final	O
volume	O
of	O
10	O
μl	O
using	O
5	O
.	O
0	O
μl	O
of	O
LightCycler	O
480	O
SYBR	O
Green	O
I	O
Master	O
(	O
Roche	O
),	O
2	O
.	O
0	O
μl	O
of	O
Aqua	O
dest	O
.,	O
10	O
μM	O
(	O
0	O
.	O
5	O
μl	O
)	O
of	O
each	O
primer	O
(	O
Table5	O
)	O
and	O
40	O
ng	O
(	O
2	O
μl	O
)	O
cDNA	O
.	O

006	O
26769	O
.	O
4	O
0	O
.	O
003	O
No320533	O
.	O
3533	O
.	O
3	O
Obstetrician	O
Yes18555	O
.	O
425576	O
.	O
325576	O
.	O
3	O
No710	O
.	O
61725	O
.	O
81725	O
.	O
8Total	O
number	O
or	O
prenatal	O
visits	O
≤	O
422	O
.	O
8	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
>	O
419057	O
.	O
925477	O
.	O
425477	O
.	O
4Gestational	O
age	O
at	O
registration	O
(	O
months	O
)	O
<	O
418053	O
.	O
7	O
<	O
0	O
.	O
001	O
19257	O
.	O
3	O
0	O
.	O
019	O
24472	O
.	O
8	O
<	O
0	O
.	O
001	O
≥	O
41218	O
.	O
52741	O
.	O
52843	O
.	O
1Nutritional	O
questionnaire	O
score	O
Low710	O
.	O
1	O
<	O
0	O
.	O
001	O
2333	O
.	O
3	O
<	O
0	O
.	O
001	O
2231	O
.	O
9	O
<	O
0	O
.	O
001	O
Medium13747	O
.	O
114756	O
.	O
819274	O
.	O
3	O
High4865	O
.	O
84967	O
.	O
65879	O
.	O
7	O
The	O
proportion	O
of	O
less	O
well	O
-	O
educated	O
women	O
(	O
less	O
than	O
8	O
years	O
of	O
school	O
completed	O
)	O
using	O
folic	O
acid	O
(	O
p	O
=	O
.	O
007	O
),	O
iron	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
)	O
increased	O
with	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

We	O
compared	O
baseline	O
characteristics	O
and	O
the	O
distribution	O
of	O
our	O
prestated	O
confounders	O
for	O
intervention	O
and	O
placebo	O
groups	O
.	O

Thyroid	O
hormones	O
(	O
thyroid	O
stimulating	O
hormone	O
,	O
thyroglobulin	O
,	O
total	O
thyroxine	O
)	O
will	O
be	O
determined	O
in	O
whole	O
blood	O
spots	O
by	O
using	O
electrochemiluminescence	O
immunoassays	O
.	O

The	O
identification	O
of	O
external	O
factors	O
particularly	O
perinatal	O
risk	O
factors	O
forms	O
the	O
initial	O
critical	O
step	O
in	O
preventing	O
and	O
alleviating	O
risks	O
.	O

Pre	O
-	O
pregnancy	O
BMI	O
based	O
on	O
pre	O
-	O
pregnancy	O
weight	O
was	O
calculated	O
using	O
the	O
following	O
equation	O
as	O
defined	O
by	O
the	O
World	O
Health	O
Organization	O
:	O
weight	O
/	O
height2	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sexPregnancy	O
ComplicationsAll	O
womenAny	O
ComplicationPEGHGDMsPTBSGA	O
n	O
(%)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
n	O
(%)	O
aRR	O
*	O
(	O
95	O
%	O
CI	O
)	O
Standardised	O
Quartiles	O
**	O
Males	O
Low367	O
(	O
26	O
)	O
173	O
(	O
47	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
18	O
)	O
24	O
(	O
7	O
)	O
1	O
.	O
24	O
(	O
0	O
.	O
65	O
,	O
2	O
.	O
34	O
)	O
31	O
(	O
8	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
64	O
,	O
1	O
.	O
94	O
)	O
18	O
(	O
5	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
58	O
,	O
2	O
.	O
68	O
)	O
22	O
(	O
6	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
60	O
,	O
1	O
.	O
98	O
)	O
43	O
(	O
12	O
)	O
1	O
.	O
14	O
(	O
0	O
.	O
73	O
,	O
1	O
.	O
79	O
)	O
Low	O
-	O
Moderate364	O
(	O
26	O
)	O
163	O
(	O
45	O
)	O
1	O
.	O
01	O
(	O
0	O
.	O
86	O
,	O
1	O
.	O
19	O
))	O
20	O
(	O
5	O
)	O
1	O
.	O
11	O
(	O
0	O
.	O
58	O
,	O
2	O
.	O
12	O
)	O
32	O
(	O
9	O
)	O
1	O
.	O
25	O
(	O
0	O
.	O
73	O
,	O
2	O
.	O
13	O
)	O
13	O
(	O
4	O
)	O
1	O
.	O
06	O
(	O
0	O
.	O
48	O
,	O
2	O
.	O
38	O
)	O
18	O
(	O
5	O
)	O
0	O
.	O
93	O
(	O
0	O
.	O
49	O
,	O
1	O
.	O
76	O
)	O
45	O
(	O
12	O
)	O
1	O
.	O
23	O
(	O
0	O
.	O
80	O
,	O
1	O
.	O
88	O
)	O
Moderate	O
-	O
High359	O
(	O
25	O
)	O
152	O
(	O
42	O
)	O
1	O
.	O
0	O
†	O
16	O
(	O
4	O
)	O
1	O
.	O
0	O
†	O
23	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
11	O
(	O
3	O
)	O
1	O
.	O
0	O
†	O
18	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
35	O
(	O
10	O
)	O
1	O
.	O
0	O
†	O
High325	O
(	O
23	O
)	O
111	O
(	O
34	O
)	O
0	O
.	O
86	O
(	O
0	O
.	O
71	O
,	O
1	O
.	O
04	O
)	O
15	O
(	O
5	O
)	O
1	O
.	O
18	O
(	O
0	O
.	O
59	O
,	O
2	O
.	O
36	O
)	O
17	O
(	O
5	O
)	O
0	O
.	O
90	O
(	O
0	O
.	O
50	O
,	O
1	O
.	O
62	O
)	O
4	O
(	O
1	O
)	O
0	O
.	O
45	O
(	O
0	O
.	O
15	O
,	O
1	O
.	O
38	O
)	O
15	O
(	O
5	O
)	O
0	O
.	O
97	O
(	O
0	O
.	O
50	O
,	O
1	O
.	O
88	O
)	O
26	O
(	O
8	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
26	O
)	O
Females	O
Low380	O
(	O
28	O
)	O
169	O
(	O
44	O
)	O
0	O
.	O
91	O
(	O
0	O
.	O
77	O
,	O
1	O
.	O
06	O
)	O
23	O
(	O
6	O
)	O
0	O
.	O
85	O
(	O
0	O
.	O
47	O
,	O
1	O
.	O
55	O
)	O
30	O
(	O
8	O
)	O
0	O
.	O
87	O
(	O
0	O
.	O
52	O
,	O
1	O
.	O
45	O
)	O
13	O
(	O
3	O
)	O
0	O
.	O
51	O
(	O
0	O
.	O
25	O
,	O
1	O
.	O
04	O
)	O
14	O
(	O
4	O
)	O
0	O
.	O
61	O
(	O
0	O
.	O
31	O
,	O
1	O
.	O
18	O
)	O
45	O
(	O
12	O
)	O
0	O
.	O
88	O
(	O
0	O
.	O
58	O
,	O
1	O
.	O
35	O
)	O
Low	O
-	O
Moderate353	O
(	O
26	O
)	O
168	O
(	O
48	O
)	O
0	O
.	O
99	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
15	O
)	O
24	O
(	O
7	O
)	O
1	O
.	O
03	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
85	O
)	O
31	O
(	O
9	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
57	O
,	O
1	O
.	O
50	O
)	O
9	O
(	O
3	O
)	O
0	O
.	O
44	O
(	O
0	O
.	O
20	O
,	O
0	O
.	O
97	O
)	O
18	O
(	O
5	O
)	O
0	O
.	O
79	O
(	O
0	O
.	O
43	O
,	O
1	O
.	O
45	O
)	O
33	O
(	O
9	O
)	O
0	O
.	O
74	O
(	O
0	O
.	O
48	O
,	O
1	O
.	O
13	O
)	O
Moderate	O
-	O
High334	O
(	O
24	O
)	O
149	O
(	O
45	O
)	O
1	O
.	O
0	O
†	O
19	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
28	O
(	O
8	O
)	O
1	O
.	O
0	O
†	O
17	O
(	O
5	O
)	O
1	O
.	O
0	O
†	O
21	O
(	O
6	O
)	O
1	O
.	O
0	O
†	O
31	O
(	O
9	O
)	O
1	O
.	O
0	O
†	O
High314	O
(	O
23	O
)	O
128	O
(	O
41	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
84	O
,	O
1	O
.	O
19	O
)	O
19	O
(	O
6	O
)	O
1	O
.	O
29	O
(	O
0	O
.	O
70	O
,	O
2	O
.	O
35	O
)	O
20	O
(	O
6	O
)	O
0	O
.	O
85	O
(	O
0	O
.	O
49	O
,	O
1	O
.	O
46	O
)	O
6	O
(	O
2	O
)	O
0	O
.	O
48	O
(	O
0	O
.	O
19	O
,	O
1	O
.	O
23	O
)	O
12	O
(	O
4	O
)	O
0	O
.	O
60	O
(	O
0	O
.	O
30	O
,	O
1	O
.	O
21	O
)	O
29	O
(	O
9	O
)	O
0	O
.	O
82	O
(	O
0	O
.	O
53	O
,	O
1	O
.	O
28	O
)	O
*	O
Relative	O
risks	O
compared	O
to	O
all	O
women	O
were	O
adjusted	O
for	O
age	O
,	O
maternal	O
body	O
mass	O
index	O
,	O
ethnicity	O
(	O
non	O
Caucasian	O
vs	O
.	O
Caucasian	O
),	O
smoking	O
status	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
(	O
no	O
vs	O
.	O
yes	O
),	O
alcohol	O
consumption	O
at	O
15	O
±	O
1	O
weeks	O
’	O
(	O
no	O
vs	O
yes	O
),	O
recreational	O
walking	O
(	O
1	O
-	O
3	O
×/	O
week	O
and	O
≥	O
4	O
×/	O
week	O
vs	O
.	O
never	O
)	O
and	O
recruitment	O
site	O
(	O
Auckland	O
vs	O
.	O
Adelaide	O
)	O
**	O
Serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
standardised	O
for	O
month	O
that	O
serum	O
was	O
sampled	O
based	O
as	O
previously	O
described	O
[	O
34	O
]	O
†	O
Reference	O
category	O
Discussion	O
This	O
study	O
adds	O
to	O
the	O
current	O
body	O
of	O
literature	O
on	O
vitamin	O
D	O
status	O
in	O
a	O
population	O
of	O
pregnant	O
Australian	O
and	O
New	O
Zealand	O
women	O
and	O
provides	O
insight	O
into	O
normal	O
circulating	O
levels	O
of	O
25	O
(	O
OH	O
)	O
D	O
in	O
early	O
pregnancy	O
.	O

At	O
188	O
dpn	O
the	O
body	O
weight	O
was	O
slightly	O
but	O
significantly	O
reduced	O
in	O
LP	O
compared	O
to	O
AP	O
(	O
LP	O
:	O
123	O
.	O
19	O
±	O
9	O
.	O
15	O
kg	O
,	O
AP	O
:	O
131	O
.	O
55	O
±	O
15	O
.	O
11	O
kg	O
,	O
P	O
-	O
0	O
.	O
03	O
;	O
n	O
-	O
32	O
).	O

Evidence	O
abounds	O
on	O
their	O
effectiveness	O
in	O
reducing	O
the	O
prevalence	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

After	O
intervention	O
,	O
the	O
two	O
groups	O
were	O
different	O
significantly	O
.	O

Based	O
on	O
aggregated	O
evidence	O
from	O
animal	O
and	O
human	O
studies	O
,	O
Witter	O
et	O
al	O
.	O

Infections	O
were	O
defined	O
as	O
discrete	O
events	O
that	O
were	O
documented	O
in	O
the	O
medical	O
record	O
and	O
/	O
or	O
the	O
primary	O
health	O
care	O
record	O
.	O

This	O
might	O
suggest	O
the	O
existence	O
of	O
social	O
inequities	O
and	O
the	O
influence	O
of	O
economic	O
factors	O
in	O
making	O
health	O
-	O
related	O
decisions	O
,	O
as	O
in	O
our	O
country	O
,	O
women	O
in	O
the	O
urban	O
area	O
,	O
more	O
educated	O
and	O
with	O
less	O
children	O
are	O
usually	O
having	O
a	O
better	O
financial	O
status	O
.	O

This	O
result	O
is	O
consistent	O
with	O
the	O
findings	O
of	O
Jeng	O
et	O
al	O
.,	O
who	O
also	O
showed	O
no	O
correlation	O
with	O
BMI	O
and	O
cathelicidin	O
in	O
adults	O
with	O
sepsis	O
[	O
9	O
].	O

We	O
were	O
unable	O
to	O
assess	O
associations	O
with	O
maternal	O
sugar	O
intake	O
in	O
early	O
pregnancy	O
;	O
however	O
,	O
intakes	O
in	O
early	O
and	O
late	O
pregnancy	O
are	O
likely	O
to	O
be	O
highly	O
correlated	O
.	O

Vitamin	O
D	O
requirement	O
during	O
pregnancy	O
Thyroidectomised	O
patients	O
often	O
need	O
calcium	O
and	O
D	O
vitamin	O
supplementation	O
,	O
and	O
the	O
treatment	O
needs	O
frequent	O
adjustment	O
during	O
the	O
pregnancy	O
to	O
prevent	O
maternal	O
and	O
neonatal	O
hypocalcemia	O
.	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

First	O
,	O
pregnant	O
women	O
were	O
briefed	O
on	O
the	O
study	O
objectives	O
and	O
the	O
confidentiality	O
of	O
maternal	O
and	O
neonatal	O
information	O
,	O
and	O
they	O
then	O
signed	O
informed	O
consents	O
.	O

Several	O
studies	O
have	O
implicated	O
SSRIs	O
in	O
autism	O
,	O
but	O
a	O
larger	O
recent	O
cohort	O
study	O
showed	O
no	O
association	O
.	O

The	O
mothers	O
of	O
autistic	O
children	O
were	O
studied	O
,	O
and	O
it	O
was	O
demonstrated	O
that	O
the	O
cases	O
with	O
autism	O
had	O
more	O
pregnancy	O
complications	B
.	O

This	O
was	O
to	O
ascertain	O
calcifediol	O
serum	O
concentrations	O
1	O
week	O
after	O
giving	O
the	O
first	O
dose	O
in	O
the	O
placebo	O
group	O
(	O
a	O
baseline	O
value	O
for	O
the	O
whole	O
population	O
)	O
as	O
well	O
as	O
early	O
concentrations	O
after	O
the	O
first	O
vitamin	O
D	O
supplementation	O
in	O
the	O
intervention	O
group	O
(	O
70	O
in	O
placebo	O
and	O
69	O
in	O
intervention	O
groups	O
).	O

In	O
Belgium	O
,	O
pregnant	O
women	O
of	O
different	O
ethnic	O
origins	O
had	O
substantially	O
lower	O
vitamin	O
D	O
concentrations	O
than	O
Caucasian	O
women	O
and	O
were	O
vitamin	O
D	O
deficient	O
all	O
year	O
long	O
except	O
during	O
summer	O
for	O
third	O
trimester	O
women	O
.	O

There	O
was	O
no	O
significant	O
difference	O
between	O
the	O
incidence	O
of	O
first	O
or	O
only	O
pneumonia	O
between	O
the	O
vitamin	O
D	O
(	O
0	O
·	O
145	O
per	O
child	O
per	O
year	O
,	O
95	O
%	O
CI	O
0	O
·	O
129	O
–	O
0	O
·	O
164	O
)	O
and	O
the	O
placebo	O
group	O
(	O
0	O
.	O
137	O
,	O
0	O
·	O
121	O
–	O
0	O
·	O
155	O
);	O
the	O
incidence	O
rate	O
ratio	O
was	O
1	O
·	O
06	O
(	O
95	O
%	O
CI	O
0	O
·	O
89	O
–	O
1	O
·	O
27	O
).	O

The	O
offspring	O
of	O
women	O
with	O
a	O
serum	O
-	O
free	O
thyroxine	O
(	O
fT4	O
)	O
concentration	O
in	O
the	O
lowest	O
decile	O
of	O
the	O
reference	O
range	O
at	O
12	O
weeks	O
of	O
gestation	O
may	O
have	O
significant	O
delays	O
in	O
neurodevelopment	O
.	O

showing	O
“	O
hyperlocomotion	O
”)[	O
9	O
],[	O
10	O
].	O

The	O
endocannabinoid	O
system	O
(	O
ECS	O
)	O
is	O
also	O
implicated	O
in	O
metabolic	O
and	O
behavioral	O
mechanisms	O
involved	O
in	O
fetal	O
programming	O
such	O
as	O
leptin	O
signaling	O
(	O
Di	O
Marzo	O
et	O
al	O
.,	O
2001	O
)	O
or	O
dopaminergic	O
system	O
(	O
Melis	O
et	O
al	O
.,	O
2004	O
).	O

We	O
also	O
aimed	O
to	O
examine	O
the	O
relationship	O
between	O
serum	O
25	O
(	O
OH	O
)	O
D	O
at	O
15	O
±	O
1	O
weeks	O
’	O
gestation	O
and	O
the	O
risk	O
of	O
an	O
adverse	O
pregnancy	O
outcome	O
and	O
included	O
determining	O
the	O
effect	O
modification	O
of	O
fetal	O
sex	O
on	O
the	O
association	O
between	O
maternal	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
.	O

Electronic	O
supplementary	O
material	O
The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12884	O
-	O
016	O
-	O
1024	O
-	O
7	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Targeted	O
16S	O
rRNA	O
gene	O
sequencing	O
The	O
V4	O
-	O
V5	O
hypervariable	O
region	O
of	O
the	O
bacterial	O
16S	O
rRNA	O
gene	O
was	O
sequenced	O
at	O
the	O
Marine	O
Biological	O
Laboratory	O
(	O
MBL	O
)	O
in	O
Woods	O
Hole	O
,	O
MA	O
,	O
using	O
established	O
methods	O
[	O
31	O
,	O
32	O
].	O

The	O
most	O
appropriate	O
treatment	O
for	O
clinical	O
N0	O
tumours	O
is	O
still	O
a	O
matter	O
of	O
debate	O
,	O
but	O
most	O
surgeons	O
prefer	O
prophylactic	O
node	O
dissection	O
because	O
MTC	O
metastasize	O
in	O
regional	O
lymph	O
nodes	O
at	O
a	O
very	O
early	O
stage	O
.	O

For	O
these	O
reasons	O
,	O
total	O
thyroidectomy	O
appears	O
to	O
be	O
the	O
appropriate	O
approach	O
to	O
MTC	O
.	O

A	O
post	O
-	O
hoc	O
analysis	O
was	O
conducted	O
to	O
determine	O
if	O
BMI	O
and	O
percent	O
fat	O
had	O
an	O
effect	O
on	O
cathelicidin	O
concentration	O
.	O

Potentially	O
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	O
been	O
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

Another	O
study	O
in	O
Angus	O
and	O
Wagyu	O
cross	O
heifers	O
raised	O
under	O
early	O
weaning	O
(	O
142	O
days	O
old	O
)	O
and	O
accelerated	O
finishing	O
programs	O
on	O
a	O
high	O
concentrate	O
diet	O
showed	O
increased	O
IMF	O
and	O
greater	O
weight	O
gain	O
compared	O
with	O
heifers	O
weaned	O
at	O
180	O
d	O
of	O
age	O
and	O
grown	O
on	O
pasture	O
for	O
16	O
months	O
before	O
entering	O
the	O
feedlot	O
[	O
53	O
].	O

Further	O
studies	O
are	O
needed	O
to	O
clarify	O
and	O
strengthen	O
the	O
role	O
of	O
BMP	O
proteins	O
in	O
the	O
regulation	O
of	O
BAT	O
or	O
“	O
brite	O
”	O
cells	O
and	O
their	O
consequences	O
on	O
metabolic	O
homeostasis	O
.	O

Indoor	O
exposures	O
to	O
these	O
agents	O
frequently	O
occur	O
[	O
29	O
,	O
30	O
].	O

General	O
Practice	O
Physical	O
Activity	O
Questionnaire	O
(	O
GPPAQ	O
)	O
was	O
used	O
to	O
assess	O
the	O
physical	O
activity	O
of	O
participants	O
[	O
22	O
].	O

If	O
there	O
are	O
more	O
than	O
5	O
%	O
errors	O
,	O
respective	O
data	O
are	O
re	O
-	O
captured	O
.	O

Her	O
serum	O
antidiuretic	O
hormone	O
level	O
,	O
at	O
the	O
time	O
of	O
birth	O
,	O
was	O
<	O
0	O
.	O
5	O
pg	O
/	O
mL	O
(	O
Normal	O
0	O
.	O
0	O
–	O
4	O
.	O
7	O
pg	O
/	O
mL	O
).	O

Inflammatory	O
responses	O
also	O
may	O
favor	O
tumor	O
development	O
[	O
93	O
].	O

Exposure	O
Maternal	O
blood	O
samples	O
were	O
collected	O
from	O
each	O
participant	O
at	O
two	O
time	O
points	O
;	O
before	O
gestational	O
week	O
16	O
(	O
predominantly	O
week	O
8	O
–	O
12	O
,	O
first	O
trimester	O
,	O
T1	O
)	O
and	O
after	O
gestational	O
week	O
31	O
(	O
predominantly	O
week	O
32	O
–	O
35	O
,	O
third	O
trimester	O
,	O
T3	O
).	O

Castration	O
Castration	O
of	O
bulls	O
generally	O
increases	O
IMF	O
content	O
in	O
several	O
cattle	O
breeds	O
,	O
although	O
it	O
reduces	O
growth	O
rate	O
[	O
40	O
].	O

##:	O
adjusted	O
OR	O
for	O
total	O
number	O
of	O
prenatal	O
checks	O
,	O
age	O
,	O
schooling	O
,	O
residence	O
area	O
.	O

While	O
a	O
similar	O
robust	O
,	O
dose	O
-	O
dependent	O
relationship	O
is	O
also	O
crucial	O
to	O
facilitate	O
the	O
development	O
of	O
testing	O
methods	O
for	O
hazard	O
assessment	O
,	O
relevant	O
environmental	O
regulation	O
and	O
/	O
or	O
appropriate	O
medical	O
intervention	O
,	O
establishing	O
causality	O
is	O
not	O
necessarily	O
essential	O
.	O

All	O
participants	O
provided	O
written	O
or	O
verbal	O
informed	O
consent	O
.	O

On	O
the	O
contrary	O
to	O
the	O
above	O
mentioned	O
studies	O
,	O
Neilson	O
et	O
al	O
.,	O
in	O
a	O
case	O
–	O
control	O
study	O
,	O
found	O
that	O
an	O
increase	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
level	O
can	O
enhance	O
the	O
possibility	O
of	O
postnatal	O
depression	O
.	O

While	O
some	O
evidence	O
suggests	O
that	O
meconium	O
aspiration	O
syndrome	O
may	O
have	O
a	O
link	O
as	O
a	O
contributing	O
factor	O
,	O
more	O
studies	O
are	O
needed	O
.	O

However	O
,	O
factors	O
including	O
ethnicity	O
,	O
paternal	O
intelligence	O
,	O
the	O
home	O
environment	O
,	O
drug	O
use	O
,	O
dietary	O
patterns	O
,	O
supplement	O
use	O
and	O
maternal	O
responsiveness	O
were	O
not	O
always	O
measured	O
.	O

In	O
contrast	O
,	O
when	O
bred	O
under	O
thermoneutral	O
conditions	O
(	O
29	O
°	O
C	O
),	O
UCP1	O
knockout	O
mice	O
exhibited	O
markedly	O
enhanced	O
metabolic	O
efficiency	O
due	O
to	O
impaired	O
thermogenesis	O
(	O
Feldmann	O
et	O
al	O
.,	O
2009	O
).	O

Expression	O
values	O
of	O
genes	O
participating	O
in	O
'	O
AMPK	O
signaling	O
'	O
and	O
'	O
mTOR	O
signaling	O
'	O
were	O
increased	O
,	O
whereas	O
genes	O
associated	O
with	O
the	O
'	O
degradation	O
of	O
valine	O
,	O
leucine	O
and	O
isoleucine	O
'	O
were	O
decreased	O
in	O
AP	O
offspring	O
.	O

The	O
aims	O
of	O
this	O
review	O
are	O
to	O
describe	O
some	O
of	O
the	O
main	O
factors	O
regulating	O
UCP1	O
activity	O
in	O
brown	O
and	O
brite	O
adipocytes	O
,	O
as	O
well	O
as	O
to	O
discuss	O
the	O
potential	O
role	O
of	O
UCP1	O
activation	O
for	O
the	O
treatment	O
of	O
insulin	O
resistance	O
and	O
type	O
2	O
diabetes	O
associated	O
with	O
obesity	O
.	O

Then	O
,	O
preadipocytes	O
can	O
differentiate	O
during	O
the	O
finishing	O
stage	O
when	O
they	O
fill	O
with	O
lipid	O
to	O
grow	O
into	O
visible	O
marbling	O
by	O
hypertrophy	O
.	O

Nutritional	O
intervention	O
is	O
important	O
for	O
the	O
control	O
of	O
GDM	O
,	O
as	O
it	O
provides	O
benefits	O
to	O
mother	O
and	O
fetal	O
health	O
.	O

The	O
analysis	O
will	O
follow	O
the	O
intention	O
to	O
treat	O
principle	O
.	O

Income	O
was	O
categorized	O
as	O
>$	O
25	O
,	O
000	O
per	O
year	O
versus	O
≤$	O
25	O
,	O
000	O
.	O

All	O
reported	O
p	O
-	O
values	O
are	O
two	O
-	O
tailed	O
.	O

In	O
view	O
of	O
the	O
multiple	O
analyses	O
carried	O
out	O
and	O
the	O
post	O
hoc	O
nature	O
of	O
the	O
findings	O
for	O
atopic	O
asthma	O
,	O
we	O
cannot	O
exclude	O
the	O
possibility	O
that	O
the	O
main	O
findings	O
occurred	O
by	O
chance	O
;	O
hence	O
,	O
they	O
should	O
be	O
interpreted	O
with	O
caution	O
.	O

Of	O
all	O
women	O
,	O
74	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
71	O
.	O
8	O
–	O
76	O
.	O
5	O
%)	O
were	O
vitamin	O
D	O
insufficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
30	O
ng	O
/	O
ml	O
),	O
44	O
.	O
6	O
%	O
(	O
95	O
%	O
CI	O
=	O
41	O
.	O
9	O
–	O
47	O
.	O
3	O
%)	O
were	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
),	O
while	O
12	O
.	O
1	O
%	O
(	O
95	O
%	O
CI	O
=	O
10	O
.	O
3	O
–	O
13	O
.	O
8	O
%)	O
were	O
severely	O
vitamin	O
D	O
deficient	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
10	O
ng	O
/	O
ml	O
).	O

Although	O
not	O
statistically	O
significant	O
,	O
a	O
slightly	O
negative	O
trend	O
of	O
increased	O
cathelicidin	O
correlated	O
with	O
a	O
decreased	O
frequency	O
of	O
diagnosed	O
infections	O
within	O
the	O
last	O
year	O
(	O
ρ	O
=	O
-	O
0	O
.	O
147	O
,	O
p	O
=	O
0	O
.	O
092	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0152711	O
.	O
g001	O
Caption	O
(	O
FIG	O
):	O
FIG	O
1	O
Cathelicidin	O
Concentration	O
by	O
Age	O
.	O

Rodent	O
models	O
The	O
deleterious	O
effects	O
of	O
exposures	O
to	O
environmental	O
factors	O
in	O
human	O
cohorts	O
have	O
stimulated	O
investigations	O
of	O
environmentally	O
induced	O
toxicity	O
in	O
rodent	O
models	O
.	O

Familial	O
cases	O
account	O
for	O
about	O
30	O
%	O
of	O
MTCs	O
.	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	O
to	O
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

Each	O
adult	O
egg	O
-	O
laying	O
hen	O
consumes	O
100	O
–	O
115	O
g	O
/	O
day	O
feeds	O
fortified	O
with	O
1600	O
IU	O
/	O
kg	O
Vitamin	O
D	O
(	O
both	O
Vitamin	O
D2	O
and	O
Vitamin	O
D3	O
),	O
as	O
indicated	O
by	O
Chinese	O
nutrition	O
standards	O
for	O
feeding	O
egg	O
-	O
laying	O
hens	O
.	O

Pregnant	O
women	O
are	O
famously	O
exhorted	O
to	O
faithfully	O
take	O
their	O
daily	O
prenatal	O
vitamins	O
,	O
which	O
often	O
contain	O
iron	O
and	O
other	O
minerals	O
.	O

1	O
.	O

Maternal	O
Diet	O
During	O
Lactation	O
Regarding	O
maternal	O
lactation	O
diets	O
,	O
a	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
[	O
99	O
]	O
found	O
some	O
evidence	O
of	O
reduced	O
atopic	O
dermatitis	O
,	O
but	O
suggested	O
that	O
more	O
studies	O
are	O
needed	O
.	O

Two	O
hundred	O
and	O
seventy	O
(	O
69	O
.	O
9	O
%)	O
respondents	O
attended	O
ANC	O
at	O
the	O
health	O
centre	O
corresponding	O
to	O
their	O
catchment	O
health	O
area	O
while	O
30	O
.	O
1	O
%	O
attended	O
at	O
a	O
different	O
health	O
centre	O
out	O
of	O
their	O
catchment	O
health	O
area	O
(	O
Figure	O
2	O
).	O

Evidence	O
that	O
treatment	O
of	O
gestational	O
diabetes	O
improves	O
pregnancy	O
outcomes	O
The	O
strongest	O
evidence	O
that	O
treatment	O
of	O
GDM	O
is	O
of	O
benefit	O
comes	O
from	O
the	O
Australian	O
Carbohydrate	O
Intolerance	O
Study	O
(	O
ACHOIS	O
)	O
in	O
Pregnant	O
Women	O
.	O
82In	O
this	O
randomized	O
controlled	O
trial	O
,	O
1000	O
women	O
fulfilling	O
the	O
1985	O
WHO	O
criteria	O
for	O
“	O
gestational	O
glucose	O
intolerance	O
”	O
were	O
recruited	O
.	O

In	O
90	O
%	O
of	O
the	O
genes	O
that	O
we	O
validated	O
by	O
qRT	O
-	O
PCR	O
,	O
significant	O
expression	O
differences	O
in	O
mRNA	O
levels	O
between	O
the	O
treatment	O
groups	O
were	O
identified	O
by	O
both	O
qRT	O
-	O
PCR	O
and	O
microarray	O
analysis	O
(	O
Table4	O
).	O

Self	O
-	O
reported	O
psychotic	O
experiences	O
in	O
the	O
general	O
population	O
may	O
represent	O
the	O
developmental	O
expression	O
of	O
population	O
genetic	O
risk	O
for	O
psychosis	O
[	O
9	O
].	O

MTRL	O
,	O
JS	O
,	O
and	O
FR	O
wrote	O
the	O
first	O
draft	O
of	O
the	O
manuscript	O
that	O
was	O
revised	O
by	O
all	O
authors	O
.	O

A	O
similar	O
pattern	O
was	O
demonstrated	O
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

It	O
was	O
demonstrated	O
that	O
when	O
the	O
serotonin	O
levels	O
were	O
altered	O
by	O
SSRIs	O
during	O
early	O
development	O
of	O
brain	O
structure	O
,	O
the	O
functions	O
were	O
altered	O
.	O

The	O
plasma	O
levels	O
of	O
LDL	O
were	O
significantly	O
increased	O
in	O
RC	O
males	O
and	O
females	O
.	O

The	O
primer	O
sequences	O
used	O
for	O
miRNAs	O
analysis	O
are	O
listed	O
inTable	O
1	O
.	O
The	O
fold	O
change	O
was	O
calculated	O
using	O
the	O
2	O
-△△	O
Ct	O
method	O
.	O

Towards	O
the	O
end	O
of	O
the	O
pregnancy	O
,	O
insulin	O
requirements	O
can	O
drop	O
.	O

Also	O
,	O
at	O
6	O
months	O
,	O
children	O
exposed	O
to	O
excessive	O
GWG	O
had	O
near	O
significant	O
(	O
P	O
=	O
.	O
06	O
)	O
higher	O
odds	O
of	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
weight	O
gain	O
(	O
OR	O
=	O
6	O
.	O
2	O
(	O
0	O
.	O
94	O
,	O
41	O
.	O
1	O
),	O
but	O
no	O
significant	O
association	O
was	O
seen	O
on	O
WFA	O
z	O
-	O
scores	O
(	O
0	O
.	O
45	O
±	O
0	O
.	O
14	O
versus	O
0	O
.	O
08	O
±	O
0	O
.	O
18	O
;	O
P	O
=	O
.	O
11	O
).	O

2	O
)	O
.	O

We	O
therefore	O
propose	O
that	O
one	O
explanation	O
for	O
our	O
main	O
findings	O
is	O
that	O
high	O
fetal	O
exposure	O
to	O
fructose	O
may	O
cause	O
persistence	O
of	O
Th2	O
immune	O
responses	O
post	O
-	O
natally	O
and	O
allergic	O
inflammation	O
in	O
the	O
developing	O
lung	O
.	O

The	O
right	O
side	O
of	O
the	O
hypothalamus	O
was	O
used	O
for	O
relative	O
gene	O
expression	O
and	O
the	O
left	O
side	O
for	O
DNA	O
methylation	O
status	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

PubMed	O
Central	O
:	O

Results	O
All	O
15	O
cases	O
of	O
anaphylaxis	O
involved	O
multi	O
ingredient	O
products	O
with	O
NHP	O
doses	O
(	O
up	O
to	O
and	O
including	O
1	O
mg	O
).	O

However	O
,	O
they	O
were	O
different	O
regarding	O
to	O
using	O
other	O
supplements	O
outside	O
the	O
study	O
’	O
s	O
protocol	O
and	O
planned	O
pregnancy	O
(	O
Table	O
1	O
).	O

Another	O
study	O
was	O
organized	O
to	O
determine	O
ASD	O
in	O
children	O
born	O
preterm	O
and	O
the	O
role	O
of	O
exposure	O
to	O
perinatal	O
inflammation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Anthropometric	O
data	O
of	O
the	O
total	O
sample	O
and	O
stratified	O
by	O
the	O
classification	O
of	O
pre	O
-	O
pregnancy	O
Body	O
Mass	O
Index	O
(	O
PPBMI	O
)	O
in	O
a	O
sample	O
of	O
pregnant	O
women	O
at	O
diagnosis	O
of	O
Gestational	O
Diabetes	O
Mellitus	O
,	O
Rio	O
Grande	O
do	O
Sul	O
/	O
Brazil	O
,	O
2014	O
.	O

We	O
will	O
publish	O
the	O
analysis	O
of	O
the	O
outcomes	O
in	O
the	O
form	O
of	O
internal	O
documents	O
,	O
working	O
papers	O
,	O
and	O
in	O
international	O
peer	O
-	O
reviewed	O
journals	O
.	O

College	O
Station	O
,	O
TX	O
:	O
Stata	O
Corp	O
LP	O
.)	O

It	O
was	O
remarkably	O
observed	O
that	O
preparation	O
for	O
hibernation	O
was	O
characterized	O
by	O
striking	O
increases	O
in	O
body	O
weight	O
and	O
in	O
fat	O
mass	O
.	O

Amongst	O
sibships	O
discordant	O
for	O
exposure	O
to	O
hyperglycemia	O
,	O
the	O
sibling	O
exposed	O
to	O
hyperglycemia	O
had	O
a	O
considerably	O
higher	O
risk	O
of	O
subsequent	O
diabetes	O
,	O
suggesting	O
that	O
genetic	O
factors	O
were	O
not	O
predominantly	O
responsible	O
for	O
the	O
difference	O
in	O
diabetes	O
incidence	O
.	O

We	O
did	O
not	O
find	O
any	O
medical	O
record	O
documentation	O
of	O
a	O
discussion	O
about	O
herb	O
use	O
.	O

However	O
,	O
as	O
misclassification	B
of	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
is	O
likely	O
to	O
have	O
been	O
random	O
with	O
respect	O
to	O
childhood	O
outcomes	O
,	O
the	O
strength	O
of	O
associations	O
may	O
have	O
been	O
underestimated	B
.	O

Introduction	O
Iron	O
deficiency	O
anaemia	O
is	O
defined	O
as	O
anaemia	O
accompanied	O
by	O
depleted	O
iron	O
stores	O
and	O
signs	O
of	O
a	O
compromised	O
supply	O
of	O
iron	O
to	O
the	O
tissues	O
[	O
1	O
].	O

We	O
conducted	O
a	O
pilot	O
study	O
in	O
four	O
BRAC	O
village	O
fieldworker	O
areas	O
,	O
two	O
with	O
intervention	O
and	O
two	O
comparison	O
areas	O
,	O
to	O
test	O
the	O
feasibility	O
of	O
our	O
intervention	O
.	O

2011	O
).	O

Vitamin	O
C	O
Vitamin	O
C	O
can	O
be	O
synthesized	O
from	O
glucose	O
in	O
the	O
liver	O
of	O
many	O
mammalian	O
species	O
other	O
than	O
guinea	O
pigs	O
,	O
humans	O
,	O
and	O
other	O
primates	O
[	O
146	O
].	O

Vitamin	O
D	O
deficiency	O
increases	O
the	O
risk	O
of	O
osteoporosis	O
[	O
3	O
]	O
and	O
fractures	O
[	O
4	O
],	O
while	O
in	O
its	O
most	O
severe	O
form	O
it	O
causes	O
rickets	O
in	O
children	O
[	O
5	O
]	O
and	O
osteomalacia	O
in	O
adults	O
[	O
6	O
].	O

The	O
size	O
of	O
each	O
point	O
indicates	O
the	O
log	O
-	O
ratio	O
transformed	O
relative	O
abundance	O
(	O
LRTA	O
)	O
of	O
each	O
OTU	O
(	O
LRTA	O
≥	O
30	O
,	O
LRTA	O
≥	O
20	O
,	O
or	O
LRTA	O
<	O
20	O
).	O

Diet	O
The	O
“	O
developmental	O
plasticity	O
hypothesis	O
”	O
refers	O
to	O
the	O
critical	O
developmental	O
period	O
in	O
utero	O
when	O
the	O
fetus	O
is	O
plastic	O
and	O
adaptively	O
imprints	O
to	O
its	O
environment	O
.	O

The	O
dissection	O
started	O
at	O
the	O
aortic	O
root	O
and	O
extended	O
inferiorly	O
into	O
the	O
descending	O
aorta	O
and	O
upper	O
abdomen	O
.	O

Both	O
intervention	O
and	O
control	O
treatment	O
arms	O
will	O
receive	O
the	O
usual	O
antenatal	O
and	O
postnatal	O
care	O
services	O
by	O
BRAC	O
.	O

Of	O
course	O
,	O
it	O
is	O
vital	O
that	O
any	O
environmental	O
toxicant	O
is	O
carefully	O
regulated	O
or	O
even	O
banned	O
from	O
use	O
.	O

This	O
test	O
allows	O
us	O
to	O
measure	O
food	O
intake	O
,	O
chocolate	O
preference	O
as	O
well	O
as	O
to	O
detect	O
the	O
development	O
of	O
inflexible	O
feeding	O
behavior	O
.	O

All	O
identified	O
observational	O
cohort	O
studies	O
in	O
the	O
current	O
review	O
used	O
food	O
frequency	O
questionnaires	O
(	O
FFQs	O
)	O
to	O
assess	O
fish	O
intake	O
.	O

There	O
was	O
no	O
effect	O
of	O
the	O
gestational	O
or	O
pup	O
diets	O
on	O
hypothalamic	O
expression	O
of	O
other	O
genes	O
.	O

While	O
we	O
did	O
not	O
identify	O
statistically	O
or	O
clinically	O
significant	O
differences	O
in	O
neurodevelopment	O
at	O
6	O
-	O
months	O
of	O
age	O
using	O
a	O
reliable	O
screening	O
tool	O
,	O
ongoing	O
follow	O
-	O
up	O
of	O
participants	O
further	O
into	O
childhood	O
will	O
again	O
be	O
important	O
to	O
determine	O
whether	O
there	O
are	O
any	O
potential	O
benefits	O
of	O
improving	O
maternal	O
diet	O
and	O
physical	O
activity	O
during	O
pregnancy	O
on	O
childhood	O
neurodevelopment	O
.	O

No	O
differences	O
in	O
large	O
for	O
gestational	O
age	O
,	O
macrosomia	O
,	O
neonatal	O
hypoglycemia	O
,	O
admission	O
to	O
neonatal	O
intensive	O
care	O
,	O
or	O
fetal	O
anomalies	O
were	O
observed	O
.	O

Currently	O
,	O
it	O
is	O
recommended	O
to	O
use	O
multiVitamin	O
or	O
calcium	O
supplements	O
containing	O
Vitamin	O
D	O
for	O
women	O
during	O
pregnancy	O
to	O
increase	O
their	O
Vitamin	O
D	O
intake	O
.	O

The	O
resulting	O
plasma	O
was	O
frozen	O
at	O
a	O
temperature	O
of	O
≤-	O
20	O
°	O
C	O
until	O
required	O
for	O
analysis	O
.	O

These	O
retained	O
histones	O
are	O
not	O
randomly	O
distributed	O
throughout	O
the	O
male	O
genome	O
,	O
they	O
are	O
particularly	O
enriched	O
at	O
the	O
promoters	O
of	O
developmental	O
genes	O
.	O

British	O
and	O
British	O
×	O
Continental	O
crossbred	O
cattle	O
grown	O
with	O
no	O
shelter	O
or	O
windbreak	O
had	O
greater	O
fat	O
thickness	O
and	O
MS	O
in	O
winter	O
than	O
did	O
animals	O
fed	O
in	O
a	O
protected	O
area	O
[	O
74	O
].	O

Forty	O
patients	O
evaluated	O
at	O
two	O
visits	O
showed	O
an	O
increase	O
of	O
24	O
.	O
0	O
ng	O
/	O
mL	O
in	O
cathelicidin	O
from	O
the	O
first	O
visit	O
to	O
the	O
next	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

This	O
tissue	O
also	O
responds	O
to	O
insulin	O
with	O
a	O
5	O
-	O
fold	O
increase	O
in	O
glucose	O
uptake	O
,	O
without	O
any	O
change	O
in	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
),	O
while	O
under	O
cold	O
exposure	O
,	O
glucose	O
uptake	O
increases	O
by	O
12	O
-	O
folds	O
,	O
dissipating	O
energy	O
as	O
a	O
function	O
of	O
increased	O
blood	O
flow	O
(	O
Orava	O
et	O
al	O
.,	O
2011	O
).	O

A	O
diagnosis	O
of	O
1	O
)	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
2	O
)	O
sensitised	O
and	O
clinically	O
tolerant	O
,	O
3	O
)	O
sensitised	O
and	O
unknown	O
clinical	O
reactivity	O
,	O
4	O
)	O
not	O
sensitised	O
with	O
clinical	O
symptoms	O
,	O
5	O
)	O
unknown	O
sensitization	O
with	O
clinical	O
symptoms	O
or	O
6	O
)	O
not	O
sensitized	O
with	O
no	O
clinical	O
symptoms	O
is	O
made	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Significantly	O
regulated	O
transcripts	O
of	O
metabolic	O
pathways	O
in	O
liver	O
tissue	O
within	O
different	O
ontogenetic	O
stages	O
(	O
Ingenuity	O
Pathway	O
Analysis	O
).	O
Ontogenetic	O
stageRegulated	O
pathwayDirection	O
of	O
regulation	O
P	O
valueNo	O
.	O

Therefore	O
,	O
the	O
transcriptional	O
control	O
of	O
cyclins	O
provides	O
an	O
additional	O
level	O
of	O
growth	O
regulation	O
.	O

This	O
concept	O
is	O
supported	O
by	O
Oken	O
et	O
al	O
.	O

Furthermore	O
,	O
genes	O
participating	O
in	O
'	O
Wnt	O
signaling	O
'	O
were	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
perinatal	O
piglets	O
.	O

For	O
the	O
remaining	O
19	O
questions	O
,	O
the	O
internal	O
fidelity	O
was	O
satisfactory	O
(	O
the	O
correlation	O
coefficient	O
between	O
the	O
two	O
halves	O
-	O
0	O
.	O
83	O
;	O
the	O
-	O
split	O
half	O
reliability	O
-	O
0	O
.	O
91	O
;	O
Guttman	O
split	O
-	O
half	O
reliability	O
coefficient	O
-	O
0	O
.	O
91	O
and	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
-	O
0	O
.	O
88	O
)	O
[	O
26	O
].	O

Eligibility	O
criteria	O
for	O
inclusion	O
of	O
cluster	O
We	O
will	O
exclude	O
any	O
potential	O
BRAC	O
PO	O
area	O
(	O
cluster	O
)	O
if	O
there	O
are	O
any	O
other	O
maternal	O
and	O
or	O
neonatal	O
interventions	O
either	O
by	O
the	O
government	O
or	O
non	O
-	O
government	O
organisations	O
in	O
the	O
area	O
.	O

With	O
1	O
ng	O
/	O
mL	O
reduction	O
in	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
,	O
the	O
anxiety	O
and	O
depression	O
levels	O
increased	O
0	O
.	O
043	O
and	O
0	O
.	O
040	O
,	O
respectively	O
[	O
64	O
].	O

Furthermore	O
,	O
that	O
study	O
was	O
unable	O
to	O
specifically	O
investigate	O
the	O
potential	O
role	O
of	O
maternal	O
intake	O
of	O
sugar	O
during	O
pregnancy	O
nor	O
the	O
specific	O
role	O
of	O
free	O
sugar	O
.	O

Conclusion	O
In	O
the	O
present	O
study	O
,	O
it	O
was	O
observed	O
that	O
2000	O
IU	O
vitamin	O
D3per	O
day	O
for	O
at	O
least	O
8	O
weeks	O
during	O
late	O
pregnancy	O
,	O
can	O
be	O
effective	O
in	O
decreasing	O
perinatal	O
depression	O
levels	O
(	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
).	O

The	O
health	O
of	O
the	O
adult	O
South	O
African	O
population	O
is	O
a	O
concern	O
.	O

OR	O
#-	O
adjusted	O
for	O
the	O
interaction	O
effect	O
(	O
PC	O
*	O
E	O
).	O

Ratios	O
range	O
from	O
0	O
to	O
1	O
:	O
β	O
=	O
1	O
indicates	O
complete	O
methylation	O
and	O
β	O
=	O
0	O
represents	O
no	O
methylation	O
.	O

The	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
,	O
Vitamin	O
D	O
supplement	O
intake	O
and	O
control	O
group	O
.	O

Neonatal	O
data	O
collected	O
at	O
birth	O
from	O
the	O
medical	O
file	O
include	O
date	O
and	O
time	O
of	O
birth	O
,	O
gender	O
,	O
Apgar	O
score	O
(	O
at	O
1	O
and	O
5	O
min	O
)	O
[	O
56	O
],	O
vital	O
signs	O
,	O
medical	O
interventions	O
required	O
,	O
foetal	O
distress	O
and	O
presence	O
of	O
meconium	O
stained	O
liquor	O
.	O

[	O
21	O
]	O
reported	O
differences	O
in	O
outcomes	O
associated	O
with	O
oily	O
fish	O
intake	O
and	O
total	O
fish	O
intake	O
in	O
early	O
compared	O
to	O
late	O
pregnancy	O
.	O

From	O
third	O
day	O
of	O
pregnancy	O
to	O
term	O
,	O
dams	O
(	O
n	O
=	O
10	O
per	O
gestational	O
diet	O
group	O
)	O
were	O
fed	O
the	O
AIN	O
-	O
93G	O
diet13containing	O
either	O
the	O
RV	O
or	O
HV	O
amount	O
of	O
the	O
multivitamin	O
mix	O
.	O

As	O
described	O
previously	O
[	O
24	O
],	O
16S	O
rDNA	O
V4	O
-	O
V5	O
amplicons	O
were	O
generated	O
from	O
purified	O
genomic	O
DNA	O
samples	O
using	O
fusion	O
primers	O
.	O

Women	O
with	O
no	O
or	O
few	O
psychotic	O
-	O
like	O
symptoms	O
smoked	O
less	O
than	O
women	O
in	O
the	O
middle	O
group	O
and	O
the	O
high	O
level	O
group	O
.	O

Anaemia	O
during	O
pregnancy	O
is	O
a	O
public	O
health	O
problem	B
that	O
affects	O
both	O
developed	O
and	O
developing	O
countries	O
and	O
has	O
an	O
impact	O
not	O
only	O
on	O
health	O
providers	O
,	O
but	O
also	O
on	O
the	O
socio	O
-	O
economic	O
environment	O
[	O
12	O
].	O

(	O
A	O
)	O
Student	O
'	O
s	O
t	O
-	O
test	O
.	O

Among	O
those	O
children	O
born	O
from	O
I	O
-	O
131	O
treated	O
women	O
,	O
the	O
authors	O
found	O
only	O
one	O
case	O
of	O
ventricular	O
septal	O
defect	O
and	O
patent	O
ductus	O
arteriosus223940	O
.	O

However	O
,	O
due	B
to	I
the	O
lack	O
of	O
sufficient	O
information	O
about	O
the	O
physiologic	O
role	O
of	O
visfatin	O
in	O
adults	O
,	O
its	O
source	O
and	O
regulation	O
mechanism	O
in	O
fetal	O
and	O
neonatal	O
stages	O
cannot	O
be	O
argued	O
absolutely	O
.	O

Thyroid	O
receptors	O
(	O
TRs	O
)	O
are	O
composed	O
of	O
several	O
isoforms	O
that	O
specifically	O
regulate	O
UCP1	O
expression	O
and	O
thermogenesis	O
.	O

Furthermore	O
,	O
men	O
were	O
not	O
included	O
in	O
the	O
study	O
and	O
there	O
is	O
gender	O
difference	O
in	O
the	O
prevalence	O
of	O
psychosis	O
[	O
59	O
].	O

The	O
control	O
group	O
consumed	O
extra	O
supplements	O
such	O
as	O
calcium	O
more	O
frequently	O
,	O
nonetheless	O
this	O
group	O
had	O
significantly	O
higher	O
depression	O
scores	O
compared	O
to	O
vitamin	O
D	O
group	O
.	O

The	O
dissected	O
hypothalamic	O
blocks	O
contained	O
preoptic	O
,	O
supraoptic	O
,	O
paraventricular	O
,	O
anterior	O
,	O
suprachiasmatic	O
,	O
dorsomedial	O
,	O
ventromedial	O
,	O
arcuate	O
,	O
mammillary	O
,	O
posterior	O
and	O
lateral	O
complex	O
nuclei	O
.	O

Results	O
Three	O
identified	O
major	O
dietary	O
patterns	O
according	O
to	O
the	O
results	O
obtained	O
from	O
the	O
factor	O
loading	O
matrix	O
were	O
(	O
i	O
)	O
“	O
western	O
dietary	O
pattern	O
”;	O
(	O
ii	O
)	O
“	O
traditional	O
dietary	O
pattern	O
”;	O
(	O
iii	O
)	O
“	O
healthy	O
dietary	O
pattern	O
”.	O

The	O
spread	O
and	O
importance	O
of	O
postpartum	O
depression	O
have	O
led	O
researchers	O
to	O
create	O
preventative	O
methods	O
such	O
as	O
educational	O
programs	O
,	O
modified	O
care	O
,	O
dietary	O
supplements	O
,	O
antidepressant	O
medication	O
and	O
social	O
support	O
[	O
12	O
–	O
14	O
].	O

of	O
expressed	O
probe	O
-	O
setsNo	O
.	O

We	O
found	O
no	O
significant	O
prenatal	O
predictors	O
of	O
change	O
in	O
WFA	O
z	O
-	O
scores	O
between	O
birth	O
and	O
6	O
months	O
.	O

(%)	O
ever16	O
258	O
(	O
88	O
)	O
12	O
614	O
(	O
88	O
)	O
668	O
(	O
82	O
)	O
never2	O
153	O
(	O
12	O
)	O
1	O
781	O
(	O
12	O
)	O
149	O
(	O
18	O
)	O
Dietary	O
intake	O
,	O
g	O
/	O
day	O
,	O
median	O
(	O
5	O
-	O
95	O
%)	O
of	O
:	O
fatty	O
fish7	O
(	O
0	O
-	O
21	O
)	O
7	O
(	O
0	O
-	O
21	O
)	O
7	O
(	O
0	O
-	O
28	O
)	O
meat76	O
(	O
26	O
-	O
144	O
)	O
78	O
(	O
22	O
-	O
149	O
)	O
77	O
(	O
3	O
-	O
167	O
)	O
dairy	O
products330	O
(	O
20	O
-	O
831	O
)	O
331	O
(	O
14	O
-	O
850	O
)	O
320	O
(	O
4	O
-	O
857	O
)	O
vegetables79	O
(	O
22	O
-	O
177	O
)	O
79	O
(	O
21	O
-	O
186	O
)	O
80	O
(	O
19	O
-	O
214	O
)	O
fruit107	O
(	O
15	O
-	O
315	O
)	O
106	O
(	O
11	O
-	O
311	O
)	O
102	O
(	O
7	O
-	O
337	O
)	O
cereals125	O
(	O
47	O
-	O
280	O
)	O
129	O
(	O
47	O
-	O
288	O
)	O
129	O
(	O
41	O
-	O
299	O
)	O
saccharides	O
(	O
sugar	O
)	O
20	O
(	O
7	O
-	O
44	O
)	O
20	O
(	O
7	O
-	O
45	O
)	O
21	O
(	O
6	O
-	O
51	O
)	O
alcohol2	O
.	O
5	O
(	O
0	O
-	O
11	O
)	O
2	O
.	O
4	O
(	O
0	O
-	O
11	O
)	O
1	O
.	O
8	O
(	O
0	O
-	O
12	O
)	O
marine	O
fatty	O
acidsc0	O
.	O
27	O
(	O
0	O
.	O
07	O
-	O
0	O
.	O
6	O
)	O
0	O
.	O
27	O
(	O
0	O
.	O
06	O
-	O
0	O
.	O
6	O
)	O
0	O
.	O
26	O
(	O
0	O
.	O
05	O
-	O
0	O
.	O
7	O
)	O
omega	O
-	O
3	O
fatty	O
acidsd1	O
.	O
3	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
1	O
.	O
3	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
1	O
.	O
2	O
(	O
0	O
.	O
6	O
-	O
2	O
)	O
omega	O
-	O
6	O
fatty	O
acidse4	O
.	O
8	O
(	O
2	O
-	O
8	O
)	O
4	O
.	O
8	O
(	O
2	O
-	O
8	O
)	O
4	O
.	O
7	O
(	O
2	O
-	O
8	O
)	O
vitamin	O
D	O
(	O
μg	O
/	O
day	O
)	O
4	O
.	O
0	O
(	O
1	O
.	O
8	O
-	O
7	O
.	O
1	O
)	O
3	O
.	O
9	O
(	O
1	O
.	O
7	O
-	O
7	O
.	O
2	O
)	O
3	O
.	O
8	O
(	O
1	O
.	O
4	O
-	O
7	O
.	O
1	O
)	O
Total	O
energy	O
intake	O
,	O
kJ	O
/	O
day	O
,	O
mean	O
(	O
SD	O
)	O
6	O
509	O
(	O
1	O
801	O
)	O
6	O
626	O
(	O
1	O
886	O
)	O
6	O
637	O
(	O
1	O
986	O
)	O
Proportion	O
of	O
total	O
energy	O
intake	O
,	O
%	O
from	O
:	O
•	O
fat313131	O
•	O
protein161616	O
•	O
carbohydrate515151	O
•	O
alcohol111	O
aParticipants	O
categorized	O
into	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
;	O
low	O
,	O
middle	O
,	O
high	O
(	O
see	O
methods	O
section	O
)	O
bAge	O
at	O
the	O
completeness	O
of	O
the	O
follow	O
-	O
up	O
questionnaire	O
cSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
and	O
docosapentaenoic	O
acid	O
dSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
),	O
docosapentaenoic	O
acid	O
and	O
α	O
-	O
linolenic	O
acid	O
eSum	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
Dietary	O
intake	O
of	O
fish	O
and	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
The	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
fish	O
is	O
shown	O
in	O
Table2	O
.	O

We	O
intended	O
to	O
recruit	O
a	O
minimum	O
of	O
250	O
participants	O
.	O

The	O
category	O
"	O
low	O
level	O
symptoms	O
group	O
"	O
(	O
no	O
psychotic	O
-	O
like	O
symptoms	O
)	O
was	O
used	O
as	O
the	O
reference	O
group	O
.	O

In	O
addition	O
,	O
a	O
significant	O
percentage	O
of	O
infants	O
from	O
families	O
with	O
an	O
atopic	O
background	O
do	O
not	O
develop	O
atopy	O
during	O
childhood	O
.	O

This	O
sample	O
would	O
allow	O
detection	O
of	O
a	O
22	O
%	O
relative	O
difference	O
between	O
treatment	O
groups	O
with	O
80	O
%	O
power	O
.	O

Also	O
,	O
impaired	O
fetal	O
growth	O
,	O
in	O
particular	O
in	O
head	O
circumference	O
,	O
is	O
associated	O
with	O
nonoptimal	O
neurodevelopmental	O
outcome	O
[	O
4	O
].	O

Given	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
and	O
probably	O
in	O
many	O
European	O
countries	O
,	O
a	O
vitamin	O
D	O
nutrition	O
policy	O
is	O
needed	O
at	O
the	O
country	O
and	O
European	O
level	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Comparison	O
of	O
demographic	O
data	O
in	O
the	O
intervention	O
and	O
control	O
groupVariablesVitamin	O
DControl	O
p	O
-	O
valueAge	O
(	O
year	O
)	O
Mean	O
±	O
sd26	O
.	O
40	O
±	O
4	O
.	O
8826	O
.	O
22	O
±	O
4	O
.	O
330	O
.	O
80Job	O
N	O
(%)	O
0	O
.	O
96	O
Housewife72	O
(	O
96	O
)	O
75	O
(	O
96	O
.	O
2	O
)	O
Employed3	O
(	O
4	O
)	O
3	O
(	O
3	O
.	O
8	O
)	O
Education	O
N	O
(%)	O
0	O
.	O
55	O
High	O
school26	O
(	O
34	O
.	O
7	O
)	O
21	O
(	O
26	O
.	O
9	O
)	O
High	O
school	O
diploma34	O
(	O
45	O
.	O
3	O
)	O
38	O
(	O
48	O
.	O
7	O
)	O
University15	O
(	O
20	O
.	O
0	O
)	O
19	O
(	O
24	O
.	O
4	O
)	O
Parity0	O
.	O
17	O
Nullipara41	O
(	O
54	O
.	O
7	O
)	O
51	O
(	O
65	O
.	O
4	O
)	O
Multipara34	O
(	O
45	O
.	O
3	O
)	O
27	O
(	O
34	O
.	O
6	O
)	O
Using	O
others	O
supplements0	O
.	O
017	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Planned	O
pregnancy0	O
.	O
01	O
Yes55	O
(	O
73	O
.	O
3	O
)	O
69	O
(	O
88	O
.	O
5	O
)	O
No20	O
(	O
26	O
.	O
7	O
)	O
9	O
(	O
11	O
.	O
5	O
)	O
Seasonal	O
distribution	O
in	O
onset	O
N	O
(%)	O
0	O
.	O
32	O
Autumn9	O
(	O
12	O
)	O
6	O
(	O
7	O
.	O
7	O
)	O
Winter11	O
(	O
14	O
.	O
7	O
)	O
7	O
(	O
9	O
)	O
Spring55	O
(	O
73	O
.	O
3	O
)	O
65	O
(	O
83	O
.	O
3	O
)	O
Sun	O
exposure	O
(	O
minutes	O
)	O
0	O
.	O
55	O
<	O
1514	O
(	O
21	O
.	O
9	O
)	O
12	O
(	O
16	O
.	O
7	O
)	O
15	O
–	O
3028	O
(	O
43	O
.	O
8	O
)	O
33	O
(	O
45	O
.	O
8	O
)	O
30	O
–	O
6010	O
(	O
15	O
.	O
6	O
)	O
17	O
(	O
23	O
.	O
6	O
)	O
>	O
6012	O
(	O
18	O
.	O
8	O
)	O
10	O
(	O
13	O
.	O
9	O
)	O
At	O
baseline	O
,	O
25	O
-	O
hydroxyvitamin	O
D	O
had	O
a	O
mean	O
value	O
of	O
12	O
.	O
35	O
±	O
7	O
.	O
17	O
ng	O
/	O
with	O
a	O
minimum	O
and	O
maximum	O
value	O
of	O
4	O
and	O
49	O
.	O
30	O
ng	O
/	O
mL	O
,	O
respectively	O
.	O

Standard	O
procedures	O
are	O
used	O
for	O
a	O
2	O
-	O
h	O
75	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
between	O
24	O
and	O
28	O
weeks	O
gestation	O
to	O
determine	O
development	O
of	O
gestational	O
diabetes	O
mellitus	O
[	O
47	O
].	O

As	O
we	O
will	O
discuss	O
below	O
,	O
these	O
sex	O
-	O
differences	O
extend	O
to	O
metabolic	O
pathways	O
under	O
the	O
control	O
of	O
the	O
endogenous	O
cannabinoid	O
system	O
,	O
as	O
previously	O
suggested	O
(	O
Wagner	O
,	O
2016	O
).	O

Mechanisms	O
leading	O
to	O
aortic	O
dissection	O
involve	O
a	O
weakening	O
of	O
the	O
layers	O
of	O
the	O
aorta	O
allowing	O
blood	O
to	O
enter	O
the	O
media	O
and	O
separate	O
the	O
intimal	O
and	O
adventitial	O
layers	O
creating	O
a	O
false	O
lumen	O
.	O

As	O
expected	O
,	O
this	O
study	O
generated	O
some	O
controversy	O
,	O
particularly	O
when	O
subsequent	O
groups	O
failed	O
to	O
reproduce	O
the	O
same	O
results	O
(	O
Gray	O
&	O
Furr2008	O
;	O
Schneider	O
et	O
al	O
.	O
2008	O
;	O
Inawaka	O
et	O
al	O
.	O
2009	O
;	O
Schneider	O
et	O
al	O
.	O
2013	O
).	O

Pregnancy	O
itself	O
may	O
also	O
affect	O
the	O
course	O
of	O
asthma	O
and	O
other	O
diseases	O
[	O
10	O
].	O

[	O
46	O
]	O
and	O
Wu	O
et	O
al	O
.	O

Determination	O
of	O
Dietary	O
Patterns	O
We	O
applied	O
principal	O
component	O
analysis	O
in	O
order	O
to	O
find	O
major	O
dietary	O
patterns	O
.	O

However	O
,	O
no	O
differences	O
in	O
body	O
weight	O
were	O
found	O
between	O
CC	O
males	O
and	O
CC	O
females	O
(	O
Figure2B	O
).	O

To	O
investigate	O
the	O
role	O
of	O
visfatin	O
in	O
the	O
growth	O
of	O
the	O
fetus	O
and	O
up	O
to	O
a	O
year	O
after	O
birth	O
,	O
we	O
measured	O
serum	O
visfatin	O
levels	O
during	O
6	O
-	O
12	O
and	O
15	O
-	O
20	O
weeks	O
of	O
gestation	O
in	O
an	O
Iranian	O
population	O
.	O

Nonetheless	O
the	O
woman	O
should	O
be	O
advised	O
regarding	O
appropriate	O
hypoglycemia	O
prevention	O
and	O
management	O
measures	O
.	O

Fatty	O
acids	O
of	O
dietary	O
origin	O
are	O
obtained	O
from	O
transporta	O
tion	O
of	O
TG	O
lipoprotein	O
and	O
subsequent	O
uptake	O
after	O
lipoprotein	O
lipase	O
hydrolysis	O
into	O
tissues	O
from	O
the	O
circulation	O
[	O
92	O
,	O
93	O
].	O

Performed	O
the	O
experiments	O
:	O
MO	O
EM	O
CCM	O
SP	O
KW	O
.	O

Results	O
General	O
characteristics	O
of	O
the	O
study	O
subjects	O
Ninety	O
-	O
eight	O
pregnant	O
women	O
with	O
GDM	O
in	O
the	O
middle	O
and	O
late	O
pregnancy	O
were	O
enrolled	O
in	O
the	O
study	O
.	O

Diagnosis	O
of	O
allergy	O
during	O
pregnancy	O
should	O
mainly	O
consist	O
of	O
the	O
patient	O
'	O
s	O
history	O
and	O
in	O
vitro	O
testing	O
.	O

Infant	O
stool	O
samples	O
were	O
collected	O
from	O
145	O
infants	O
,	O
and	O
maternal	O
prenatal	O
diet	O
was	O
assessed	O
using	O
a	O
food	O
frequency	O
questionnaire	O
.	O

The	O
primary	O
analyses	O
will	O
compare	O
the	O
neonatal	O
mortality	O
rates	O
and	O
their	O
95	O
%	O
confidence	O
intervals	O
adjusted	O
for	O
clustering	O
and	O
groundwater	O
iron	O
level	O
in	O
each	O
group	O
.	O

Conclusion	O
Providing	O
pregnant	O
women	O
who	O
were	O
overweight	O
or	O
obese	O
with	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
did	O
not	O
alter	O
6	O
-	O
month	O
infant	O
growth	O
and	O
adiposity	O
.	O

While	O
high	O
fructose	O
consumption	O
has	O
been	O
proposed	O
as	O
a	O
risk	O
factor	O
for	O
obesity	O
[	O
45	O
],	O
we	O
found	O
no	O
evidence	O
to	O
suggest	O
that	O
the	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
and	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
were	O
mediated	O
by	O
maternal	O
BMI	O
,	O
gestational	O
weight	O
gain	O
or	O
child	O
'	O
s	O
BMI	O
,	O
nor	O
by	O
prematurity	O
or	O
low	O
birthweight	O
,	O
assuming	O
key	O
assumptions	O
necessary	O
for	O
mediation	O
analyses	O
were	O
met	O
[	O
46	O
,	O
47	O
].	O

Oral	O
iron	O
,	O
either	O
as	O
iron	O
sulphate	O
or	O
fumarate	O
,	O
is	O
the	O
most	O
commonly	O
used	O
preventive	O
treatment	O
for	O
iron	O
deficiency	O
and	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
.	O

However	O
,	O
little	O
research	O
has	O
comprehensively	O
examined	O
the	O
impact	O
of	O
maternal	O
prenatal	O
behaviors	O
and	O
psychosocial	O
variables	O
measured	O
during	O
pregnancy	O
on	O
subsequent	O
offspring	O
weight	O
status	O
at	O
birth	O
and	O
6	O
months	O
.	O

The	O
associations	O
of	O
other	O
maternal	O
dietary	O
factors	O
with	O
specific	O
infant	O
gut	O
microbes	O
were	O
also	O
somewhat	O
unexpected	O
,	O
namely	O
for	O
red	O
and	O
processed	O
meat	O
and	O
for	O
fruit	O
consumption	O
.	O

Our	O
findings	O
represent	O
an	O
important	O
key	O
point	O
to	O
understand	O
the	O
complexity	O
of	O
the	O
fetal	O
programming	O
process	O
and	O
might	O
be	O
particularly	O
useful	O
in	O
the	O
searching	O
of	O
efficient	O
therapies	O
against	O
a	O
malprogramming	O
.	O

Of	O
those	O
invited	O
,	O
over	O
half	O
decided	O
to	O
participate	O
.	O

In	O
both	O
rodents	O
and	O
humans	O
,	O
this	O
BA	O
-	O
D2	O
-	O
UCP1	O
pathway	O
appears	O
to	O
be	O
crucial	O
for	O
the	O
fine	O
-	O
tuning	O
of	O
energy	O
homeostasis	O
,	O
improving	O
the	O
metabolic	O
control	O
(	O
Watanabe	O
et	O
al	O
.,	O
2006	O
).	O

During	O
pregnancy	O
vitamin	O
D	O
and	O
calcium	O
metabolism	O
undergo	O
significant	O
changes	O
to	O
provide	O
the	O
calcium	O
needed	O
for	O
maternal	O
skeletal	O
preservation	O
and	O
foetal	O
skeletal	O
formation	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
quality	O
and	O
apnea	O
are	O
needed	O
to	O
obtain	O
more	O
precise	O
estimates	O
of	O
observed	O
associations	O
.	O

Researchers	O
compared	O
138	O
mothers	O
of	O
children	O
diagnosed	O
with	O
ALL	O
with	O
a	O
control	O
group	O
of	O
138	O
mothers	O
whose	O
children	O
did	O
not	O
have	O
cancer	O
.	O

Thirty	O
-	O
six	O
hours	O
after	O
birth	O
,	O
the	O
lightest	O
and	O
the	O
heaviest	O
piglet	O
within	O
one	O
litter	O
were	O
killed	O
by	O
i	O
.	O
m	O
.	O

Bonferroni	O
analysis	O
indicated	O
that	O
the	O
RC	O
males	O
showed	O
a	O
significant	O
increase	O
in	O
the	O
plasma	O
levels	O
of	O
leptin	O
,	O
triglycerides	O
,	O
VLDL	O
,	O
and	O
bilirubin	O
compared	O
to	O
the	O
plasma	O
of	O
CC	O
males	O
.	O

Interestingly	O
,	O
some	O
of	O
these	O
molecules	O
can	O
be	O
secreted	O
by	O
BAT	O
itself	O
,	O
indicating	O
the	O
occurrence	O
of	O
autocrine	O
effects	O
.	O

The	O
activity	O
of	O
glycerol	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
,	O
a	O
biomarker	O
for	O
adipogenesis	O
,	O
decreases	O
in	O
bovine	O
preadipocytes	O
cultured	O
with	O
retinol	O
[	O
129	O
].	O

Test	O
for	O
normality	O
will	O
be	O
performed	O
by	O
the	O
Shapiro	O
-	O
Wilk	O
test	O
.	O

While	O
there	O
is	O
still	O
room	O
for	O
much	O
further	O
research	O
,	O
current	O
understanding	O
suggests	O
that	O
length	O
of	O
labor	O
is	O
possibly	O
associated	O
with	O
autism	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

During	O
lactation	O
,	O
all	O
dams	O
were	O
fed	O
the	O
RV	O
diet	O
.	O

Concerns	B
have	O
been	O
expressed	O
about	O
the	O
use	O
of	O
glargine	O
in	O
pregnancy	O
,	O
because	B
of	O
its	O
potential	O
effect	O
on	O
mitogenesis	O
,	O
mediated	O
by	O
its	O
high	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
,	O
which	O
is	O
six	O
times	O
that	O
of	O
natural	O
insulin48	O
,	O
49Whilst	O
insulin	O
detemir	O
has	O
a	O
lower	O
binding	O
affinity	O
to	O
the	O
IGF	O
-	O
1	O
receptor	O
than	O
natural	O
insulin	O
,	O
there	O
is	O
even	O
less	O
information	O
regarding	O
its	O
use	O
in	O
pregnancy	O
.	O

Antiproliferative	O
and	O
proapoptotic	O
activity	O
of	O
vitamin	O
D3	O
has	O
been	O
noted	O
in	O
model	O
glioma	O
cell	O
lines	O
and	O
a	O
primary	O
culture	O
,	O
as	O
well	O
as	O
tumor	O
tissue	O
experiments	O
[	O
145	O
].	O

This	O
kind	O
of	O
damage	O
has	O
been	O
implicated	O
in	O
cancer	O
induction	O
.	O

Because	O
it	O
is	O
possible	O
to	O
consume	O
fish	O
and	O
seafood	O
safely	O
during	O
pregnancy	O
,	O
through	O
following	O
recommendations	O
to	O
limit	O
high	O
mercury	O
species	O
,	O
it	O
is	O
prudent	O
to	O
recommend	O
that	O
pregnant	O
women	O
consume	O
these	O
foods	O
,	O
rather	O
than	O
rely	O
on	O
supplementation	O
,	O
in	O
order	O
to	O
maximise	O
infant	O
neurodevelopment	O
outcomes	O
.	O

Results	O
A	O
total	O
of	O
1055	O
newborns	O
were	O
included	O
in	O
the	O
study	O
:	O
62	O
.	O
4	O
%	O
were	O
African	O
Americans	O
and	O
49	O
.	O
4	O
%	O
were	O
female	O
.	O

[	O
20	O
]	O
included	O
the	O
home	O
environment	O
as	O
a	O
confounder	B
,	O
but	O
not	O
paternal	O
IQ	O
.	O

The	O
condition	O
may	O
be	O
defined	O
as	O
a	O
chronic	O
neurodevelopmental	O
disorder	O
that	O
first	O
becomes	O
prevalent	O
in	O
an	O
individual	O
during	O
his	O
/	O
her	O
early	O
childhood	O
.	O

In	O
summer	O
,	O
light	O
-	O
skinned	O
people	O
who	O
spend	O
at	O
least	O
15	O
minutes	O
outside	O
during	O
the	O
day	O
with	O
their	O
hands	O
and	O
face	O
exposed	O
will	O
have	O
adequate	O
vitamin	O
D	O
levels	O
.	O

We	O
used	O
targeted	O
sequencing	O
of	O
the	O
16S	O
rRNA	O
V4	O
-	O
V5	O
hypervariable	O
region	O
to	O
characterize	O
infant	O
gut	O
microbiota	O
.	O

Conclusion	O
In	O
conclusion	O
,	O
lower	O
early	O
pregnancy	O
25OHD	O
was	O
associated	O
with	O
pregnancy	O
loss	O
.	O

Drugs	O
All	O
nonprescription	O
drugs	O
(	O
eg	O
,	O
antiacids	O
)	O
should	O
be	O
avoided	O
during	O
pregnancy	O
and	O
lactation	O
unless	O
recommended	O
by	O
a	O
physician	O
;	O
patients	O
should	O
avoid	O
intake	O
of	O
any	O
medication	O
including	O
over	O
-	O
the	O
-	O
counter	O
substances	O
without	O
consulting	O
their	O
physicians	O
.	O

Results	O
:	O
The	O
infants	O
were	O
followed	O
up	O
for	O
a	O
mean	O
duration	O
of	O
10	O
.	O
19	O
±	O
2	O
.	O
83	O
months	O
.	O

Though	O
consistent	O
with	O
studies	O
of	O
men	O
and	O
non	O
-	O
pregnant	O
women	O
,	O
larger	O
prospective	O
studies	O
that	O
include	O
objective	O
measures	O
of	O
sleep	O
duration	O
,	O
sleep	O
quality	O
,	O
and	O
sleep	O
apnea	O
during	O
pregnancy	O
are	O
needed	O
to	O
confirm	O
our	O
findings	O
.	O

Even	O
during	O
pregnancy	O
,	O
US	O
guided	O
fine	O
-	O
needle	O
aspiration	O
biopsy	O
(	O
FNA	O
)	O
is	O
the	O
investigation	O
of	O
choice	O
,	O
thanks	O
to	O
its	O
reliability	O
and	O
safety1926	O
.	O

Background	O
Pregnancy	O
and	O
fetal	O
development	O
are	O
periods	O
of	O
rapid	O
growth	O
and	O
cell	O
differentiation	O
when	O
mother	O
and	O
offspring	O
are	O
vulnerable	O
to	O
changes	O
in	O
dietary	O
supply	O
.	O

In	O
addition	O
to	O
clinical	O
similarity	O
,	O
AAOC	O
could	O
be	O
misdiagnosed	B
as	O
PG	O
with	O
ossification	O
because	O
of	O
the	O
vascular	O
and	O
bony	O
growth	O
on	O
histology	O
.	O

Methods	O
/	O
design	O
The	O
effect	O
of	O
the	O
early	O
use	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
on	O
neonatal	O
mortality	O
will	O
be	O
examined	O
using	O
a	O
community	O
based	O
,	O
cluster	O
randomised	O
controlled	O
trial	O
in	O
five	O
districts	O
with	O
30	O
,	O
000	O
live	O
births	O
.	O

Among	O
the	O
animals	O
used	O
for	O
the	O
microarray	O
expression	O
analysis	O
,	O
weaners	O
of	O
the	O
LP	O
group	O
showed	O
numerically	O
but	O
not	O
significantly	O
lower	O
body	O
weight	O
than	O
the	O
AP	O
group	O
,	O
(	O
LP	O
:	O
7	O
.	O
24	O
±	O
1	O
.	O
56	O
kg	O
,	O
AP	O
:	O
7	O
.	O
59	O
±	O
2	O
.	O
14	O
kg	O
,	O
P	O
=	O
0	O
.	O
30	O
,	O
n	O
=	O
32	O
).	O

Heat	O
stress	O
can	O
also	O
negatively	O
affect	O
animal	O
performance	O
,	O
including	O
growth	O
,	O
milk	O
production	O
,	O
reproduction	O
,	O
feed	O
intake	O
,	O
overall	O
health	O
,	O
and	O
well	O
-	O
being	O
in	O
cattle	O
[	O
79	O
,	O
80	O
].	O

Central	O
administration	O
of	O
BMP8B	O
induced	O
thermogenesis	O
and	O
increased	O
core	O
temperature	O
,	O
leading	O
to	O
weight	O
loss	O
(	O
Contreras	O
et	O
al	O
.,	O
2014	O
).	O

In	O
contrast	O
,	O
a	O
lower	O
weight	O
at	O
birth	O
has	O
been	O
described	O
in	O
several	O
studies	O
when	O
the	O
calorie	O
-	O
restricted	O
diet	O
was	O
prolonged	O
to	O
birth	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

As	O
with	O
other	O
studies	O
,	O
dietary	O
calcium	O
deficiency	O
might	O
have	O
led	O
to	O
so	O
-	O
called	O
wastage	O
of	O
body	O
stores	O
of	O
vitamin	O
D	O
in	O
both	O
groups	O
,	O
affecting	O
the	O
maintenance	O
of	O
even	O
higher	O
vitamin	O
D	O
levels	O
in	O
the	O
intervention	O
group	O
.	O

Pathways	O
between	O
the	O
LP	O
stages	O
indicate	O
processes	O
and	O
metabolic	O
regulation	O
,	O
which	O
occur	O
in	O
the	O
LP	O
offspring	O
but	O
not	O
in	O
the	O
AP	O
offspring	O
in	O
the	O
corresponding	O
developmental	O
period	O
.	O

Women	O
with	O
T3	O
25OHD	O
concentrations	O
≥	O
100	O
nmol	O
/	O
L	O
and	O
30	O
–	O
50	O
nmol	O
/	O
L	O
had	O
lower	O
OR	O
for	O
LBW	O
(	O
OR	O
=	O
0	O
.	O
22	O
,	O
p	O
=	O
0	O
.	O
046	O
and	O
OR	O
=	O
0	O
.	O
07	O
,	O
p	O
=	O
0	O
.	O
017	O
,	O
respectively	O
),	O
compared	O
to	O
vitamin	O
D	O
deficiency	O
.	O

Abstract	O
:	O
SHORT	O
Higher	O
maternal	O
intake	O
of	O
sugar	O
in	O
pregnancy	O
may	O
increase	O
the	O
risk	O
of	O
allergy	O
and	O
allergic	O
asthma	O
in	O
the	O
offspring	O
http	O
://	O
ow	O
.	O
ly	O
/	O
zehc30bFswP	O
Introduction	O
There	O
has	O
been	O
considerable	O
interest	O
in	O
the	O
role	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
in	O
the	O
aetiology	O
of	O
childhood	O
asthma	O
and	O
atopy	O
[	O
1	O
].	O

To	O
further	O
evaluate	O
the	O
association	O
between	O
infant	O
birth	O
weight	O
and	O
repetitive	O
element	O
methylation	O
identified	O
in	O
the	O
univariate	O
analyses	O
,	O
controlled	O
for	O
confounders	O
,	O
we	O
used	O
multiple	O
linear	O
regression	O
.	O

Previous	O
studies	O
have	O
shown	O
that	O
BDNF	O
increases	O
serotonin	O
turnover	O
in	O
the	O
hypothalamus	O
,	O
30	O
,	O
31suggesting	O
that	O
the	O
effect	O
of	O
gestational	O
and	O
post	O
-	O
weaning	O
diets	O
on	O
BDNF	O
mRNA	O
levels	O
may	O
explain	O
some	O
compensatory	O
response	O
in	O
SeroR2A	O
expression	O
.	O

Other	O
neuro	O
-	O
oncogenic	O
viruses	O
implicated	O
in	O
gliomas	O
under	O
laboratory	O
conditions	O
include	O
human	O
adenovirus	O
type	O
12	O
and	O
Rous	O
sarcoma	O
virus	O
[	O
133	O
].	O

It	O
is	O
the	O
first	O
study	O
to	O
capture	O
mothers	O
’	O
overall	O
dietary	O
patterns	O
and	O
relate	O
them	O
to	O
child	O
leukemia	O
.	O

Cold	O
stress	O
stimulates	O
lipolysis	O
by	O
increasing	O
the	O
secretion	O
of	O
stress	O
hormones	O
including	O
epinephrine	O
and	O
norepinephrine	O
in	O
humans	O
[	O
101	O
].	O

BMP	O
-	O
7	O
can	O
also	O
affect	O
energy	O
homeostasis	O
by	O
acting	O
on	O
mature	O
brown	O
adipocytes	O
,	O
resulting	O
in	O
the	O
induction	O
of	O
UCP1	O
,	O
thereby	O
enhancing	O
thermogenesis	O
.	O

Thus	O
,	O
environmental	O
exposures	O
to	O
those	O
oocytes	O
and	O
spermatozoa	O
that	O
go	O
onto	O
produce	O
an	O
embryo	O
(	O
pre	O
-	O
conception	O
exposures	O
)	O
are	O
also	O
an	O
important	O
consideration	O
.	O

At	O
6	O
months	O
,	O
the	O
strongest	O
predictors	O
of	O
higher	O
WFA	O
z	O
-	O
scores	O
were	O
greater	O
percentage	O
of	O
calories	O
from	O
sweets	O
early	O
in	O
pregnancy	O
(	O
beta	O
=	O
0	O
.	O
30	O
;	O
t	O
=	O
3	O
.	O
2	O
;	O
P	O
=	O
0	O
.	O
002	O
)	O
and	O
also	O
greater	O
increases	O
in	O
percentage	O
of	O
calories	O
from	O
protein	O
during	O
pregnancy	O
beta	O
=	O
0	O
.	O
20	O
;	O
Table	O
3	O
).	O

Maximum	O
starch	O
utilization	O
can	O
be	O
achieved	O
by	O
optimizing	O
fermentation	O
of	O
starch	O
in	O
the	O
rumen	O
to	O
produce	O
propionate	O
(	O
gluconeogenic	O
precursor	O
)	O
and	O
maximizing	O
starch	O
digestion	O
and	O
absorption	O
in	O
the	O
small	O
intestine	O
.	O

Our	O
present	O
pilot	O
study	O
has	O
several	O
important	O
strengths	O
.	O

To	O
calculate	O
individual	O
food	O
intake	O
when	O
animals	O
were	O
housed	O
in	O
groups	O
,	O
total	O
food	O
intake	O
from	O
each	O
cage	O
was	O
measured	O
and	O
equally	O
divided	O
according	O
to	O
the	O
number	O
of	O
pups	O
per	O
cage	O
.	O

Alternatively	O
,	O
fructose	O
might	O
influence	O
atopic	O
immune	O
responses	O
by	O
conditioning	O
the	O
gut	O
microbiome	O
[	O
40	O
,	O
41	O
].	O

Already	O
widely	O
used	O
in	O
the	O
pharmaceutical	O
industry	O
for	O
developmental	O
toxicity	O
screening	O
,	O
zebrafish	O
models	O
appear	O
to	O
be	O
a	O
promising	O
alternative	O
to	O
mice	O
.	O

The	O
reaction	O
was	O
quenched	O
by	O
adding	O
10	O
mM	O
DTT	O
followed	O
by	O
20	O
mg	O
citric	O
acid	O
to	O
adjust	O
pH	O
to	O
approximately	O
pH	O
6	O
.	O
0	O
.	O

This	O
creates	O
a	O
hat	O
trick	O
of	O
DNA	O
damage	O
:	O
Uranium	O
’	O
s	O
radioactive42and	O
chemical43properties	O
both	O
can	O
harm	O
DNA	O
,	O
and	O
the	O
presence	O
of	O
arsenic	O
may	O
prevent	O
cells	O
from	O
repairing	O
the	O
damage	O
.	O

Thus	O
,	O
the	O
impact	O
of	O
early	O
IFA	O
supplements	O
on	O
neonatal	O
mortality	O
needs	O
confirmation	O
in	O
a	O
larger	O
scale	O
trial	O
.	O

[	O
6	O
]	O
While	O
treating	O
young	O
infants	O
with	O
acute	O
stridor	O
and	O
or	O
wheeze	O
,	O
it	O
would	O
be	O
prudent	O
to	O
consider	O
hypocalcemia	O
especially	O
when	O
one	O
or	O
several	O
risk	O
factors	O
are	O
present	O
.	O

Moreover	O
,	O
subsequent	O
studies	O
have	O
further	O
demonstrated	O
that	O
early	O
life	O
trauma	O
or	O
parental	O
stress	O
can	O
induce	O
altered	O
miRNA	O
expression	O
in	O
sperm	O
,	O
which	O
in	O
turn	O
can	O
transmit	O
behavioral	O
and	O
metabolic	O
abnormalities	O
through	O
to	O
the	O
next	O
murine	O
generation	O
(	O
Rodgers	O
et	O
al	O
.	O
2013	O
;	O
Gapp	O
et	O
al	O
.	O
2014	O
;	O
Rodgers	O
et	O
al	O
.	O
2015	O
).	O

The	O
problem	O
of	O
pregnancy	O
-	O
associated	O
thyroid	O
cancer	O
can	O
affect	O
three	O
groups	O
of	O
patients	O
:	O
New	O
diagnosis	O
Patients	O
with	O
no	O
prior	O
history	O
of	O
cancer	O
,	O
in	O
whom	O
a	O
malignant	O
thyroid	O
nodule	O
is	O
suspected	O
or	O
diagnosed	O
during	O
pregnancy	O
.	O

Key	O
components	O
in	O
terms	O
of	O
cell	O
cycle	O
regulation	O
are	O
cyclins	O
.	O

Analysis	O
of	O
data	O
from	O
the	O
Massachusetts	O
Male	O
Aging	O
Study	O
revealed	O
that	O
short	O
sleep	O
duration	O
at	O
baseline	O
(≤	O
5	O
or	O
6	O
hours	O
per	O
night	O
)	O
was	O
associated	O
with	O
elevated	O
risk	O
of	O
developing	O
incident	O
type	O
2	O
diabetes	O
after	O
adjustment	O
for	O
covariates	O
,	O
including	O
age	O
,	O
hypertension	O
,	O
smoking	O
,	O
self	O
-	O
rated	O
health	O
,	O
waist	O
circumference	O
,	O
education	O
,	O
total	O
testosterone	O
and	O
cortisol	O
[	O
11	O
].	O

We	O
observed	O
consistent	O
associations	O
between	O
maternal	O
DHA	O
and	O
EPA	O
intake	O
and	O
infant	O
gut	O
microbiota	O
.	O

Therefore	O
,	O
it	O
is	O
crucial	O
for	O
dermatologists	O
to	O
be	O
aware	O
of	O
this	O
condition	O
,	O
as	O
it	O
is	O
rare	O
and	O
likely	O
often	O
misdiagnosed	B
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
study	O
to	O
have	O
examined	O
the	O
factors	O
that	O
influence	O
use	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
during	O
pregnancy	O
in	O
Eastern	O
Europe	O
.	O

[	O
15	O
]	O
evaluated	O
vitamin	O
D	O
status	O
in	O
a	O
younger	O
group	O
of	O
premenopausal	O
women	O
found	O
the	O
prevalence	O
of	O
vitamin	O
D	O
insufficiency	O
to	O
be	O
77	O
.	O
8	O
%,	O
which	O
was	O
as	O
high	O
as	O
the	O
rate	O
found	O
in	O
elderly	O
Thai	O
women	O
living	O
in	O
nursing	O
homes	O
.	O

This	O
was	O
the	O
first	O
use	O
of	O
a	O
newly	O
developed	O
questionnaire	O
,	O
which	O
we	O
administered	O
2	O
–	O
3	O
days	O
after	O
delivery	O
,	O
to	O
include	O
women	O
who	O
may	O
not	O
have	O
engaged	O
with	O
prenatal	O
care	O
.	O

Hypocalcemia	O
is	O
common	O
in	O
preterm	O
infants	O
,	O
infants	O
born	O
to	O
gestational	O
diabetic	O
mothers	O
and	O
infants	O
on	O
cow	O
'	O
s	O
milk	O
.	O

Effect	O
of	O
weaning	O
age	O
has	O
been	O
studied	O
in	O
Shorthorn	O
calves	O
[	O
52	O
].	O

The	O
continued	O
transcriptional	O
silencing	O
of	O
such	O
regions	O
is	O
essential	O
for	O
early	O
embryogenesis	O
and	O
genome	O
stability	O
,	O
respectively	O
.	O

Airborne	O
farm	O
pollutants	O
also	O
may	O
enter	O
the	O
home	O
environment	O
by	O
way	O
of	O
the	O
wind	O
,	O
after	O
spraying	O
,	O
gassing	O
,	O
or	O
open	O
-	O
air	O
application	O
.	O

The	O
lower	O
acceptance	O
to	O
novel	O
foods	O
has	O
been	O
found	O
in	O
animals	O
with	O
protein	O
deficiency	O
from	O
early	O
gestational	O
stages	O
(	O
Peregoy	O
et	O
al	O
.,	O
1972	O
;	O
Pettus	O
et	O
al	O
.,	O
1974	O
)	O
and	O
could	O
be	O
associated	O
with	O
abnormal	O
behaviors	O
in	O
adulthood	O
related	O
to	O
anxiety	O
(	O
Peleg	O
-	O
Raibstein	O
et	O
al	O
.,	O
2012	O
).	O

We	O
think	O
that	O
confounding	B
of	O
the	O
main	O
findings	O
by	O
lifestyle	O
or	O
other	O
aspects	O
of	O
maternal	O
diet	O
in	O
pregnancy	O
is	O
unlikely	O
,	O
as	O
we	O
controlled	O
for	O
numerous	O
potential	O
confounders	B
in	O
the	O
analyses	O
,	O
including	O
nutrients	O
and	O
foods	O
that	O
have	O
been	O
previously	O
linked	O
to	O
childhood	O
asthma	O
and	O
atopy	O
.	O

SIRT	O
Nampt	O
expression	O
increased	O
in	O
both	O
cell	O
models	O
in	O
the	O
course	O
of	O
bone	O
tissue	O
differentiation	O
from	O
multipotent	O
fibroblast	O
and	O
monopotent	O
pre	O
-	O
osteoblast	O
in	O
rats	O
.	O

All	O
these	O
mechanisms	O
play	O
critical	O
roles	O
throughout	O
normal	O
mammalian	O
development	O
,	O
particularly	O
during	O
early	O
embryo	O
and	O
germ	O
cell	O
development	O
(	O
Cook	O
&	O
Blelloch2013	O
;	O
Beaujean2014	O
;	O
Dean2014	O
;	O
Hale	O
et	O
al	O
.	O
2014	O
;	O
Luk	O
et	O
al	O
.	O
2014	O
;	O
Messerschmidt	O
et	O
al	O
.	O
2014	O
;	O
Mukherjee	O
et	O
al	O
.	O
2014	O
;	O
O	O
'	O
Doherty	O
&	O
McGettigan2014	O
;	O
Grote	O
&	O
Herrmann2015	O
;	O
Hogg	O
&	O
Western2015	O
;	O
Marcho	O
et	O
al	O
.	O
2015	O
).	O

Based	O
on	O
maternal	O
colostrum	O
visfatin	O
levels	O
,	O
the	O
aurors	O
were	O
able	O
to	O
predict	O
neonatal	O
weight	O
loss	O
in	O
the	O
first	O
three	O
days	O
of	O
birth	O
(	O
25	O
,	O
26	O
).	O

No	O
data	O
are	O
available	O
as	O
yet	O
with	O
regard	O
to	O
the	O
impact	O
of	O
early	O
leptin	O
administration	O
on	O
the	O
subsequent	O
“	O
browning	O
”	O
of	O
WAT	O
and	O
the	O
related	O
regulation	O
of	O
glucose	O
metabolism	O
,	O
as	O
well	O
as	O
the	O
response	O
to	O
hypercaloric	O
diets	O
later	O
in	O
life	O
in	O
the	O
offspring	O
.	O

Conclusions	O
Vitamin	O
D	O
deficiency	O
in	O
late	O
pregnancy	O
was	O
associated	O
with	O
higher	O
odds	O
of	O
SGA	O
and	O
LBW	O
.	O

Additionally	O
,	O
a	O
main	O
effect	O
of	O
sex	O
was	O
also	O
detected	O
on	O
the	O
gene	O
expression	O
of	O
Ppar	O
α	O
in	O
liver	O
.	O

Data	O
include	O
date	O
and	O
country	O
of	O
birth	O
,	O
marital	O
status	O
,	O
educational	O
level	O
,	O
home	O
language	O
,	O
employment	O
status	O
,	O
household	O
income	O
,	O
number	O
of	O
members	O
in	O
the	O
household	O
,	O
and	O
beneficiaries	O
of	O
social	O
grants	O
.	O

Unlike	O
the	O
previously	O
published	O
data	O
on	O
vitamin	O
D	O
in	O
the	O
Auckland	O
cohort	O
[	O
20	O
],	O
serum	O
25	O
(	O
OH	O
)	O
D	O
was	O
measured	O
using	O
the	O
IDS	O
-	O
iSYS	O
chemiluminescent	O
-	O
based	O
assay	O
(	O
Abacus	O
,	O
ALS	O
)	O
as	O
per	O
the	O
manufacturer	O
’	O
s	O
instructions	O
.	O

The	O
percentage	O
of	O
women	O
with	O
vitamin	O
D	O
insufficiency	O
and	O
deficiency	O
was	O
higher	O
in	O
the	O
first	O
than	O
in	O
the	O
third	O
trimester	O
of	O
pregnancy	O
but	O
the	O
prevalence	O
of	O
severe	O
vitamin	O
D	O
deficiency	O
was	O
higher	O
in	O
the	O
third	O
trimester	O
(	O
Table	O
3	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t003	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
in	O
pregnant	O
women	O
(	O
n	O
=	O
1311	O
)	O
(	O
Belgian	O
national	O
survey	O
on	O
vitamin	O
D	O
status	O
in	O
pregnant	O
women	O
,	O
2010	O
–	O
2011	O
).	O
All	O
womenWalloniaFlanders1sttrimester3rdtrimesterN1300453633633665Age28	O
.	O
5	O
±	O
5	O
.	O
127	O
.	O
9	O
±	O
5	O
.	O
528	O
.	O
8	O
±	O
4	O
.	O
728	O
.	O
3	O
±	O
5	O
.	O
128	O
.	O
8	O
±	O
5	O
.	O
1Gestational	O
weeks22	O
.	O
2	O
±	O
12	O
.	O
522	O
.	O
1	O
±	O
12	O
.	O
822	O
.	O
4	O
±	O
12	O
.	O
39	O
.	O
9	O
±	O
2	O
.	O
834	O
.	O
1	O
±	O
3	O
.	O
625	O
-(	O
OH	O
)	O
D	O
(	O
ng	O
/	O
ml	O
)	O
Median21	O
.	O
220	O
.	O
922	O
.	O
320	O
.	O
422	O
.	O
7	O
*	O
IQR13	O
.	O
8	O
–	O
30	O
.	O
013	O
.	O
5	O
–	O
29	O
.	O
114	O
.	O
6	O
–	O
30	O
.	O
613	O
.	O
6	O
–	O
26	O
.	O
714	O
.	O
3	O
–	O
34	O
.	O
195	O
%	O
CI20	O
.	O
5	O
–	O
22	O
.	O
219	O
.	O
8	O
–	O
22	O
.	O
321	O
.	O
2	O
–	O
23	O
.	O
219	O
.	O
3	O
–	O
21	O
.	O
121	O
.	O
6	O
–	O
24	O
.	O
4	O
%	O
<	O
10	O
ng	O
/	O
ml12	O
.	O
112	O
.	O
310	O
.	O
911	O
.	O
612	O
.	O
6	O
%	O
<	O
20	O
ng	O
/	O
ml44	O
.	O
645	O
.	O
742	O
.	O
347	O
.	O
042	O
.	O
3	O
%	O
<	O
30	O
ng	O
/	O
ml74	O
.	O
176	O
.	O
372	O
.	O
582	O
.	O
266	O
.	O
7	O
Different	O
from	O
first	O
trimester	O
pregnant	O
women	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O

We	O
have	O
shown	O
recently	O
that	O
feeding	O
a	O
diet	O
containing	O
10	O
-	O
fold	O
the	O
recommended	O
multivitamin	O
content	O
(	O
HV	O
)	O
to	O
Wistar	O
rats	O
during	O
pregnancy	O
results	O
in	O
increased	O
food	O
intake	O
,	O
obesity	O
and	O
characteristics	O
of	O
the	O
metabolic	O
syndrome	O
in	O
both	O
adult	O
male4and	O
female5offspring	O
weaned	O
to	O
the	O
recommended	O
vitamin	O
(	O
RV	O
)	O
diet	O
.	O

These	O
children	O
were	O
more	O
often	O
born	O
first	O
,	O
had	O
a	O
low	O
Apgar	O
score	O
,	O
and	O
tended	O
to	O
have	O
more	O
complications	B
[	O
8	O
].	O

Such	O
an	O
approach	O
would	O
also	O
respect	O
the	O
3Rs	O
.	O

However	O
,	O
the	O
associations	O
with	O
dietary	O
components	O
and	O
health	O
are	O
often	O
non	O
-	O
linear	O
with	O
advantageous	O
effects	O
of	O
a	O
balanced	O
nutrition	O
[	O
47	O
-	O
50	O
].	O

However	O
,	O
it	O
is	O
unknown	O
whether	O
changes	O
in	O
nutritional	O
programming	O
by	O
maternal	O
diet	O
restriction	O
during	O
fetal	O
development	O
could	O
modify	O
the	O
expression	O
of	O
ECS	O
components	O
later	O
in	O
life	O
and	O
lead	O
to	O
long	O
-	O
lasting	O
impact	O
on	O
energy	O
metabolism	O
and	O
feeding	O
behavior	O
.	O

RPMM	O
was	O
selected	O
for	O
this	O
analysis	O
because	O
we	O
have	O
demonstrated	O
that	O
RPMM	O
provides	O
more	O
consistent	O
clustering	O
and	O
more	O
robustness	O
in	O
the	O
selection	O
of	O
the	O
number	O
of	O
classes	O
because	O
of	O
its	O
hierarchical	O
presentation	O
of	O
classes	O
,	O
compared	O
with	O
metric	O
hierarchical	O
clustering	O
,	O
for	O
this	O
data	O
set	O
[	O
see	O
Supplemental	O
Material	O
,	O
Supplementary	O
Text	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

While	O
association	O
between	O
β	O
2	O
adrenergic	O
receptor	O
agonists	O
and	O
autism	O
spectrum	O
disorders	O
is	O
not	O
strong	O
,	O
exposure	O
to	O
terbutaline	O
during	O
the	O
third	O
trimester	O
has	O
shown	O
to	O
increase	O
incidence	O
.	O

The	O
means	O
at	O
each	O
time	O
point	O
and	O
for	O
hypothalamic	O
gene	O
expression	O
,	O
folate	O
status	O
and	O
glucose	O
response	O
were	O
compared	O
by	O
one	O
-	O
way	O
analysis	O
of	O
variance	O
using	O
the	O
PROC	O
GLM	O
followed	O
by	O
a	O
Tukey	O
’	O
s	O
post	O
-	O
hoc	O
test	O
.	O

Thus	O
,	O
the	O
researchers	O
suggest	O
that	O
excess	O
iron	O
supplementation	O
can	O
cause	O
the	O
same	O
problems	B
it	O
is	O
supposed	O
to	O
correct	O
.	O

Thyroid	O
nodules	O
in	O
pregnancy	O
are	O
often	O
misdiagnosed	B
because	B
of	O
physiological	O
thyroid	O
increases	O
during	O
pregnancy	O
,	O
but	O
clinical	O
and	O
ultrasound	O
findings	O
are	O
sufficient	O
to	O
suspect	O
malignancy	O
.	O

In	O
a	O
recent	O
population	O
-	O
based	O
cohort	O
study	O
in	O
Norway	O
,	O
it	O
was	O
shown	O
that	O
a	O
positive	O
association	O
exists	O
for	O
cesarean	O
delivery	O
and	O
risk	O
of	O
asthma	O
in	O
the	O
child	O
(	O
especially	O
when	O
the	O
cesarean	O
delivery	O
was	O
performed	O
because	B
of	O
an	O
emergency	O
in	O
contrast	O
to	O
a	O
planned	O
section	O
)	O
[	O
92	O
].	O

As	O
our	O
results	O
suggest	O
,	O
distinct	O
mechanisms	O
and	O
selective	O
pressures	O
are	O
likely	O
responsible	O
for	O
their	O
alteration	O
.	O

However	O
,	O
we	O
should	O
not	O
discard	O
a	O
predictive	O
marker	O
of	O
impaired	O
fetal	O
nutrition	O
in	O
those	O
cases	O
with	O
absence	O
of	O
low	O
birth	O
weight	O
.	O

By	O
use	O
of	O
the	O
randomisation	O
list	O
,	O
a	O
pharmacist	O
in	O
the	O
Department	O
of	O
Pharmacy	O
,	O
Aga	O
Khan	O
University	O
Hospital	O
,	O
Karachi	O
prepared	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
in	O
olive	O
oil	O
(	O
Sinochem	O
Ningbo	O
Laboratory	O
,	O
China	O
)	O
or	O
placebo	O
(	O
olive	O
oil	O
)	O
in	O
sealed	O
2	O
mL	O
plastic	O
syringes	O
labelled	O
with	O
the	O
unique	O
identification	O
numbers	O
.	O

Socio	O
-	O
demographic	O
characteristics	O
of	O
the	O
study	O
group	O
and	O
description	O
of	O
prenatal	O
care	O
The	O
mean	O
age	O
of	O
participants	O
was	O
27	O
.	O
5	O
years	O
:	O
63	O
.	O
8	O
%	O
were	O
aged	O
between	O
19	O
and	O
30	O
years	O
,	O
5	O
.	O
3	O
%	O
were	O
≤	O
18	O
years	O
and	O
8	O
.	O
8	O
%	O
were	O
aged	O
over	O
35	O
years	O
.	O

Regardless	O
of	O
vitamin	O
D	O
status	O
,	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
cathelicidin	O
concentrations	O
between	O
subjects	O
,	O
consistent	O
with	O
the	O
findings	O
of	O
other	O
recent	O
studies	O
[	O
6	O
,	O
7	O
,	O
12	O
,	O
14	O
,	O
17	O
,	O
20	O
].	O

If	O
a	O
child	O
was	O
not	O
seen	O
for	O
more	O
than	O
45	O
days	O
,	O
at	O
the	O
two	O
weekly	O
visits	O
,	O
or	O
at	O
the	O
hospital	O
,	O
they	O
were	O
censored	O
for	O
that	O
period	O
of	O
our	O
study	O
.	O

Intriguingly	O
,	O
our	O
data	O
indicated	O
that	O
either	O
male	O
or	O
female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
did	O
not	O
display	O
higher	O
caloric	O
intake	O
after	O
weaning	O
,	O
despite	O
of	O
the	O
fact	O
that	O
the	O
males	O
exhibited	O
greater	O
body	O
weight	O
at	O
adulthood	O
.	O

*	O
Studies	O
directly	O
sampling	O
the	O
target	O
tissue	O
or	O
validating	O
the	O
same	O
change	O
in	O
the	O
blood	O
and	O
target	O
tissue	O
of	O
an	O
appropriate	O
in	O
vivo	O
model	O
.	O

Thus	O
,	O
the	O
association	O
between	O
vitamin	O
D	O
status	O
and	O
risk	O
of	O
miscarriage	O
needs	O
further	O
investigation	O
.	O

In	O
a	O
population	O
-	O
based	O
Swedish	O
study	O
of	O
2	O
,	O
668	O
men	O
followed	O
for	O
10	O
-	O
years	O
,	O
investigators	O
reported	O
that	O
the	O
multivariable	O
adjusted	O
relative	O
risk	O
for	O
incident	O
type	O
2	O
diabetes	O
was	O
highest	O
for	O
obese	O
snorers	O
(	O
OR	O
=	O
7	O
.	O
0	O
;	O
95	O
%	O
CI	O
2	O
.	O
9	O
-	O
16	O
.	O
9	O
)	O
than	O
for	O
lean	O
non	O
-	O
snorers	O
[	O
38	O
].	O

Patients	O
with	O
active	O
DTC	O
can	O
be	O
reassured	O
that	O
,	O
as	O
mentioned	O
above	O
,	O
pregnancy	O
itself	O
does	O
not	O
appear	O
to	O
increase	O
disease	O
progression	O
,	O
and	O
therefore	O
a	O
gap	O
in	O
treatment	O
during	O
pregnancy	O
is	O
not	O
contraindicated	O
.	O

Further	O
studies	O
are	O
needed	O
to	O
better	O
elucidate	O
the	O
role	O
of	O
dietary	O
factors	O
and	O
specific	O
nutrients	O
in	O
the	O
risk	O
for	O
this	O
disease	O
.	O

TG	O
synthesis	O
is	O
a	O
key	O
factor	O
for	O
IMF	O
deposition	O
[	O
69	O
].	O

Autism	O
spectrum	O
disorders	O
in	O
childhood	O
have	O
also	O
been	O
observed	O
and	O
diagnosed	O
more	O
frequently	O
among	O
children	O
born	O
to	O
women	O
with	O
metabolic	O
conditions	O
identified	O
during	O
pregnancy	O
,	O
including	O
diabetes	O
and	O
obesity	O
[	O
47	O
].	O

Interpretation	O
of	O
the	O
findings	O
with	O
respect	O
to	O
mechanistic	O
connections	O
between	O
environmental	O
factors	O
,	O
epigenetic	O
changes	O
and	O
adverse	O
effects	O
in	O
the	O
target	O
organ	O
/	O
tissue	O
can	O
therefore	O
be	O
challenging	O
.	O

After	O
that	O
,	O
several	O
studies	O
have	O
validated	O
its	O
use	O
throughout	O
the	O
antenatal	O
period	O
[	O
37	O
–	O
39	O
].	O

Interaction	O
between	O
time	O
and	O
diet	O
,	O
time	O
and	O
sex	O
,	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
were	O
also	O
significant	O
[	O
F	O
(	O
16	O
,	O
58	O
)=	O
1	O
.	O
83	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
72	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
2	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
].	O

Little	O
is	O
known	O
about	O
the	O
dietary	O
behaviour	O
and	O
nutritional	O
status	O
of	O
pregnant	O
women	O
living	O
in	O
South	O
Africa	O
.	O

Low	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
during	O
pregnancy	O
is	O
reported	O
to	O
increase	O
the	O
risk	O
for	O
a	O
low	O
IQ	O
and	O
suboptimal	O
neuro	O
-	O
developmental	O
outcomes	O
in	O
childhood	O
[	O
10	O
],	O
factors	O
that	O
in	O
turn	O
are	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
adult	O
mental	O
disorders	O
like	O
schizophrenia	O
[	O
11	O
].	O

These	O
results	O
likely	O
indicate	O
that	O
the	O
up	O
-	O
expression	O
of	O
the	O
cannabinoid	O
receptors	O
in	O
the	O
hypothalamus	O
at	O
adulthood	O
may	O
result	O
from	O
a	O
lower	O
long	O
-	O
term	O
cannabinoid	O
activity	O
that	O
,	O
in	O
turn	O
,	O
could	O
be	O
produced	O
by	O
lower	O
levels	O
of	O
eCBs	O
and	O
N	O
-	O
acylethanolamines	O
(	O
NAEs	O
)	O
in	O
the	O
hypothalamus	O
of	O
male	O
offspring	O
as	O
was	O
previous	O
described	O
at	O
birth	O
(	O
Ramírez	O
-	O
López	O
et	O
al	O
.,	O
2016	O
).	O

Ironically	O
,	O
both	O
early	O
gestational	O
iron	O
-	O
deficiency	O
anemia	O
and	O
hemoconcentration	O
later	O
in	O
pregnancy	O
increase	O
the	O
risk	O
of	O
premature	O
birth	O
and	O
low	O
birth	O
weight	O
.	O

Therefore	O
,	O
pregnancy	O
following	O
thyroid	O
cancer	O
is	O
not	O
infrequent	O
,	O
and	O
about	O
10	O
%	O
of	O
thyroid	O
cancers	O
occurring	O
during	O
the	O
reproductive	O
years	O
are	O
diagnosed	O
during	O
pregnancy	O
or	O
in	O
the	O
early	O
post	O
-	O
partum	O
period	O
.	O

Following	O
background	O
subtraction	O
and	O
volume	O
normalization	O
of	O
all	O
gels	O
,	O
average	O
gels	O
were	O
created	O
for	O
each	O
group	O
to	O
assist	O
comparison	O
and	O
reduce	O
within	O
group	O
variations	O
.	O

The	O
results	O
demonstrated	O
that	O
terbutaline	O
increased	O
microglial	O
activation	O
in	O
the	O
subjects	O
'	O
cerebral	O
cortex	O
,	O
cerebellar	O
,	O
and	O
cerebrocortical	O
white	O
matter	O
[	O
23	O
].	O

N	O
—	O
sample	O
size7421	O
mother	O
-	O
child	O
pairs	O
.	O
135	O
mother	O
-	O
child	O
pairs5449	O
children	O
assessed	O
.	O
217	O
mother	O
-	O
child	O
pairs	O
.	O
MethodMeasured	O
fish	O
intake	O
during	O
at	O
32	O
weeks	O
gestation	O
by	O
Food	O
Frequency	O
Questionnaire	O
(	O
FFQ	O
)	O
during	O
.	O

This	O
is	O
an	O
exciting	O
area	O
of	O
study	O
;	O
especially	O
as	O
antibiotic	O
resistance	O
becomes	O
an	O
increasing	O
problem	B
.	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Data	O
collection	O
related	O
to	O
depression	O
,	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
were	O
done	O
by	O
a	O
trained	O
midwife	O
outside	O
the	O
research	O
team	O
.	O

Oesophageal	O
cancer	O
studies	O
in	O
the	O
Caspian	O
Littoral	O
of	O
Iran	O
:	O
results	O
of	O
a	O
case	O
-	O
control	O
study	O
.	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
,	O
compared	O
with	O
the	O
Standard	O
Care	O
group	O
(	O
Lifestyle	O
Advice	O
233	O
(	O
21	O
.	O
71	O
%)	O
vs	O
.	O
Standard	O
Care	O
233	O
(	O
21	O
.	O
90	O
%);	O
adjusted	O
relative	O
risk	O
(	O
aRR	O
)	O
0	O
.	O
99	O
;	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
82	O
to	O
1	O
.	O
18	O
;	O
p	O
=	O
0	O
.	O
88	O
).	O

[	O
6	O
]	O
sampled	O
women	O
in	O
gestational	O
week	O
26	O
–	O
28	O
,	O
and	O
found	O
a	O
higher	O
OR	O
for	O
SGA	O
than	O
the	O
two	O
studies	O
that	O
sampled	O
women	O
in	O
T1	O
.	O

An	O
above	O
average	O
level	O
of	O
nutritional	O
knowledge	O
was	O
significantly	O
associated	O
with	O
the	O
use	O
of	O
supplements	O
,	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
consultations	O
,	O
age	O
,	O
area	O
of	O
residence	O
or	O
formal	O
education	O
(	O
Table	O
5	O
),	O
but	O
also	O
when	O
the	O
interaction	O
effect	O
of	O
prenatal	O
care	O
and	O
formal	O
education	O
together	O
was	O
taken	O
into	O
consideration	O
(	O
Table	O
4	O
).	O

This	O
case	O
report	O
highlights	O
the	O
importance	O
of	O
measuring	O
serum	O
calcium	O
levels	O
in	O
infants	O
with	O
acute	O
stridor	O
and	O
or	O
wheeze	O
.	O

In	O
resource	O
-	O
poor	O
countries	O
,	O
rates	O
of	O
maternal	O
anaemia	O
remain	O
high	O
.	O

There	O
are	O
few	O
trials	O
examining	O
the	O
efficacy	O
of	O
dietary	O
therapy	O
for	O
GDM	O
,	O
However	O
,	O
a	O
cluster	O
randomized	O
controlled	O
study	O
has	O
provided	O
support	O
for	O
Medical	O
Nutrition	O
Therapy	O
(	O
MNT	O
)	O
for	O
GDM	O
,	O
as	O
recommended	O
by	O
the	O
American	O
Diabetes	O
Association	O
(	O
ADA	O
)	O
(	O
2004	O
).	O

This	O
adjunctive	O
therapy	O
is	O
supposed	O
to	O
destroy	O
occult	O
microscopic	O
carcinoma	O
within	O
the	O
thyroid	O
remnant	O
by	O
being	O
actively	O
trapped	O
both	O
by	O
normal	O
and	O
pathological	O
thyroid	O
cells	O
,	O
and	O
to	O
facilitate	O
follow	O
-	O
up	O
because	O
serum	O
thyroglobulin	O
(	O
HTG	O
)	O
measurements	O
are	O
more	O
reliable	O
after	O
the	O
destruction	O
of	O
residual	O
normal	O
thyroid	O
tissue	O
.	O

In	O
terms	O
of	O
seasonal	O
difference	O
,	O
during	O
autumn	O
,	O
the	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
level	O
in	O
the	O
group	O
who	O
took	O
Vitamin	O
D	O
supplements	O
was	O
significantly	O
higher	O
than	O
control	O
group	O
(	O
78	O
.	O
59	O
±	O
27	O
.	O
54	O
vs	O
46	O
.	O
18	O
±	O
18	O
.	O
77	O
nmol	O
/	O
L	O
,	O
p	O
=	O
0	O
.	O
045	O
).	O

This	O
could	O
lead	O
to	O
activation	O
of	O
TEs	O
,	O
and	O
abnormal	O
imprinting	O
and	O
gene	O
expression	O
.	O

The	O
mothers	O
with	O
depression	O
score	O
of	O
0	O
–	O
13	O
were	O
entered	O
in	O
the	O
study	O
.	O

Insulin	O
resistance	O
is	O
present	O
even	O
in	O
simple	O
obesity	O
,	O
without	O
hyperglycemia	O
,	O
indicating	O
a	O
fundamental	O
abnormality	O
of	O
insulin	O
signaling	O
in	O
states	O
of	O
excess	O
adipose	O
tissue	O
mass	O
.	O

In	O
vivo	O
testing	O
should	O
generally	O
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	O
needed	O
.	O

All	O
are	O
assured	O
that	O
participation	O
is	O
voluntary	O
and	O
that	O
participation	O
or	O
non	O
-	O
participation	O
in	O
the	O
study	O
will	O
not	O
affect	O
their	O
clinical	O
care	O
.	O

A	O
major	O
issue	B
in	O
sex	O
differences	O
is	O
the	O
need	O
for	O
control	O
the	O
estrous	O
phase	O
on	O
which	O
the	O
evaluations	O
were	O
performed	O
in	O
order	O
to	O
clarify	O
the	O
impact	O
of	O
sex	O
hormones	O
variations	O
in	O
the	O
female	O
.	O

The	O
findings	O
were	O
similar	O
to	O
the	O
overall	O
population	O
except	O
one	O
thing	O
.	O

2	O
.	O
5	O
.	O

The	O
significant	O
associations	O
of	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
with	O
childhood	O
atopy	O
and	O
atopic	O
asthma	O
remained	O
,	O
unattenuated	O
,	O
on	O
mutual	O
adjustment	O
for	O
paternal	O
(	O
respectively	O
,	O
maternal	O
)	O
post	O
-	O
natal	O
exposure	O
(	O
table	O
4and	O
supplementary	O
table	O
E4	O
,	O
respectively	O
).	O

To	O
account	O
for	O
differences	O
in	O
baseline	O
and	O
trajectories	O
of	O
infant	O
gut	O
microbial	O
profiles	O
,	O
we	O
stratified	O
analyses	O
by	O
delivery	O
mode	O
.	O

It	O
can	O
be	O
observed	O
that	O
a	O
slight	O
increase	O
in	O
fT4	O
and	O
a	O
reduction	O
in	O
TSH	O
occur	O
between	O
the	O
9thand	O
12thweeks	O
of	O
gestation	O
;	O
subsequently	O
,	O
HCG	O
levels	O
decrease	O
and	O
TSH	O
reaches	O
normal	O
non	O
-	O
pregnant	O
levels	O
.	O

Effects	O
of	O
an	O
antenatal	O
dietary	O
intervention	O
in	O
overweight	O
and	O
obese	O
women	O
on	O
6	O
month	O
infant	O
outcomes	O
:	O
follow	O
-	O
up	O
from	O
the	O
LIMIT	O
randomised	O
trial	O
Abstract	O
Background	O
The	O
immediate	O
impact	O
of	O
providing	O
an	O
antenatal	O
dietary	O
intervention	O
during	O
pregnancy	O
has	O
been	O
extensively	O
studied	O
,	O
but	O
little	O
is	O
known	O
of	O
the	O
effects	O
beyond	O
the	O
neonatal	O
period	O
.	O

(	O
2012	O
)*	O
Jiang	O
et	O
al	O
.	O

Some	O
validation	O
rules	O
will	O
be	O
set	O
in	O
the	O
application	O
to	O
prevent	O
errors	O
during	O
data	O
collection	O
.	O

Half	O
took	O
60	O
mg	O
of	O
iron	O
as	O
ferrous	O
sulfate	O
with	O
200	O
μg	O
of	O
folic	O
acid	O
and	O
1	O
μg	O
of	O
vitamin	O
B12once	O
a	O
day	O
;	O
the	O
others	O
took	O
double	O
this	O
dose	O
once	O
a	O
week	O
.	O

Bell	O
and	O
Greenwood	O
[	O
158	O
]	O
also	O
suggest	O
that	O
effects	O
of	O
fetal	O
programming	O
during	O
early	O
-	O
mid	O
-	O
gestation	O
on	O
postnatal	O
growth	O
or	O
composition	O
are	O
generally	O
minor	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

